data_2mjl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mjl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.388 -0.597 . . . . 73.51 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.551 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 74.21 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 75.11 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 72.52 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 75.03 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 74.41 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.32 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 74.04 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 64.13 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.631 ' HG2' HD13 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 75.45 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.682 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB1' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 64.21 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 71.24 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.701 ' HD1' HG23 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 75.31 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 73.11 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 75.23 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 73.34 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.54 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 72.14 111.714 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 75.32 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.841 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 83.0 t60 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 74.22 111.259 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.841 ' HB ' ' HD2' ' A' ' 38' ' ' HIS . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 72.5 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 71.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 74.12 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.4 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.32 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HD2' HD11 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 71.01 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.585 ' HB ' HD11 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.24 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 75.43 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 71.3 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 73.24 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.13 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 60.33 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.476 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 74.04 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 74.1 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 71.43 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 74.3 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 63.22 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 75.41 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 74.22 111.468 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 74.03 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.704 HD11 HG23 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD22 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 75.44 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 72.15 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 70.35 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 73.41 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.794 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 70.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.794 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 74.23 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 75.03 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 71.54 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 88' ' ' LYS . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 75.3 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.636 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 74.04 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.622 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 64.35 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.85 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.669 HD21 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 73.24 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 74.55 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 74.52 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.3 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 65.34 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' PRO . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 74.52 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 75.32 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 74.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' N ' HD21 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.885 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 74.12 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.605 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 8.0 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 70.52 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.885 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 70.31 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 62.31 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 74.41 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.478 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 64.13 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.704 HG23 HD11 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.56 ' HA ' HD22 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 74.24 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 73.13 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 70.41 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.56 HD22 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 71.41 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 65.13 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.605 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 71.01 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.63 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 74.33 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.85 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 74.05 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 72.31 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 74.2 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.631 HD13 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 72.22 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 75.32 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 71.42 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 74.51 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 75.2 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 74.54 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.6 ' O ' HG21 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 73.05 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 60.43 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 74.51 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.1 111.101 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 74.33 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 74.52 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.701 HG23 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 72.04 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.725 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 72.41 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 75.52 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.725 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 63.35 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.53 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 75.45 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.21 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.617 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 64.41 112.537 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.825 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 73.44 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.617 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 63.35 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 72.01 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.46 HD12 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 65.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 74.53 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.43 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.515 ' HB2' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 71.45 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 73.54 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.683 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.75 0.31 . . . . 74.15 110.698 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 75.34 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 74.22 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 73.21 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 72.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.784 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 75.23 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 72.43 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.784 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 74.24 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 52.44 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 74.43 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.528 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 73.32 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 63.44 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 72.52 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 74.31 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 75.53 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.578 HD22 HD12 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 75.31 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 75.41 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 73.42 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 74.21 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 72.43 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 74.51 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 72.34 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.524 HG23 HD13 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 55.32 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 75.31 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.35 109.317 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.52 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 74.4 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 73.45 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 72.13 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 71.35 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 74.32 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 71.44 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.533 HD21 ' HD2' ' A' ' 76' ' ' LYS . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 74.51 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HD2' HD21 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 75.52 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 62.21 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 74.52 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 62.13 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD11 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 74.2 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 74.54 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 73.25 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 74.21 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 71.23 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.683 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 75.13 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.624 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.595 ' HE3' ' HB2' ' A' ' 95' ' ' ALA . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 75.31 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 75.23 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 93' ' ' MET . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 73.01 109.805 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' OD2' HG13 ' A' ' 140' ' ' ILE . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 54.34 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 73.53 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.25 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 74.32 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 75.42 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 70.14 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.493 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.45 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' ' HB1' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 75.24 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.41 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 73.33 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 73.33 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 75.21 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' MET . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 75.34 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.69 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 73.15 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 65.04 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.4 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 74.21 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.536 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 74.13 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 61.3 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 74.43 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 64.32 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 65.34 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.924 ' HA ' HG12 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.924 HG12 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 75.54 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 61.31 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 70.52 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 73.12 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 73.24 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 74.02 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 65.23 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 74.2 111.657 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 75.24 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 71.13 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.627 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 75.22 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.778 ' HB ' ' HB3' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 75.13 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 75.14 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 75.53 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 44.53 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 75.4 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 65.33 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 75.31 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 74.14 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.42 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.439 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 73.04 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 75.54 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.52 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 72.41 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 74.23 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 71.44 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.699 -0.482 . . . . 64.34 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HE22 ' A' ' 60' ' ' GLN . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.92 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 73.52 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 65' ' ' LEU . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD11 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 75.41 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 74.44 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 75.45 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 63.14 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 55.1 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.618 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.54 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.596 ' HA ' HG11 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 73.12 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.21 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 71.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 72.42 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 72.54 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 72.2 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 75.33 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 75.04 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 74.41 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 75.23 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 60.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 71.34 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 74.4 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 75.11 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 74.14 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 65.2 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 71.22 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 t30 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 63.41 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.507 HE22 ' HB ' ' A' ' 6' ' ' ILE . 45.6 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 75.02 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 73.0 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' CB ' HD23 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 73.24 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.573 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 74.53 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 75.35 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 73.21 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.67 ' H ' HG23 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 74.24 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 72.14 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.553 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 64.53 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 74.25 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 64.53 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 74.31 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 65.32 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 75.13 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 72.13 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.92 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 74.11 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 73.43 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 74.11 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 72.13 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 74.42 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.476 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 72.52 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 75.32 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 75.15 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 73.44 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 75.22 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.552 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 75.53 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.472 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 65.23 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 75.34 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 73.42 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 74.21 111.735 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.23 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 74.34 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 75.41 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.12 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.684 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.35 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 73.42 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 75.23 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.552 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.53 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 73.51 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 72.42 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.747 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.13 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 74.45 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 75.31 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 74.25 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 73.4 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.491 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 73.13 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.673 ' HB2' HD23 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 73.41 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.32 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 52.14 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 74.0 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 73.21 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 74.32 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 75.52 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 64.24 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 75.54 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.539 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 29' ' ' TRP . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 72.12 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.52 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 72.13 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.806 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 74.21 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 74.05 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.414 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.538 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 75.33 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.538 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 74.54 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.35 110.256 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 73.23 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.427 ' O ' HG21 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 74.01 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.806 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.2 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 70.13 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 74.14 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 74.41 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 74.31 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.689 0.28 . . . . 73.33 111.355 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 75.14 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.699 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 74.32 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.672 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 73.23 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 74.24 110.714 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.688 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 78.0 m-20 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 74.31 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 75.43 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 73.32 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 71.22 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 72.22 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 64.41 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 72.13 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.516 ' HD2' HG11 ' A' ' 153' ' ' VAL . 7.3 t-80 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 74.3 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.432 HD21 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' HD11 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 73.11 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.688 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 75.14 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 73.51 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD23 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 73.5 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 73.25 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 72.4 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.678 ' HB3' HD22 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 73.13 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.44 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 75.05 109.503 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 72.54 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 71.33 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 71.24 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 75.53 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 71.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 72.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 71.12 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.487 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 75.24 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 75.24 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 72.14 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.636 HD23 HD13 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 73.45 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.731 HD11 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 74.35 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 74.31 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 73.04 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.52 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.545 ' H ' HG23 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.535 HD21 ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 73.23 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 53.34 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 75.31 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 74.44 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.41 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 72.1 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 74.14 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 71.02 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.683 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 72.21 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 64.2 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 75.32 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.64 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.68 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 74.32 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.683 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 74.12 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 63.33 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 61.41 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 73.24 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HG12 ' A' ' 153' ' ' VAL . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 65.22 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 75.4 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 74.11 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.22 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.546 ' HB3' HD21 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 71.11 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.607 HG21 HD11 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 72.32 109.992 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 74.4 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.54 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 51.14 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 75.13 111.412 -176.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 72.41 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 74.54 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 70.13 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.683 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.52 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 71.44 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.589 ' H ' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 74.31 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 61.33 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 71.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.762 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 73.02 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 75.24 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 72.41 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 72.53 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 72.41 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 24' ' ' HIS . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 70.32 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 74.33 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.51 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 74.33 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 71.13 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 73.31 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.688 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.583 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.44 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 72.25 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.74 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 75.11 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 75.24 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.511 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 73.53 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 64.14 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.511 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 73.04 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 64.14 111.46 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 184' ' ' LEU . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 74.25 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 74.41 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 65.51 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 75.04 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 74.42 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 75.33 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.529 ' O ' HG11 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 71.13 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 70.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.056 -0.35 . . . . 74.32 110.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 71.53 110.653 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 73.4 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 73.25 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 74.42 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 75.4 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 63.34 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 73.45 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 74.44 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 73.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.691 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 72.03 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.524 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 74.31 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 75.32 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 64.05 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 74.52 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.22 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.83 HG11 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 75.22 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 75.11 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 75.34 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 74.41 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 74.2 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 75.51 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.32 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 74.21 111.705 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 74.42 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.403 ' HB3' ' HE3' ' A' ' 180' ' ' MET . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 72.05 111.06 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 74.12 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.849 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 74.14 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 71.31 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 74.53 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 73.42 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 73.22 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 74.53 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 72.24 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 75.34 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 74.05 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.697 HD23 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 70.44 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 70.24 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.672 ' HG2' HD22 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 74.23 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' CE1' ' A' ' 134' ' ' TYR . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 74.3 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 75.45 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.505 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 70.34 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 74.14 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.67 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.671 ' H ' HD22 ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 75.35 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 75.44 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.904 HD13 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 74.01 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 74.44 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 73.31 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.631 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 74.4 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 64.43 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.904 ' HG3' HD13 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 74.13 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.521 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.976 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 75.41 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 63.11 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 64.14 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.843 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 75.31 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 75.14 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.464 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 72.25 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 61.42 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 74.12 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HZ3' ' HB3' ' A' ' 126' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 72.32 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 72.3 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 74.32 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.672 HD22 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 74.3 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.976 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 75.41 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.67 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 72.05 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 72.13 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 75.01 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 74.22 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 75.15 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.33 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.462 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 75.14 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 75.4 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' HB3' ' OE1' ' A' ' 162' ' ' GLN . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 73.13 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 73.34 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 72.33 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 72.45 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 74.34 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 72.43 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.635 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 74.35 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 55.45 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 75.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 72.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 74.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD22 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 72.35 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 60' ' ' GLN . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 72.05 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.535 HD22 ' HG ' ' A' ' 179' ' ' LEU . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 74.15 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.421 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 75.43 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 72.14 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 75.53 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 71.11 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.42 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.631 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 73.23 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 73.34 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.493 0.187 . . . . 74.11 110.712 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' H ' ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.85 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 75.13 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.531 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 74.42 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 74.21 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 72.54 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 64.44 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.702 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 74.4 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 74.22 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.642 ' H ' HG23 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 74.52 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.787 ' HD1' HG23 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 74.3 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 71.23 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 75.22 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.43 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.13 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG12 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 73.55 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 65.21 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.699 HD22 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 71.05 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 70.34 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 70.45 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.33 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.603 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 75.12 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 73.42 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.406 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 64.11 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 73.23 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 63.13 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 73.23 111.038 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 1.039 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 74.33 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.507 HD12 ' HB1' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 75.24 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 71.12 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 73.13 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 73.32 112.781 -170.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 74.44 112.716 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.542 HD21 HD23 ' A' ' 73' ' ' LEU . 10.2 t30 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 73.03 112.822 -167.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.785 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 75.53 111.355 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 75.12 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 74.32 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.42 110.466 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 71.1 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 73.14 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 HD22 HD22 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 75.33 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.785 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 73.11 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 73.51 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.456 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.85 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 64.11 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.769 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 71.43 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.769 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.909 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 75.23 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.662 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 74.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 75.32 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 54.22 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.44 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 71.54 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.73 ' HA3' ' HB2' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 73.04 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 75.52 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.804 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 73.24 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.692 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.04 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 63.31 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.3 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 74.24 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 75.31 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 75.11 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 72.23 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.593 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 73.22 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.909 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 75.03 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.804 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 71.01 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 75.33 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 73.32 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 75.31 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.813 HD12 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 73.25 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 73.31 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 74.2 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 73.43 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 74.1 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 73.51 111.709 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 75.43 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 75.35 112.05 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.813 HG13 HD12 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 64.22 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 73.42 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 64.54 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 72.3 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.818 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 63.3 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 73.31 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 74.03 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 75.15 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 72.53 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.787 HG23 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 75.45 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 74.14 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.34 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.673 ' HB3' HD11 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.511 HD13 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 75.55 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 75.11 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 74.12 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 64.14 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.54 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.511 HH21 HD13 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 74.1 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.693 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 73.21 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.73 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 65.05 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.534 -0.543 . . . . 73.24 109.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 73.52 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 71.05 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.772 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 74.23 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.13 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 75.21 110.511 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 75.24 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 73.25 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.633 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.496 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.641 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 75.33 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.498 ' HB3' HG22 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.22 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.526 ' HA ' HG11 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 73.11 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 74.1 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 75.55 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 75.41 111.505 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 73.43 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 75.13 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 71.1 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 73.33 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 55.31 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 72.02 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 74.42 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 54.4 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 71.52 112.052 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 73.1 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.781 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 75.23 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 73.43 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 74.53 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 75.43 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 73.54 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 74.24 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 73.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 52.34 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 74.04 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 72.41 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 73.24 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.755 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 65.13 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.4 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.51 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 73.33 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.772 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 75.02 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 75.44 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.509 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 71.21 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.614 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.52 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE2' HG12 ' A' ' 6' ' ' ILE . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 71.15 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.757 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 60.31 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 70.31 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 45.25 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 74.44 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 73.24 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 75.33 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 73.52 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 65.02 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 73.11 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 65.25 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 74.05 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.42 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 71.11 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 126' ' ' LYS . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 62.15 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 75.45 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 65.14 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 131' ' ' LYS . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 130' ' ' ASN . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 75.42 111.258 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 72.12 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.768 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 74.53 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 75.13 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 75.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.757 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 65.43 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 74.51 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 65.34 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' HH ' ' A' ' 152' ' ' TYR . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 72.21 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.34 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 71.43 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.651 ' HH ' HG22 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 74.23 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.496 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 72.33 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 63.22 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.43 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.44 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 75.34 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.415 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 70.22 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.527 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 74.03 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 72.35 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 61.11 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 72.52 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 75.31 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 64.51 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 74.33 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 75.4 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 75.15 111.208 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 73.44 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.1 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.781 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 63.31 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.909 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 70.33 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 72.53 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 64.4 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 73.4 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 75.3 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 71.21 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 72.15 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.983 -0.377 . . . . 73.32 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.657 HD11 ' H ' ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.32 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG2' HE21 ' A' ' 60' ' ' GLN . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 74.05 113.035 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 64.02 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.533 ' HB3' ' HE2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 74.42 110.306 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 72.41 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 71.32 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 74.22 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.595 ' O ' HG21 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 73.3 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 71.11 111.044 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 63.14 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.475 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.511 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 74.23 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.41 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.751 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.24 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.557 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 74.32 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 64.33 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.723 ' HA ' HD23 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 75.13 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB3' HD21 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 73.3 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 64.33 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.51 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.844 ' HB3' HD13 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 73.51 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 73.4 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 75.32 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 62.34 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.844 HD13 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 74.22 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 70.4 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 75.13 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.723 HD23 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 75.55 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.857 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.23 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 74.22 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.695 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 71.14 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.578 HE21 ' HG2' ' A' ' 7' ' ' LYS . 58.0 tp60 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.857 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 74.54 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 73.41 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.574 ' H ' HG21 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 70.14 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 61.51 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HZ1' ' CG ' ' A' ' 122' ' ' ASP . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 73.31 110.925 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.512 HD13 HG21 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 74.31 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.668 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.652 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 72.4 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 73.11 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 74.15 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 74.31 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.623 ' HB2' HG22 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 75.22 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.522 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.522 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 74.0 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 75.31 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 64.33 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 73.15 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 74.24 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.582 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 75.31 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.609 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 73.33 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 61.41 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 54.43 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.706 ' HB3' HD21 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 74.51 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 64.14 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 64.44 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 74.24 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HD2' HD11 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 72.32 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 72.15 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.52 ' HA ' ' HZ1' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.32 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.497 HD11 HD21 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 74.01 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 74.25 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.497 HD21 HD11 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 64.54 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.758 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.55 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.582 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 73.44 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.485 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.771 HD12 ' HB3' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 74.55 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 63.4 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.733 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 73.1 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 64.24 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.47 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 73.25 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 74.21 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 74.52 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 73.23 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.511 ' HB2' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 70.31 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 75.11 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.475 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 74.11 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 72.41 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.733 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 74.34 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.61 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 72.24 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.751 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 65.44 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.676 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 72.32 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.61 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 73.52 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 73.51 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 73.25 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.711 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 72.33 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 73.22 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.711 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 75.31 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 61.14 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 74.3 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 75.41 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 74.12 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 75.33 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.579 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 70.13 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 71.15 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.656 -0.868 . . . . 65.45 108.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 73.14 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 74.22 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 74.32 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD21 HD23 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 64.11 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.21 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 45.3 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 71.13 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB1' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.647 ' H ' HG23 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.31 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 63.12 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HD1' HG22 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.701 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.31 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.878 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 73.25 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 75.44 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.947 ' HB3' HD13 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 64.21 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 73.22 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 75.31 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 70.55 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.14 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 74.12 109.679 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 74.14 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.54 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 55.53 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.43 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 72.25 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 75.22 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 75.23 109.049 172.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 75.03 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.538 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 75.51 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 74.35 110.424 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 74.31 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 75.33 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.84 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 71.41 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 73.33 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 72.11 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 73.11 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 75.52 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.31 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 75.21 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HA ' HD13 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD23 HD21 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.45 111.695 -171.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.799 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 75.01 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 71.01 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 70.44 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 75.41 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 53.33 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.764 HD13 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 75.14 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' HG21 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 60.41 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 74.4 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 75.24 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 73.03 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.764 ' HB2' HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.542 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 72.44 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 55.21 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 55.31 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 72.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 63.13 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 70.42 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 74.32 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.01 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 71.33 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.498 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 74.13 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 42.32 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.966 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 71.5 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 74.04 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 71.32 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.55 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 71.41 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.542 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 74.52 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 64.01 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 64.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG23 ' HB1' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 75.35 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 74.41 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 72.14 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 72.24 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 71.51 112.03 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 75.12 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 75.23 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 71.42 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 74.52 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 63.53 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB1' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.523 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 74.42 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 70.34 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 71.15 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.701 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.22 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 75.14 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 72.32 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 73.43 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.741 ' HA ' ' HE1' ' A' ' 180' ' ' MET . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 73.11 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.733 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 73.05 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.741 ' HE1' ' HA ' ' A' ' 177' ' ' GLU . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 74.13 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 62.42 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.733 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 74.53 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.53 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 73.12 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 74.15 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.601 ' HA ' HG21 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 73.31 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.04 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 74.32 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 74.11 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.638 HG13 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 62.02 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 73.24 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB1' HD12 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 72.34 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.712 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 71.44 112.581 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.24 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 73.42 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.548 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.525 ' ND2' ' HB1' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 73.43 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB1' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 55.31 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.784 ' HD1' HG23 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 74.31 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.549 ' HA ' HG11 ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 71.33 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 73.11 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 74.12 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HA ' HG13 ' A' ' 40' ' ' VAL . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 73.53 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.31 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 73.32 111.404 -173.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 62.33 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 75.23 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.33 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 73.13 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 73.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.932 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.31 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' HG ' HD11 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 75.21 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 73.31 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.575 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 75.42 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 55' ' ' LEU . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 75.23 111.681 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.53 HD11 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 73.21 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 75.43 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 73.22 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.932 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 65.34 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB1' ' A' ' 13' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 74.43 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 73.1 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 73.11 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 75.21 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 73.34 112.942 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.548 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 74.13 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.827 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 71.42 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.638 HG12 HG13 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 75.44 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.445 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 73.25 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 75.22 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 72.34 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 72.53 111.124 -175.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.654 ' HE1' HD13 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.43 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 72.42 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.627 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 73.11 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.748 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 72.12 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 62.01 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.627 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 73.41 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 63.22 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.548 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 74.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 43.22 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.7 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 71.52 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 55.3 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.549 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 75.14 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.616 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.707 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.402 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 70.32 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 52.4 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.32 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 72.24 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 74.44 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.548 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 72.43 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 75.02 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.591 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.52 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.5 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 74.02 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.827 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 74.21 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.22 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 73.11 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 74.35 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.1 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 64.12 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.707 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 73.14 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 HD12 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 75.24 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 60.55 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 64.03 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 71.43 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 60.31 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 61.43 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 75.34 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 73.21 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 74.3 112.945 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 63.13 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.525 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 73.44 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 73.54 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 74.44 111.295 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.51 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.526 ' HG2' ' HB2' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.32 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 70.45 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 72.12 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 75.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.512 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 73.45 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.784 HG23 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 72.12 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 75.41 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 64.11 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 71.12 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 75.41 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.692 ' HB3' HD22 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 61.11 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 64.14 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.2 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 75.43 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 73.53 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 54.32 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 73.2 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 73.01 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 72.1 110.094 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.616 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.12 111.196 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.746 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.725 0.298 . . . . 75.24 110.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 HG12 HD21 ' A' ' 184' ' ' LEU . 20.0 m -123.28 144.55 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.894 0.378 . . . . 71.04 110.766 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -83.59 -62.38 1.59 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.561 -0.533 . . . . 72.33 109.561 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -115.8 130.59 24.25 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.388 -0.597 . . . . 73.51 109.388 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.551 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 74.21 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 74.41 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 75.11 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 72.52 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 75.03 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 74.41 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.32 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 74.04 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 64.13 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.631 ' HG2' HD13 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 75.45 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.682 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB1' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 64.21 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 71.24 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.701 ' HD1' HG23 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 75.31 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 73.11 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 75.23 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.459 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 73.34 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.54 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 72.14 111.714 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 75.32 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.841 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 83.0 t60 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 74.22 111.259 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.841 ' HB ' ' HD2' ' A' ' 38' ' ' HIS . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 72.5 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 71.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 74.12 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.4 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.32 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' HD2' HD11 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 71.01 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.585 ' HB ' HD11 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.24 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 75.43 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 71.3 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 73.24 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.13 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 60.33 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.476 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 74.04 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 74.1 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 71.43 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 74.3 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 63.22 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 75.41 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 74.22 111.468 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 74.03 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.704 HD11 HG23 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD22 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 75.44 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 72.15 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 70.35 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 73.41 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.794 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 70.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.794 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 74.23 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 75.03 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 71.54 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 88' ' ' LYS . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 75.3 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.636 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 74.04 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.622 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 64.35 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.85 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.669 HD21 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 73.24 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 74.55 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 74.52 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.3 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 65.34 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' PRO . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 74.52 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 75.32 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 74.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' N ' HD21 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.885 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 74.12 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.605 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 8.0 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 70.52 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.502 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.885 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 70.31 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 62.31 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 74.41 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.478 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 64.13 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.704 HG23 HD11 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.56 ' HA ' HD22 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 74.24 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 73.13 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 70.41 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.56 HD22 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 71.41 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 65.13 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.605 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 71.01 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.63 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 74.33 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.85 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 74.05 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 72.31 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 74.2 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.631 HD13 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 72.22 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 75.32 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 71.42 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 74.51 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 75.2 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 74.54 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.6 ' O ' HG21 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 73.05 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 60.43 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 74.51 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.1 111.101 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 74.33 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 74.52 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.701 HG23 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 72.04 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.725 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 72.41 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 75.52 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.725 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 63.35 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.53 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 75.45 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.21 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.617 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 64.41 112.537 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.825 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 73.44 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.617 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 63.35 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 72.01 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.46 HD12 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 65.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 74.53 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.43 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.515 ' HB2' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 71.45 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 73.54 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.574 -0.528 . . . . 74.32 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.577 HG12 ' HH ' ' A' ' 134' ' ' TYR . 8.6 m -128.7 143.61 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 74.1 111.717 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.415 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 28.9 m -94.44 5.04 53.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 75.4 110.111 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.683 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 -97.6 108.85 47.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 74.15 110.698 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 3' ' ' SER . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 75.34 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 74.22 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 73.21 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 72.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.784 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 75.23 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 72.43 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.784 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 74.24 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 52.44 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 74.43 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.528 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 73.32 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.917 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 63.44 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 72.52 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 74.31 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 75.53 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.578 HD22 HD12 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 75.31 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 75.41 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 73.42 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 74.21 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' CD2' ' HB1' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 72.43 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.676 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 74.51 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 72.34 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.524 HG23 HD13 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 55.32 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 75.31 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.35 109.317 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.52 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 74.4 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 73.45 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 72.13 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 71.35 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 74.32 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 71.44 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.533 HD21 ' HD2' ' A' ' 76' ' ' LYS . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 74.51 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HD2' HD21 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 75.52 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 62.21 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 74.52 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.777 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 62.13 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD11 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 74.2 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 74.54 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 73.25 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 74.21 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 71.23 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.683 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 75.13 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.624 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.595 ' HE3' ' HB2' ' A' ' 95' ' ' ALA . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 75.31 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 75.23 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 93' ' ' MET . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 73.01 109.805 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' OD2' HG13 ' A' ' 140' ' ' ILE . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 54.34 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 73.53 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.25 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.69 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 74.32 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 75.42 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 70.14 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.493 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.45 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' ' HB1' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.777 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 75.24 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.41 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 73.33 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 73.33 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 75.21 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.577 ' HH ' HG12 ' A' ' 2' ' ' VAL . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 75.34 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.69 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 73.15 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 65.04 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD13 ' HB2' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.4 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 74.21 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.536 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 74.13 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 61.3 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 74.43 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 64.32 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 65.34 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.924 ' HA ' HG12 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.924 HG12 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 75.54 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 61.31 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 70.52 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 73.12 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 73.24 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 74.02 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 65.23 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 74.2 111.657 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 75.24 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.588 HG12 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.694 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 71.13 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.627 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 75.22 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.778 ' HB ' ' HB3' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 75.13 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 75.14 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 75.53 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 44.53 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.751 HD12 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 75.4 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 65.33 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 75.31 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 74.14 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.42 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.439 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 73.04 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 75.54 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.52 ' HB3' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 72.41 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 74.23 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 71.44 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.438 -0.578 . . . . 72.43 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -140.23 123.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.548 -0.751 . . . . 75.24 109.806 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -70.53 -23.97 62.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 70.15 110.128 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.97 116.35 59.8 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.083 -0.508 . . . . 64.34 109.699 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' HB ' HE22 ' A' ' 60' ' ' GLN . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.92 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 73.52 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.493 HD23 ' CB ' ' A' ' 65' ' ' LEU . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 74.11 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD11 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 75.41 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 74.44 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 75.45 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.747 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 63.14 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 55.1 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.618 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 72.54 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.596 ' HA ' HG11 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 73.12 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.21 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 71.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.694 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 72.42 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 72.54 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 72.2 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 75.33 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 75.04 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 74.41 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 75.23 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 60.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 71.34 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 74.4 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 75.11 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 74.14 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 65.2 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 71.22 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 t30 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 63.41 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.507 HE22 ' HB ' ' A' ' 6' ' ' ILE . 45.6 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.693 HD21 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 75.02 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 73.0 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' CB ' HD23 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 73.24 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.573 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 74.53 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 75.35 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 73.21 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.67 ' H ' HG23 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 74.24 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 72.14 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.553 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 64.53 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 74.25 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 64.53 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.629 HG12 HG23 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 74.31 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 65.32 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 75.13 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 72.13 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.92 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 74.11 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.466 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 73.43 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 74.11 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 72.13 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 74.42 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.436 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.476 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 72.52 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 75.32 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 75.15 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 73.44 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 75.22 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.552 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 75.53 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.472 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 65.23 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 75.34 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 73.42 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 74.21 111.735 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.23 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 74.34 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 75.41 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.12 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.684 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.35 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.435 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 73.42 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 75.23 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.552 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.53 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 73.51 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 72.42 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.747 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.13 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 74.45 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 75.31 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 74.25 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 73.4 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.491 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 73.13 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.673 ' HB2' HD23 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 73.41 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.32 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 52.14 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 74.0 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 73.21 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 74.32 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 75.52 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 64.24 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 75.54 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.539 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 29' ' ' TRP . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 72.12 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.52 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 72.13 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.806 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 74.21 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 74.05 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.414 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.538 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 75.33 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.538 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 74.54 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.35 110.256 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.617 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 73.23 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.427 ' O ' HG21 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 74.01 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.806 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.2 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 70.13 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 74.14 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 74.41 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 74.31 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.765 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 21.6 ttt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.283 -0.636 . . . . 73.41 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.765 ' H ' ' HG2' ' A' ' 1' ' ' MET . 37.5 t 76.14 -88.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.394 0.677 . . . . 73.21 109.835 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 7.7 t 171.91 -63.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.587 0.555 . . . . 72.21 110.273 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.496 ' OE1' ' HB3' ' A' ' 3' ' ' SER . 19.6 mp0 -99.21 132.83 22.7 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 73.33 111.355 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 75.14 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.699 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 74.32 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.672 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 73.23 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 74.24 110.714 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.688 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 78.0 m-20 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 74.31 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 75.43 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 73.32 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.617 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 71.22 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.688 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 72.22 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 64.41 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 72.13 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.516 ' HD2' HG11 ' A' ' 153' ' ' VAL . 7.3 t-80 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 74.3 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.432 HD21 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.859 ' HB2' HD11 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 73.11 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.688 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 75.14 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 73.51 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD23 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 73.5 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 73.25 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 72.4 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.678 ' HB3' HD22 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 73.13 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.44 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 75.05 109.503 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 72.54 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 71.33 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 71.24 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 75.53 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 71.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 72.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.33 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.525 HG21 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 71.12 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.487 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 75.24 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 75.24 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 72.14 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.919 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.636 HD23 HD13 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.868 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 73.45 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.731 HD11 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 74.35 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 74.31 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 73.04 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.52 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.545 ' H ' HG23 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.535 HD21 ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 73.23 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 53.34 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 75.31 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 74.44 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.41 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 72.1 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 74.14 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 71.02 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.683 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 72.21 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 64.2 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 75.32 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.749 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.64 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.68 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 74.32 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.683 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 74.12 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 63.33 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 61.41 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 73.24 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD22 HG12 ' A' ' 153' ' ' VAL . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.762 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 65.22 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 75.4 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 74.11 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.22 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.546 ' HB3' HD21 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 71.11 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.607 HG21 HD11 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 72.32 109.992 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 74.4 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.54 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 51.14 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 75.13 111.412 -176.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 72.41 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 74.54 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 70.13 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.683 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.52 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 71.44 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.589 ' H ' HD21 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 74.31 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.859 HD11 ' HB2' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 61.33 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 71.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.762 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 73.02 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 75.24 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 72.41 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 72.53 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 72.41 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG11 ' HD2' ' A' ' 24' ' ' HIS . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 70.32 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 74.33 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.51 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 74.33 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 71.13 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 73.31 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.688 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.74 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.583 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.44 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 72.25 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.74 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 75.11 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 75.24 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.511 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 73.53 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 64.14 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.511 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 73.04 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 64.14 111.46 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 1' ' ' MET . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 2' ' ' VAL . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 74.25 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 74.41 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 65.51 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 75.04 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 74.42 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 75.33 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.529 ' O ' HG11 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 71.13 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 70.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 111.321 0.119 . . . . 74.55 111.321 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.562 ' CG1' ' HG ' ' A' ' 184' ' ' LEU . 7.9 m -142.68 148.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 64.34 111.496 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -87.3 -32.57 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.563 -0.744 . . . . 75.34 110.083 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -104.69 125.43 33.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.537 -0.756 . . . . 74.32 110.056 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 71.53 110.653 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 73.4 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.71 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 73.25 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 74.42 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 75.4 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 63.34 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 73.45 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 74.44 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 73.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.691 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 72.03 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.524 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 74.31 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG11 HG12 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 75.32 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 64.05 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.83 ' HA ' HG11 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 74.52 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.22 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.83 HG11 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 75.22 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 75.11 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 75.34 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 74.41 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 74.2 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 75.51 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.32 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 74.21 111.705 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 74.42 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.403 ' HB3' ' HE3' ' A' ' 180' ' ' MET . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 72.05 111.06 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 74.12 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.849 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 74.14 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 71.31 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 74.53 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.587 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 73.42 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 73.22 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 74.53 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 72.24 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 75.34 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 74.05 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.697 HD23 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 70.44 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 70.24 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.672 ' HG2' HD22 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 74.23 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' CE1' ' A' ' 134' ' ' TYR . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 74.3 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 75.45 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.505 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 70.34 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 74.14 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.67 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.671 ' H ' HD22 ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 75.35 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 75.44 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.904 HD13 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 74.01 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 74.44 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 73.31 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.631 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 74.4 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 64.43 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.904 ' HG3' HD13 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 74.13 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.521 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.976 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 75.41 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 63.11 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 64.14 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.843 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 75.31 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 75.14 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.464 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 72.25 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 61.42 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 74.12 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.476 ' HZ3' ' HB3' ' A' ' 126' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 72.32 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 72.3 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 74.32 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.672 HD22 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 74.3 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.976 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 75.41 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.67 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 72.05 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 72.13 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.459 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 75.01 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 74.22 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 75.15 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.33 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.462 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 75.14 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 75.4 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' HB3' ' OE1' ' A' ' 162' ' ' GLN . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 73.13 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 73.34 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 72.33 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 72.45 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.718 HG12 HG11 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 74.34 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 72.43 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.635 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 74.35 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 55.45 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.434 ' HB3' HD12 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 75.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 72.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 74.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD22 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 72.35 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.403 ' HE3' ' HB3' ' A' ' 60' ' ' GLN . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 72.05 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.562 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 74.15 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.421 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 75.43 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 72.14 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 75.53 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 71.11 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.42 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.42 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.631 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 73.23 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 73.34 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.753 0.311 . . . . 74.3 111.036 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.48 106.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.385 . . . . 75.12 110.871 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.4 t -80.5 -57.35 3.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 75.01 110.402 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 -134.31 123.78 16.81 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.712 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' H ' ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.85 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 75.13 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.531 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 74.42 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 74.21 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.702 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 72.54 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 64.44 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.702 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 74.4 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 74.22 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.642 ' H ' HG23 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 74.52 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB2' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.787 ' HD1' HG23 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 74.3 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 71.23 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.699 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 75.22 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.43 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.13 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG12 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 73.55 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 65.21 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.699 HD22 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 71.05 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 70.34 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 70.45 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.33 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.603 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 75.12 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 73.42 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.406 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 64.11 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 73.23 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.947 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 63.13 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 73.23 111.038 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 1.039 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG22 HG21 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 74.33 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.507 HD12 ' HB1' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 75.24 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 71.12 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 73.13 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 73.32 112.781 -170.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 74.44 112.716 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.542 HD21 HD23 ' A' ' 73' ' ' LEU . 10.2 t30 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 73.03 112.822 -167.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.785 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 75.53 111.355 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 75.12 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 74.32 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.42 110.466 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 71.1 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 73.14 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 HD22 HD22 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 75.33 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.785 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 73.11 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.785 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 73.51 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.456 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.85 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 64.11 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.769 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 71.43 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.769 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.909 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 75.23 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.662 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 74.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 75.32 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 54.22 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.44 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 71.54 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.73 ' HA3' ' HB2' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 73.04 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 75.52 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.804 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 73.24 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.692 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.04 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 63.31 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.3 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 74.24 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 75.31 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 75.11 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 72.23 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.593 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 73.22 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.909 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 75.03 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.804 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 71.01 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 75.33 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 73.32 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 75.31 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.813 HD12 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 73.25 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 73.31 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 74.2 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 73.43 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 74.1 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 73.51 111.709 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 75.43 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 75.35 112.05 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.813 HG13 HD12 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 64.22 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 73.42 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 64.54 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 72.3 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.818 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 63.3 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 73.31 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 74.03 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 75.15 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 72.53 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.787 HG23 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 75.45 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 74.14 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.34 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.673 ' HB3' HD11 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.511 HD13 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 75.55 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 75.11 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 74.12 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 64.14 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.54 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.511 HH21 HD13 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 74.1 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.693 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 73.21 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.73 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 65.05 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.657 0.265 . . . . 73.04 110.718 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 m -105.66 108.93 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 74.14 111.023 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -70.08 -51.71 29.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 75.03 110.739 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -115.96 97.71 49.76 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.775 -0.648 . . . . 73.24 109.534 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 73.52 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 71.05 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.772 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.511 ' H ' HD22 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 74.23 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.13 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 75.21 110.511 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 75.24 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 73.25 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.633 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.496 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.641 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.858 ' HB3' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 75.33 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.498 ' HB3' HG22 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.22 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.526 ' HA ' HG11 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 73.11 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 74.1 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 75.55 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 75.41 111.505 -176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 73.43 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 75.13 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 71.1 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 73.33 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 55.31 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 72.02 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 74.42 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 54.4 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.538 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 71.52 112.052 -175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 73.1 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.781 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 75.23 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 73.43 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 74.53 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.735 HD11 HD21 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 75.43 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 73.54 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 74.24 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 73.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 52.34 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 74.04 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 72.41 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 73.24 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.755 ' HA ' HD23 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.735 HD21 HD11 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 65.13 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.503 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.4 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.51 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 73.33 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.772 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 75.02 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 75.44 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.509 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 71.21 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.614 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.52 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.496 ' HE2' HG12 ' A' ' 6' ' ' ILE . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 71.15 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.477 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.757 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 60.31 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 70.31 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 45.25 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 74.44 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 73.24 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 75.33 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 73.52 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 65.02 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 73.11 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 65.25 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 74.05 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.42 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 71.11 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' CG ' ' HZ3' ' A' ' 126' ' ' LYS . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 62.15 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 75.45 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 65.14 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 131' ' ' LYS . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' H ' ' HB3' ' A' ' 130' ' ' ASN . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 75.42 111.258 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 72.12 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.768 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 74.53 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 75.13 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 75.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.757 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 65.43 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 74.51 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 65.34 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.651 HG22 ' HH ' ' A' ' 152' ' ' TYR . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 72.21 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.34 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 71.43 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.651 ' HH ' HG22 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 74.23 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.496 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 72.33 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 63.22 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.43 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.44 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 75.34 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.415 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 70.22 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.527 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 74.03 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 72.35 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 61.11 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 72.52 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 75.31 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 64.51 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 74.33 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 75.4 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.721 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 75.15 111.208 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 73.44 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.1 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.781 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 63.31 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.909 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 70.33 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 72.53 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 64.4 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.909 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 73.4 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 75.3 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 71.21 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 72.15 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.759 0.314 . . . . 74.41 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.73 103.76 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.461 0.648 . . . . 75.31 111.945 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -90.79 -44.38 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.145 -0.934 . . . . 64.45 109.532 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -117.34 92.9 41.53 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.05 -0.977 . . . . 73.32 109.983 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.657 HD11 ' H ' ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.32 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG2' HE21 ' A' ' 60' ' ' GLN . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 74.05 113.035 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 64.02 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.533 ' HB3' ' HE2' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 74.42 110.306 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 72.41 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 71.32 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 74.22 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.595 ' O ' HG21 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 73.3 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 71.11 111.044 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 71.12 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.595 HG21 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 63.14 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.475 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.511 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 74.23 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.41 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.771 ' HB3' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.751 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.24 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.557 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 74.32 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 64.33 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.723 ' HA ' HD23 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 75.13 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.464 ' HB3' HD21 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.573 HG12 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 73.3 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 64.33 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.51 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.844 ' HB3' HD13 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 73.51 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 73.4 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 75.32 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 62.34 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.844 HD13 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 74.22 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 70.4 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 75.13 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.723 HD23 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 75.55 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.857 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.23 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 74.22 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.695 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 71.14 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.578 HE21 ' HG2' ' A' ' 7' ' ' LYS . 58.0 tp60 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.857 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.713 HD12 HD13 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 74.54 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 73.41 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.574 ' H ' HG21 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.638 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 70.14 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 61.51 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HZ1' ' CG ' ' A' ' 122' ' ' ASP . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 73.31 110.925 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.512 HD13 HG21 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 74.31 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.668 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.668 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.652 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 72.4 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 73.11 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 74.15 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.758 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.431 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 74.31 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.623 ' HB2' HG22 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 75.22 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.522 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.522 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 74.0 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 75.31 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 64.33 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 73.15 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 74.24 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.582 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.55 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 75.31 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.609 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 73.33 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 61.41 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 54.43 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.706 ' HB3' HD21 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 74.51 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 64.14 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 64.44 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 74.24 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HD2' HD11 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' CG ' ' HZ1' ' A' ' 76' ' ' LYS . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.512 HG21 HD13 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 72.32 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 72.15 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.52 ' HA ' ' HZ1' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.32 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.497 HD11 HD21 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 74.01 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 74.25 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.497 HD21 HD11 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 64.54 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.758 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.55 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.582 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 73.44 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.485 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.771 HD12 ' HB3' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 74.55 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 63.4 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.733 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 73.1 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 64.24 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.47 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 73.25 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 74.21 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 74.52 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 73.23 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.511 ' HB2' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 70.31 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 75.11 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.475 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 74.11 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 72.41 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.733 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 74.33 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 74.34 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.61 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 72.24 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.751 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 65.44 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.676 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 72.32 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.61 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 73.52 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 73.51 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 73.25 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.695 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.711 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 72.33 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 73.22 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.711 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 75.31 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 61.14 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 74.3 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 75.41 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 74.12 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 75.33 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.579 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 70.13 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 71.15 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.861 -0.422 . . . . 63.05 109.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.17 137.12 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 71.21 109.545 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -82.02 -43.08 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 74.14 108.654 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 -107.42 119.49 50.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.656 -0.868 . . . . 65.45 108.656 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 73.14 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 74.22 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 74.32 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD21 HD23 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 64.11 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.7 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.21 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 45.3 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 71.13 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HD3' ' HB1' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.647 ' H ' HG23 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.31 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 63.12 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HD1' HG22 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.701 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.31 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.878 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 73.25 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 75.44 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.947 ' HB3' HD13 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 64.21 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 73.22 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 75.31 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 70.55 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.14 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 74.12 109.679 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 74.14 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.54 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 55.53 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.43 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 72.25 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.947 HD13 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 75.22 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 75.23 109.049 172.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 75.03 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.538 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 75.51 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 74.35 110.424 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 74.31 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.7 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 75.33 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.84 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 71.41 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 73.33 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 72.11 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 73.11 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 75.52 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.31 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 75.21 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HA ' HD13 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD23 HD21 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.677 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.677 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.45 111.695 -171.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.799 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.799 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 75.01 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 71.01 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 70.44 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 75.41 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 53.33 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.764 HD13 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 75.14 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' HG21 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 60.41 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 74.4 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 75.24 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 73.03 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.764 ' HB2' HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.542 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.492 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 72.44 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 55.21 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 55.31 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 72.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 63.13 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.696 ' HB2' HD21 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 70.42 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 74.32 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.01 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 71.33 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.498 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 74.13 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 42.32 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.966 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 71.5 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 74.04 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 71.32 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.55 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 71.41 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.542 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 74.52 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 64.01 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 64.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG23 ' HB1' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 75.35 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 74.41 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 72.14 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 72.24 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 71.51 112.03 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.53 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 75.12 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 75.23 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 71.42 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 74.52 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 63.53 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' HB1' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.523 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 74.42 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 70.34 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 71.15 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.701 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.22 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 75.14 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 72.32 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 73.43 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.741 ' HA ' ' HE1' ' A' ' 180' ' ' MET . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 73.11 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.733 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 73.05 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.741 ' HE1' ' HA ' ' A' ' 177' ' ' GLU . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 74.13 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 62.42 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.733 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 74.53 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.53 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 73.12 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 74.15 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.601 ' HA ' HG21 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.587 HD21 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 73.31 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.04 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 74.32 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.936 0.398 . . . . 75.14 110.521 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.26 146.51 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.128 -0.487 . . . . 73.25 109.753 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -70.17 -42.4 72.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 74.22 109.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -134.96 149.04 69.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD11 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 74.11 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.638 HG13 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 74.2 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 62.02 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 73.24 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HB1' HD12 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 72.34 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.712 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 71.44 112.581 -174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.24 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 73.42 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.548 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.525 ' ND2' ' HB1' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.915 ' HB2' HD13 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 73.43 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' HB1' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 55.31 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.784 ' HD1' HG23 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 74.31 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.549 ' HA ' HG11 ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 71.33 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 73.11 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 74.12 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HA ' HG13 ' A' ' 40' ' ' VAL . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 73.53 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.31 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' HD1' ' HB ' ' A' ' 40' ' ' VAL . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 73.32 111.404 -173.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 62.33 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 75.23 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.33 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 73.13 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 73.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.932 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.31 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' HG ' HD11 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 75.21 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 73.31 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.575 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 75.42 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 55' ' ' LEU . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 75.23 111.681 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.53 HD11 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 73.21 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 75.43 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 73.21 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 73.22 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.932 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 65.34 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB1' ' A' ' 13' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 74.43 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 73.1 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 73.11 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 75.21 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 73.34 112.942 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.548 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 74.13 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.827 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 71.42 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.638 HG12 HG13 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 75.44 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.445 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 73.25 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.654 HD13 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 75.22 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 72.34 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 72.53 111.124 -175.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.654 ' HE1' HD13 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.43 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 72.42 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.627 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 73.11 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.748 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 72.12 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 62.01 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.627 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 73.41 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 63.22 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.548 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 74.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 43.22 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.7 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 71.52 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 55.3 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.549 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 75.14 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.616 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.707 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.402 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 72.41 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 70.32 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 52.4 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.32 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 72.24 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 74.44 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.548 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 72.43 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 75.02 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.591 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.52 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.5 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 74.02 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.827 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 74.21 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.22 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 73.11 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 74.35 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.1 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.515 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 64.12 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.707 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 73.14 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.915 HD13 ' HB2' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 HD12 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 75.24 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 60.55 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 64.03 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 71.43 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 60.31 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 61.43 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.464 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 75.34 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 73.21 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 74.3 112.945 -173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 63.13 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.525 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 73.44 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 73.54 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 74.44 111.295 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.51 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.526 ' HG2' ' HB2' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.32 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 70.45 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 72.12 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 75.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.512 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 73.45 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.784 HG23 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 72.12 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 75.41 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 64.11 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 71.12 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 75.41 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.692 ' HB3' HD22 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 61.11 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.4 HD13 HD12 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 64.14 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.2 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 75.43 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 73.53 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 54.32 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 73.2 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 73.01 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 72.1 110.094 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.616 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.12 111.196 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.746 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.388 -0.597 . . . . 65.44 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 53.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 62.02 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 44.24 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 54.23 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 73.23 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.2 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 63.51 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 63.31 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HG2' HD12 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 72.12 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.445 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.705 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 61.42 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 50.32 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.719 ' HD1' HG21 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 52.14 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 54.3 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 63.54 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 63.35 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 65.11 111.714 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 53.15 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 62.53 111.259 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t30 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 35' ' ' ALA . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 42.32 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 52.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 64.14 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.13 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.12 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.46 ' HD2' HD13 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 52.34 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.607 ' HB ' HD13 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.02 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 72.41 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 51.32 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 54.43 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.12 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 41.31 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 62.51 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 53.51 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 70.21 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 60.0 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 62.13 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 69' ' ' THR . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 70.11 111.468 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 63.43 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 54.22 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 62.23 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 50.02 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 63.33 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.834 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 62.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.834 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 72.41 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 65.13 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 61.13 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LEU . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 72.45 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 64.43 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.454 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 51.44 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 72.34 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 55.45 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 73.23 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.21 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 62.22 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 195' ' ' LYS . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 63.15 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 71.14 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 65.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' N ' HD23 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.904 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 70.34 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.608 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 51.3 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 44.53 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.904 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 53.33 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 33.24 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 50.23 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.436 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 63.24 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.754 HG22 HD12 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.591 ' HA ' HD21 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 71.11 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 64.42 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 65.52 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.591 HD21 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 51.33 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 50.22 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 64.24 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 72.53 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.846 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 71.13 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.517 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 70.45 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 64.14 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 42.34 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 60.33 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 61.12 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 64.22 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 72.22 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 72.13 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 63.31 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 44.3 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 63.21 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.04 111.101 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 71.15 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 25.03 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.719 HG21 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 62.23 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 55.53 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 31.44 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.733 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.47 ' SG ' HD13 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 60.44 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.854 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.33 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 74.25 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.1 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.628 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 61.32 112.537 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.854 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 62.43 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.628 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 62.55 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 64.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 62.32 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.15 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HB2' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 72.11 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 61.11 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 71.24 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.704 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.75 0.31 . . . . 74.15 110.698 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 74.33 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 73.3 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 45.13 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 65.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.925 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 71.33 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 60.01 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 71.01 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 43.01 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 73.13 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 64.01 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.925 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 63.14 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 61.52 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 54.45 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 73.44 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 71.13 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 73.02 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' GLU . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 71.24 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 71.01 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 63.53 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 71.53 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 73.12 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 71.3 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 44.44 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 62.11 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 63' ' ' ARG . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.02 109.317 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.25 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 60.04 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 51.2 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 62.01 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 65.33 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 64.44 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 61.05 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 72.52 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HD2' HD23 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 71.44 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 54.45 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 64.34 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 60.24 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 70.5 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HE1' HD12 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 72.44 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 60.11 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 73.23 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 54.04 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.704 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 61.22 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 74.33 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 71.55 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 70.04 109.805 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 32.54 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.53 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.516 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 63.22 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.01 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.718 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 70.33 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 74.32 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 50.34 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.23 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.796 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 60.15 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.25 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 64.22 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 70.35 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.584 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 72.1 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' MET . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 64.53 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.718 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 71.3 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 64.23 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.564 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB1' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.33 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 60.14 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.541 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 64.05 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 45.22 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 62.33 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 63.0 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 64.31 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.925 ' HA ' HG13 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 50.32 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 43.34 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 65.44 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 71.35 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 71.21 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 64.43 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 54.43 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 70.24 111.657 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.561 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 62.14 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.601 HG13 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.624 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 70.15 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.814 ' HB ' ' HB2' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 73.31 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.749 HD12 HD13 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 72.23 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.405 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 72.01 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 42.23 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.749 HD13 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 74.3 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 54.34 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 71.02 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB2' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 71.1 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.41 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 55.43 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 65.34 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 62.21 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 71.31 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 63.31 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.699 -0.482 . . . . 64.34 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 65.43 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 70.53 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 63.53 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.654 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 72.35 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.482 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.715 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 62.52 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 54.01 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 61.32 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 70.13 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.14 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 53.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 65.55 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 64.23 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 71.22 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 60.52 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 65.25 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 64.23 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 54.4 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 24.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 64.3 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 72.33 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 63.41 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 70.34 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 61.03 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 65.53 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 44.51 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 72.35 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 70.01 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 71.31 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.594 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 73.03 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 73.51 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 54.33 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.724 ' H ' HG22 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 63.35 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 64.51 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 51.25 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 72.52 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 52.13 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 HG21 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 62.13 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 74.44 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 70.12 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 65.12 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 53.14 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 72.45 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 64.42 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 70.53 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 64.0 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 72.12 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 73.33 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 71.11 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 65.05 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 73.52 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 131' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 64.15 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 72.35 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 34.43 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 51.55 111.735 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.2 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 71.23 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 73.11 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.11 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.24 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.463 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 62.4 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 65.12 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.566 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.14 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 64.31 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 71.12 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.715 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.01 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 54.31 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 72.23 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 61.44 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 63.0 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.509 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 63.4 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.698 ' HB2' HD22 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 72.03 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.24 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 51.23 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 71.1 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 71.32 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.488 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 72.12 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 72.43 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 52.13 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 64.41 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.544 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.626 HG13 ' HA ' ' A' ' 30' ' ' VAL . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 63.21 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 65.23 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.8 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 73.42 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 52.24 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.426 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 74.11 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 64.3 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 186' ' ' LYS . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.11 110.256 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 50.54 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 72.01 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' HG22 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 64.11 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.8 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 51.41 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 65.04 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 63.1 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 73.25 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 70.42 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.647 HE21 ' N ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.689 0.28 . . . . 64.43 111.355 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 63.3 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.9 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.45 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 65.24 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 70.31 110.714 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.0 m120 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 64.2 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 71.23 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 71.51 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 52.24 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.719 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 70.01 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 35.43 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 70.04 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 3.9 t60 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 72.54 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.463 HD22 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 43.51 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.707 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 74.23 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 64.23 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 62.43 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 61.41 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 62.05 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.703 ' HB3' HD23 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 33.24 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.12 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 62.12 109.503 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 71.01 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 53.52 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 63.41 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 51.32 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 53.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 24.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.24 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 55.41 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 72.41 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 73.42 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 65.0 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.9 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 73.3 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 64.43 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD13 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 54.42 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 52.32 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 52.41 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.22 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.588 ' H ' HG22 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 62.34 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 31.32 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 74.53 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 73.1 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.12 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 HD13 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 45.13 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 71.12 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 62.45 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.678 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 71.12 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 62.32 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 55.3 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 63.44 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 63.22 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 61.34 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 53.2 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 60.3 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.788 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 45.01 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 72.11 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 72.54 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.12 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.568 ' HB3' HD23 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 64.42 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 72.21 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 120' ' ' LEU . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 51.51 109.992 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.41 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 44.21 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 73.42 111.412 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 55.31 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 71.12 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 62.31 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.557 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 64.14 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 72.2 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.855 HD12 ' HB1' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 53.41 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 55.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.788 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 64.14 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 64.5 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 71.12 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 71.52 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 71.34 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 149' ' ' VAL . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 63.13 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 70.15 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.44 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 62.13 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 55.4 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 71.24 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.59 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.59 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.11 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 55.02 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 74.3 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 70.21 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.532 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 182' ' ' ASP . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 54.44 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.437 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 42.21 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 64.03 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 178' ' ' ILE . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 55.54 111.46 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 65.34 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 44.32 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 61.52 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 33.44 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 71.34 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 72.42 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.537 ' O ' HG12 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 70.11 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 62.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.758 HE21 ' N ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.056 -0.35 . . . . 53.13 110.056 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 42.32 110.653 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 62.11 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.859 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 43.43 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 73.11 112.082 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 65.35 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 44.41 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 63.22 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 73.42 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.755 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 51.52 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.542 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 71.13 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.751 HG12 HG13 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 71.42 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 63.33 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 72.01 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.02 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 73.15 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 73.32 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 63.11 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 72.45 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 54.54 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 70.45 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.02 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 71.41 111.705 177.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 64.34 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 61.14 111.06 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 64.55 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.859 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 51.44 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 63.45 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 65.13 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 71.31 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.642 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 61.54 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 32.42 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 62.14 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 73.1 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 55.15 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 65.1 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HG2' HD21 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 55.42 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 62.55 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 64.35 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 52.31 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 41.0 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.675 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 54.14 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 62.4 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 63.31 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 63.14 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 61.04 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 73.33 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 60.53 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG3' HD11 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 51.22 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.991 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 73.32 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 61.03 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 30.25 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.853 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 74.12 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 52.21 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 54.34 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 72.11 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 76' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 62.23 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 63.12 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 71.21 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 54.04 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.505 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.991 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 64.0 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.675 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 62.4 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.548 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 64.03 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 71.34 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 73.12 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 71.14 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.22 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 73.32 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 62.14 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 42.1 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 62.11 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 71.23 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 42.53 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.751 HG13 HG12 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 63.22 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 53.14 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 41.21 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 52.55 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD11 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 73.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 70.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 73.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD23 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 71.22 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 60.35 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.535 HD23 ' HG ' ' A' ' 179' ' ' LEU . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 71.04 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 70.33 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.535 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 73.22 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 63.33 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.23 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.33 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.646 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 70.32 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 72.45 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.493 0.187 . . . . 74.11 110.712 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.659 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.881 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 62.14 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 62.32 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 71.51 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB1' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.739 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 41.34 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 24.52 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.739 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 71.13 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 65.03 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.732 ' H ' HG22 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.548 ' OD1' ' HB1' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 73.4 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.796 ' HD1' HG21 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.721 HG12 HG13 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 72.23 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 65.53 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 44.44 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 64.04 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.02 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 72.1 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.34 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 65.02 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 61.31 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 60.33 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.23 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 74.55 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 71.13 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 63.31 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 55.44 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 61.03 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 176' ' ' LEU . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 43.11 111.038 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 1.067 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 55.12 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 74.12 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 54.33 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 63.32 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 71' ' ' MET . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 55.23 112.781 -170.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.4 ' HG2' ' CE2' ' A' ' 70' ' ' PHE . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 73.41 112.716 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 51.44 112.822 -167.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 78' ' ' ILE . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 71.35 111.355 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 55.42 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 64.34 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' SER . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.21 110.466 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 43.15 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 64.22 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 HD21 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 70.52 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 41.01 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.484 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.784 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 71.41 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.881 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 51.22 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 63.12 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' LYS . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.939 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 65.1 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 65.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 70.14 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 53.11 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.12 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 62.34 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.758 ' HA3' ' HB3' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 64.31 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 73.34 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.839 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 63.03 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.695 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.01 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 61.52 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.02 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 64.53 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 63.01 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 74.42 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 71.34 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 72.3 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.939 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 74.11 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.839 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 64.04 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 72.14 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 65.24 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.504 HD12 ' HB1' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 74.04 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 62.03 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 71.11 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 71.11 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 51.15 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 62.3 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 53.41 111.709 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 65.21 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 62.41 112.05 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 50.42 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 70.23 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.498 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 44.25 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 63.41 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.847 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 62.23 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 64.34 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.23 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 43.13 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 32.33 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.796 HG21 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 63.43 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 73.34 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.1 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.678 ' HB3' HD12 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.509 HD12 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 73.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 72.15 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 72.24 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 73.15 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 63.43 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.509 HH21 HD12 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 73.04 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 64.14 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.758 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 63.33 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.534 -0.543 . . . . 73.24 109.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 43.41 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 51.11 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 61.04 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.1 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.635 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 70.54 110.511 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 73.22 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 64.32 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.504 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 65.22 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.05 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 61.55 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' GLY . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 73.02 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 72.11 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.58 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 74.23 111.505 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 55.32 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 72.54 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 60.31 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 64.1 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 52.53 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 64.12 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 72.34 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 51.12 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 61.4 112.052 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 62.21 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.811 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 73.51 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 72.22 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 71.12 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 53.4 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 61.13 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 72.34 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 55.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 43.43 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 64.14 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 65.34 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.741 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 61.4 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.21 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.12 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 52.24 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.786 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 64.32 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 74.23 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 61.33 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.645 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.01 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.79 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 62.4 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.771 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 52.21 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 55.23 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 40.11 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 63.31 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 63.25 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 71.11 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 71.12 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 55.31 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 72.41 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 44.12 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 63.12 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.24 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 42.22 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 54.41 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 52.4 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 60.33 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 74.45 111.258 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 71.22 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.79 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 61.4 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 73.21 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.881 HD12 ' HB1' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 54.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 34.32 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 64.11 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 54.11 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 63.44 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.2 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 64.34 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.412 ' OH ' HG23 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 65.11 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 65.31 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 61.33 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.12 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.43 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 73.33 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 64.02 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 54.42 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 65.52 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 55.21 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 53.25 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 45.02 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 62.11 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 74.44 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 61.21 111.208 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 52.02 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.727 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.04 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 172' ' ' SER . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.811 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 62.23 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.94 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 63.52 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 50.55 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 60.03 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.94 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 71.34 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 64.22 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 64.43 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.469 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 62.12 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.983 -0.377 . . . . 71.11 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.72 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.12 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 73.11 113.035 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 61.04 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 70.31 110.306 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 54.24 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 70.21 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 72.51 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 72.34 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 63.23 111.044 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 55.42 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 52.44 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.476 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.571 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 62.53 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.32 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.766 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.745 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.11 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 71.24 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD22 HD13 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 53.1 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB3' HD23 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 71.23 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 61.53 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.43 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.845 ' HB3' HD12 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 61.12 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 70.22 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 74.41 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 35.24 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 61.5 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 63.12 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 63.11 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 73.5 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.22 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.716 HD11 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 65.21 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.711 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 65.13 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 HD11 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 72.22 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' HG21 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 62.34 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 53.54 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 53.32 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 64.53 110.925 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 72.12 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.678 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.704 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 54.2 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 53.35 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 54.35 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.767 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 72.34 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.679 ' HB2' HG21 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 63.33 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.03 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 73.23 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 74.24 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 62.44 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 53.12 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 64.43 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.589 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 62.33 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.606 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 64.34 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 54.45 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 52.31 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.72 ' HB3' HD23 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 72.13 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 31.53 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 62.1 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 64.11 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HD2' HD12 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 65.0 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.584 HD12 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 55.14 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.14 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 72.04 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 64.32 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.529 HD22 HD13 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 63.45 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.767 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.59 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.589 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 63.33 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.482 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.766 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 62.14 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 52.02 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 72.4 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.512 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 52.23 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 54.43 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 54.11 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 73.44 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 71.21 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 60.54 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 72.33 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.476 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 71.31 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 62.12 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.736 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 73.51 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 52.52 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.618 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 71.12 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.745 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 62.13 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 64.41 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 54.45 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 63.15 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 64.41 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 54.42 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 45.13 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.725 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 73.45 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 53.35 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 72.35 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 72.25 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 72.35 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 72.12 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 64.0 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 55.22 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.656 -0.868 . . . . 55.13 108.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 54.32 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 72.44 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 62.34 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 41.54 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.02 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 23.33 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 63.45 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.25 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 33.44 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HD1' HG21 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.3 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 71.13 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 53.52 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.962 ' HB3' HD12 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 62.24 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 71.54 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 73.21 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 63.33 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.04 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 71.11 109.679 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 70.3 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.3 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 50.52 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.42 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 61.44 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.962 HD12 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 74.2 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 71.42 109.049 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.794 HD12 HD12 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 63.54 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 55.33 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 54.44 110.424 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HD12 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 71.21 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 72.24 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.849 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 63.52 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 54.42 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 61.23 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 55.22 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 45.12 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.23 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 70.44 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.718 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.695 -171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.31 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 64.51 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 64.53 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 74.14 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 50.03 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 71.24 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 54.4 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 60.1 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 70.42 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.748 ' HB2' HD11 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 71.31 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.561 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 65.42 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 23.12 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 44.42 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 62.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 62.44 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.738 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 61.33 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 63.41 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 64.31 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.506 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 72.01 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 41.12 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 55.13 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 51.12 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 52.2 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 42.42 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.561 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 72.31 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 34.33 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 53.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 51.34 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 61.3 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 51.13 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 53.43 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 149' ' ' VAL . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 64.42 112.03 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 72.13 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.785 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 63.34 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.785 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 70.41 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 HD22 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 70.31 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 51.14 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.528 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 64.51 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 65.31 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 62.22 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.718 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.14 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 74.25 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' HD23 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 71.45 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 62.31 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 62.53 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 72.02 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 71.42 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 55.35 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.749 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 71.11 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.14 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 70.14 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 73.35 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HA ' HG22 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 63.14 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.633 HG22 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.0 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 54.24 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 62.24 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 61.01 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 72.32 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 34.31 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 64.43 112.581 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.02 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 71.0 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 24.4 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 54.2 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.79 ' HD1' HG21 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 72.53 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 63.24 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 70.12 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 65.4 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 64.33 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.03 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 55.53 111.404 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 43.14 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 64.03 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.1 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 62.24 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 64.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.964 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.03 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 72.44 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.617 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 71.42 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 72.13 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 71.11 111.681 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 54.25 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 74.41 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 71.53 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 72.21 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 42.4 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 73.34 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 62.31 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 72.33 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 71.02 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 69' ' ' THR . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 65.35 112.942 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 61.32 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.85 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 54.24 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.649 HG12 HG11 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 72.22 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.444 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 40.11 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 65.41 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 24.9 t-20 -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 71.31 111.124 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HE1' HD12 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.33 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 61.2 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.644 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 72.15 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.775 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 65.45 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 53.24 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 72.24 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 60.25 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 65.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 31.53 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.705 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 45.22 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 53.15 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 53.45 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.62 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.4 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 63.42 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 23.21 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.635 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 44.31 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.31 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 44.34 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 73.34 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 62.13 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 45.23 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.602 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.13 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.05 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.85 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 63.11 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.11 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 53.34 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 54.22 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.03 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 60.25 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.739 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 51.04 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.463 HD13 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 52.15 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 53.54 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 51.54 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 51.41 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 53.22 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.62 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 54.34 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 65.35 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 31.02 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HA ' HG23 ' A' ' 22' ' ' THR . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 73.55 112.945 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 42.11 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 61.12 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.505 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 72.21 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 65.55 111.295 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.23 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.12 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 54.21 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 71.34 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 73.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 62.35 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 62.55 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 61.21 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 60.44 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 62.22 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 60.12 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 53.02 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 62.3 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.05 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 73.4 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 71.14 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 35.51 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 54.11 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 42.13 110.094 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 190' ' ' ARG . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.1 111.196 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' HA3' ' A' ' 183' ' ' GLY . 2.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.725 0.298 . . . . 75.24 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 184' ' ' LEU . 20.0 m -123.28 144.55 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.894 0.378 . . . . 71.04 110.766 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -83.59 -62.38 1.59 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.561 -0.533 . . . . 72.33 109.561 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -115.8 130.59 24.25 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.388 -0.597 . . . . 65.44 109.388 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 53.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 62.02 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 44.24 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 54.23 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 73.23 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.2 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 63.51 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 63.31 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HG2' HD12 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 72.12 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.445 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.705 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 61.42 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 50.32 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.719 ' HD1' HG21 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 52.14 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 54.3 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 63.54 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 63.35 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 65.11 111.714 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 53.15 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 62.53 111.259 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t30 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 35' ' ' ALA . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 42.32 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 52.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 64.14 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.13 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.12 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.46 ' HD2' HD13 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 52.34 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.607 ' HB ' HD13 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.02 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 72.41 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 51.32 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 54.43 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.12 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 41.31 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 62.51 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 53.51 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 70.21 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 60.0 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 62.13 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 69' ' ' THR . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 70.11 111.468 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 63.43 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 54.22 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 62.23 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 50.02 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 63.33 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.834 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 62.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.834 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 72.41 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 65.13 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 61.13 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LEU . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 72.45 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 64.43 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 51.44 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 72.34 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 55.45 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 73.23 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.21 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 62.22 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 195' ' ' LYS . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 63.15 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 71.14 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 65.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' N ' HD23 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.904 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 70.34 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.608 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 51.3 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 44.53 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.904 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 53.33 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 33.24 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 50.23 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 63.24 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.754 HG22 HD12 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.591 ' HA ' HD21 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 71.11 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 64.42 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 65.52 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.591 HD21 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 51.33 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 50.22 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 64.24 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 72.53 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.846 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 71.13 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 70.45 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 64.14 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 42.34 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 60.33 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 61.12 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 64.22 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 72.22 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 72.13 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 63.31 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 44.3 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 63.21 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.04 111.101 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 71.15 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 25.03 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.719 HG21 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 62.23 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 55.53 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 31.44 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.733 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.47 ' SG ' HD13 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 60.44 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.854 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.33 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 74.25 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.1 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.628 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 1' ' ' MET . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 61.32 112.537 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.854 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 62.43 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.628 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 62.55 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 64.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 62.32 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.15 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HB2' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 72.11 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 61.11 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 71.24 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.574 -0.528 . . . . 51.2 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.7 143.61 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 74.1 111.717 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.411 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 28.9 m -94.44 5.04 53.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 75.4 110.111 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.704 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 -97.6 108.85 47.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 74.15 110.698 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 3' ' ' SER . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 74.33 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 73.3 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 45.13 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 65.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.925 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 71.33 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 60.01 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 71.01 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 43.01 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 73.13 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 64.01 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.925 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 63.14 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 61.52 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 54.45 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 73.44 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 71.13 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 73.02 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' GLU . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 71.24 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 71.01 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 63.53 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 71.53 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 73.12 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 71.3 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 44.44 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 62.11 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 63' ' ' ARG . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.02 109.317 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.25 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 60.04 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 51.2 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 62.01 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 65.33 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 64.44 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 61.05 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 72.52 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HD2' HD23 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 71.44 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 54.45 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 64.34 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 60.24 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 70.5 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HE1' HD12 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 72.44 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 60.11 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 73.23 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 54.04 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.704 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 61.22 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 74.33 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 71.55 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 70.04 109.805 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 32.54 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.53 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.516 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 63.22 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.01 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.718 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 70.33 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 74.32 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 50.34 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.23 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.796 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 60.15 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.25 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 64.22 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 70.35 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.584 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 72.1 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' MET . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 64.53 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.718 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 71.3 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 64.23 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.564 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB1' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.33 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 60.14 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.541 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 64.05 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 45.22 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 62.33 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 63.0 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 64.31 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.925 ' HA ' HG13 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 50.32 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 43.34 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 65.44 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 71.35 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 71.21 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 64.43 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 54.43 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 70.24 111.657 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.561 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 62.14 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.601 HG13 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.624 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 70.15 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.814 ' HB ' ' HB2' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 73.31 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.749 HD12 HD13 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 72.23 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.405 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 72.01 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 42.23 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.749 HD13 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 74.3 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 54.34 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 71.02 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB2' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 71.1 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.41 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 55.43 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 65.34 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 62.21 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 71.31 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 63.31 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.438 -0.578 . . . . 72.43 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -140.23 123.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.548 -0.751 . . . . 75.24 109.806 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -70.53 -23.97 62.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 61.11 110.128 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.97 116.35 59.8 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.083 -0.508 . . . . 64.34 109.699 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' HA ' ' HB3' ' A' ' 91' ' ' GLU . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 65.43 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 70.53 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 63.53 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.654 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 72.35 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.482 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.715 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 62.52 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 54.01 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 61.32 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 70.13 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.14 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 53.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 65.55 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 64.23 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 71.22 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 60.52 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 65.25 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 64.23 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 54.4 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 24.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 64.3 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 72.33 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 63.41 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 70.34 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 61.03 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 65.53 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 44.51 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 72.35 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 70.01 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 71.31 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.594 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 73.03 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 73.51 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 54.33 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.724 ' H ' HG22 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 63.35 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 64.51 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 51.25 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 72.52 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 52.13 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 HG21 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 62.13 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 74.44 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 70.12 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 65.12 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 53.14 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 72.45 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 64.42 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 70.53 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 64.0 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 72.12 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 73.33 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 71.11 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 65.05 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 73.52 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 131' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 64.15 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 72.35 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 34.43 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 51.55 111.735 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.2 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 71.23 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 73.11 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.11 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.24 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 62.4 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 65.12 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.566 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.14 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 64.31 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 71.12 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.715 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.01 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 54.31 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 72.23 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 61.44 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 63.0 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.509 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 63.4 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.698 ' HB2' HD22 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 72.03 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.24 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 51.23 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 71.1 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 71.32 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.488 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 72.12 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 72.43 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 52.13 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 64.41 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.544 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.626 HG13 ' HA ' ' A' ' 30' ' ' VAL . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 63.21 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 65.23 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.8 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 73.42 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 52.24 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.426 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 74.11 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 64.3 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 186' ' ' LYS . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.11 110.256 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 50.54 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 72.01 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' HG22 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 64.11 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.8 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 51.41 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 65.04 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 63.1 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 73.25 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 70.42 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.807 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 21.6 ttt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.283 -0.636 . . . . 73.41 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.807 ' H ' ' HG2' ' A' ' 1' ' ' MET . 37.5 t 76.14 -88.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.394 0.677 . . . . 72.23 109.835 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 7.7 t 171.91 -63.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.587 0.555 . . . . 72.21 110.273 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 3' ' ' SER . 19.6 mp0 -99.21 132.83 22.7 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 64.43 111.355 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 63.3 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.9 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.45 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 65.24 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 70.31 110.714 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.0 m120 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 64.2 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 71.23 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 71.51 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 52.24 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.719 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 70.01 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 35.43 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 70.04 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 3.9 t60 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 72.54 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.463 HD22 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 43.51 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.707 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 74.23 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 64.23 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 62.43 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 61.41 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 62.05 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.703 ' HB3' HD23 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 33.24 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.12 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 62.12 109.503 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 71.01 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 53.52 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 63.41 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 51.32 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 53.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 24.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.24 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 55.41 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 72.41 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 73.42 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 65.0 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.9 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 73.3 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 64.43 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD13 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 54.42 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 52.32 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 52.41 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.22 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.588 ' H ' HG22 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 62.34 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 31.32 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 74.53 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 73.1 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.12 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 HD13 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 45.13 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 71.12 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 62.45 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.678 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 71.12 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 62.32 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 55.3 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 63.44 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 63.22 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 61.34 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 53.2 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 60.3 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.788 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 45.01 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 72.11 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 72.54 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.12 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.568 ' HB3' HD23 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 64.42 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 72.21 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 120' ' ' LEU . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 51.51 109.992 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.41 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 44.21 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 73.42 111.412 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 55.31 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 71.12 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 62.31 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.557 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 64.14 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 72.2 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.855 HD12 ' HB1' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 53.41 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 55.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.788 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 64.14 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 64.5 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 71.12 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 71.52 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 71.34 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 149' ' ' VAL . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 63.13 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 70.15 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.44 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 62.13 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 55.4 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 71.24 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.59 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.59 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.11 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 55.02 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 74.3 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 70.21 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 182' ' ' ASP . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 54.44 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.437 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 42.21 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 64.03 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 178' ' ' ILE . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 55.54 111.46 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 1' ' ' MET . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 2' ' ' VAL . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 65.34 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 44.32 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 61.52 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 33.44 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 71.34 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 72.42 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.537 ' O ' HG12 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 70.11 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 62.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 111.321 0.119 . . . . 74.55 111.321 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG1' ' HG ' ' A' ' 184' ' ' LEU . 7.9 m -142.68 148.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 61.33 111.496 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -87.3 -32.57 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.563 -0.744 . . . . 75.34 110.083 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 19.4 mp0 -104.69 125.43 33.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.537 -0.756 . . . . 53.13 110.056 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 42.32 110.653 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 62.11 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.859 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 43.43 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 73.11 112.082 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 65.35 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 44.41 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 63.22 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 73.42 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.755 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 51.52 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.542 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 71.13 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.751 HG12 HG13 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 71.42 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 63.33 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 72.01 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.02 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 73.15 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 73.32 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 63.11 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 72.45 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 54.54 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 70.45 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.02 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 71.41 111.705 177.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 64.34 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 61.14 111.06 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 64.55 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.859 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 51.44 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 63.45 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 65.13 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 71.31 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.642 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 61.54 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 32.42 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 62.14 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 73.1 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 55.15 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 65.1 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HG2' HD21 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 55.42 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 62.55 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 64.35 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 52.31 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 41.0 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.675 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 54.14 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 62.4 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 63.31 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 63.14 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 61.04 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 73.33 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 60.53 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG3' HD11 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 51.22 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.991 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 73.32 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 61.03 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 30.25 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.853 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 74.12 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 52.21 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 54.34 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 72.11 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 76' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 62.23 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 63.12 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 71.21 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 54.04 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.505 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.991 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 64.0 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.675 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 62.4 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.548 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 64.03 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 71.34 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 73.12 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 71.14 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.22 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 73.32 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 62.14 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 42.1 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 62.11 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 71.23 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 42.53 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.751 HG13 HG12 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 63.22 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 53.14 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 41.21 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 52.55 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD11 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 73.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 70.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 73.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD23 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 71.22 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 60.35 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.563 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 71.04 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 70.33 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.535 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 73.22 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 63.33 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.23 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.33 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.646 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 70.32 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 72.45 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.753 0.311 . . . . 35.4 111.036 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.48 106.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.385 . . . . 74.53 110.871 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.4 t -80.5 -57.35 3.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 75.01 110.402 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 -134.31 123.78 16.81 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.712 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.659 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.881 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 62.14 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 62.32 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 71.51 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB1' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.739 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 41.34 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 24.52 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.739 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 71.13 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 65.03 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.732 ' H ' HG22 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.548 ' OD1' ' HB1' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 73.4 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.796 ' HD1' HG21 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.721 HG12 HG13 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 72.23 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 65.53 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 44.44 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 64.04 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.02 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 72.1 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.34 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 65.02 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 61.31 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 60.33 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.23 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 74.55 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 71.13 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 63.31 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 55.44 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 61.03 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 176' ' ' LEU . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 43.11 111.038 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 1.067 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 55.12 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 74.12 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 54.33 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 63.32 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 71' ' ' MET . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 55.23 112.781 -170.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HG2' ' CE2' ' A' ' 70' ' ' PHE . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 73.41 112.716 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 51.44 112.822 -167.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 78' ' ' ILE . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 71.35 111.355 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 55.42 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 64.34 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' SER . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.21 110.466 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 43.15 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 64.22 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 HD21 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 70.52 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 41.01 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.484 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.784 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 71.41 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.881 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 51.22 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 63.12 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' LYS . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.939 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 65.1 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 65.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 70.14 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 53.11 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.12 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 62.34 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.758 ' HA3' ' HB3' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 64.31 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 73.34 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.839 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 63.03 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.695 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.01 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 61.52 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.02 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 64.53 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 63.01 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 74.42 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 71.34 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 72.3 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.939 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 74.11 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.839 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 64.04 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 72.14 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 65.24 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.504 HD12 ' HB1' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 74.04 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 62.03 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 71.11 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 71.11 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 51.15 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 62.3 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 53.41 111.709 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 65.21 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 62.41 112.05 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 50.42 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 70.23 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.498 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 44.25 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 63.41 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.847 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 62.23 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 64.34 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.23 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 43.13 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 32.33 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.796 HG21 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 63.43 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 73.34 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.1 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.678 ' HB3' HD12 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.509 HD12 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 73.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 72.15 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 72.24 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 73.15 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 63.43 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.509 HH21 HD12 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 73.04 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 64.14 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.758 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 63.33 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.657 0.265 . . . . 73.04 110.718 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 m -105.66 108.93 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 73.23 111.023 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -70.08 -51.71 29.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 71.02 110.739 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -115.96 97.71 49.76 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.775 -0.648 . . . . 73.24 109.534 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 43.41 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 51.11 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 61.04 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.1 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.635 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 70.54 110.511 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 73.22 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 64.32 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.504 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 65.22 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.05 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 61.55 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' GLY . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 73.02 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 72.11 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.58 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 74.23 111.505 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 55.32 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 72.54 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 60.31 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 64.1 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 52.53 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 64.12 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 72.34 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 51.12 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 61.4 112.052 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 62.21 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.811 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 73.51 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 72.22 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 71.12 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 53.4 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 61.13 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 72.34 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 55.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 43.43 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 64.14 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 65.34 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.741 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 61.4 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.21 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.12 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 52.24 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.786 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 64.32 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 74.23 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 61.33 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.645 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.01 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.79 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 62.4 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.771 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 52.21 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 55.23 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 40.11 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 63.31 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 63.25 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 71.11 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 71.12 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 55.31 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 72.41 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 44.12 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 63.12 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.24 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 42.22 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 54.41 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 52.4 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 60.33 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 74.45 111.258 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 71.22 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.79 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 61.4 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 73.21 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.881 HD12 ' HB1' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 54.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 34.32 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 64.11 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 54.11 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 63.44 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.2 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 64.34 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.412 ' OH ' HG23 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 65.11 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 65.31 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 61.33 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.12 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.43 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 73.33 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 64.02 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 54.42 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 65.52 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 55.21 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 53.25 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 45.02 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 62.11 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 74.44 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 61.21 111.208 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 52.02 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.727 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.04 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 172' ' ' SER . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.811 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 62.23 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.94 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 63.52 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 50.55 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 60.03 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.94 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 71.34 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 64.22 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 64.43 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.469 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 62.12 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.759 0.314 . . . . 74.22 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.73 103.76 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.461 0.648 . . . . 75.31 111.945 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -90.79 -44.38 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.145 -0.934 . . . . 63.43 109.532 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -117.34 92.9 41.53 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.05 -0.977 . . . . 71.11 109.983 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.72 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.12 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 73.11 113.035 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 61.04 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 70.31 110.306 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 54.24 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 70.21 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 72.51 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 72.34 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 63.23 111.044 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 55.42 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 52.44 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.476 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.571 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 62.53 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.32 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.766 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.745 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.11 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 71.24 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD22 HD13 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 53.1 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB3' HD23 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 71.23 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 61.53 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.43 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.845 ' HB3' HD12 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 61.12 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 70.22 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 74.41 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 35.24 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 61.5 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 63.12 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 63.11 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 73.5 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.22 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.716 HD11 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 65.21 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.711 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 65.13 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 HD11 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 72.22 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' HG21 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 62.34 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 53.54 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 53.32 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 64.53 110.925 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 72.12 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.678 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.704 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 54.2 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 53.35 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 54.35 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.767 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 72.34 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.679 ' HB2' HG21 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 63.33 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.03 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 73.23 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 74.24 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 62.44 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 53.12 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 64.43 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.589 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 62.33 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.606 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 64.34 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 54.45 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 52.31 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.72 ' HB3' HD23 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 72.13 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 31.53 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 62.1 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 64.11 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HD2' HD12 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 65.0 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.584 HD12 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 55.14 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.14 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 72.04 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 64.32 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.529 HD22 HD13 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 63.45 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.767 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.59 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.589 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 63.33 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.482 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.766 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 62.14 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 52.02 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 72.4 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.512 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 52.23 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 54.43 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 54.11 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 73.44 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 71.21 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 60.54 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 72.33 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.476 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 71.31 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 62.12 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.736 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 73.51 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 52.52 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.618 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 71.12 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.745 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 62.13 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 64.41 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 54.45 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 63.15 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 64.41 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 54.42 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 45.13 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.725 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 73.45 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 53.35 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 72.35 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 72.25 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 72.35 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 72.12 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 64.0 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 55.22 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.861 -0.422 . . . . 63.05 109.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.17 137.12 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 71.21 109.545 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -82.02 -43.08 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 74.14 108.654 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 -107.42 119.49 50.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.656 -0.868 . . . . 55.13 108.656 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 54.32 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 72.44 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 62.34 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 41.54 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.02 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 23.33 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 63.45 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.25 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 33.44 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HD1' HG21 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.3 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 71.13 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 53.52 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.962 ' HB3' HD12 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 62.24 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 71.54 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 73.21 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 63.33 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.04 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 71.11 109.679 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 70.3 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.3 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 50.52 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.42 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 61.44 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.962 HD12 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 74.2 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 71.42 109.049 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.794 HD12 HD12 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 63.54 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 55.33 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 54.44 110.424 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HD12 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 71.21 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 72.24 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.849 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 63.52 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 54.42 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 61.23 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 55.22 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 45.12 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.23 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 70.44 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.718 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.695 -171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.31 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 64.51 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 64.53 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 74.14 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 50.03 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 71.24 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 54.4 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 60.1 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 70.42 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.748 ' HB2' HD11 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 71.31 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.561 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 65.42 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 23.12 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 44.42 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 62.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 62.44 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.738 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 61.33 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 63.41 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 64.31 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.506 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 72.01 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 41.12 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 55.13 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 51.12 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 52.2 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 42.42 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.561 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 72.31 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 34.33 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 53.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 51.34 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 61.3 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 51.13 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 53.43 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 149' ' ' VAL . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 64.42 112.03 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 72.13 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.785 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 63.34 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.785 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 70.41 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 HD22 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 70.31 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 51.14 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.528 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 64.51 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 65.31 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 62.22 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.718 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.14 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 74.25 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' HD23 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 71.45 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 62.31 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 62.53 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 72.02 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 71.42 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 55.35 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.749 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 71.11 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.14 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 70.14 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 73.35 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HA ' HG22 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 63.14 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.633 HG22 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.0 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 54.24 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.936 0.398 . . . . 75.14 110.521 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.26 146.51 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.128 -0.487 . . . . 73.25 109.753 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -70.17 -42.4 72.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 61.01 109.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -134.96 149.04 69.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 62.24 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 61.01 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 72.32 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 34.31 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 64.43 112.581 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.02 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 71.0 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 1.0 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 24.4 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 54.2 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.79 ' HD1' HG21 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 72.53 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 63.24 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 70.12 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 65.4 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 64.33 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.03 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 55.53 111.404 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 43.14 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 64.03 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.1 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 62.24 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 64.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.964 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.03 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 72.44 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.617 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 71.42 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 72.13 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 71.11 111.681 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 54.25 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 74.41 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 71.53 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 72.21 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 42.4 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 73.34 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 62.31 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 72.33 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 71.02 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 69' ' ' THR . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 65.35 112.942 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 61.32 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.85 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 54.24 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.649 HG12 HG11 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 72.22 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.444 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 40.11 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 65.41 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 24.9 t-20 -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 71.31 111.124 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HE1' HD12 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.33 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 61.2 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.644 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 72.15 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.775 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 65.45 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 53.24 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 72.24 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 60.25 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 65.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 31.53 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.705 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 45.22 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 53.15 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 53.45 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.62 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.4 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 63.42 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 23.21 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.635 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 44.31 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.31 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 44.34 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 73.34 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 62.13 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 45.23 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.602 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.13 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.05 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.85 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 63.11 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.11 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 53.34 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 54.22 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.03 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 60.25 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.739 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 51.04 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.463 HD13 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 52.15 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 53.54 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 51.54 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 51.41 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 53.22 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.62 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 54.34 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 65.35 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 31.02 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HA ' HG23 ' A' ' 22' ' ' THR . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 73.55 112.945 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 42.11 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 61.12 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 72.21 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 65.55 111.295 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.23 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.12 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 54.21 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 71.34 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 73.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 62.35 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 62.55 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 61.21 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 60.44 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 62.22 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 60.12 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 53.02 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 62.3 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.05 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 73.4 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 71.14 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 35.51 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 54.11 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 42.13 110.094 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 190' ' ' ARG . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.1 111.196 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.388 -0.597 . . . . 65.44 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 53.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 62.02 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 44.24 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 54.23 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 73.23 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.2 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 63.51 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 63.31 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HG2' HD12 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 72.12 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.445 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.705 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 61.42 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 50.32 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.719 ' HD1' HG21 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 52.14 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 54.3 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 63.54 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 63.35 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 65.11 111.714 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 53.15 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.851 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 83.0 t60 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 62.53 111.259 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' A' ' 38' ' ' HIS . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 42.32 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 52.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 64.14 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.13 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.12 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.46 ' HD2' HD13 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 52.34 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.607 ' HB ' HD13 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.02 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 72.41 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 51.32 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 54.43 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.12 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 41.31 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 62.51 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 53.51 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 70.21 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 60.0 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 62.13 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 69' ' ' THR . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 70.11 111.468 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 63.43 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 54.22 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 62.23 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 50.02 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 63.33 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.834 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 62.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.834 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 72.41 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 65.13 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 61.13 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LEU . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 72.45 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 64.43 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.454 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 51.44 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 72.34 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 55.45 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 73.23 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.21 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 62.22 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 195' ' ' LYS . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 63.15 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 71.14 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 65.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' N ' HD23 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.904 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 70.34 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.608 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 8.0 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 44.53 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.904 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 53.33 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 33.24 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 50.23 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.436 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 63.24 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.754 HG22 HD12 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.591 ' HA ' HD21 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 71.11 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 64.42 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 65.52 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.591 HD21 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 51.33 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 50.22 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.608 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 64.24 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 72.53 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.846 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 71.13 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.517 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 70.45 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 64.14 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 42.34 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 60.33 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 61.12 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 64.22 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 72.22 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 72.13 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 63.31 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 44.3 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 63.21 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.04 111.101 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 71.15 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 25.03 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.719 HG21 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 62.23 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 55.53 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 31.44 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.733 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.47 ' SG ' HD13 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 60.44 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.854 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.33 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 74.25 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.1 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.628 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 61.32 112.537 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.854 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 62.43 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.628 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 62.55 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 64.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 62.32 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.15 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HB2' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 72.11 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 61.11 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 71.24 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.704 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.75 0.31 . . . . 74.15 110.698 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 74.33 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 73.3 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 45.13 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 65.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.925 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 71.33 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 60.01 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 71.01 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 43.01 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 73.13 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 64.01 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.925 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 63.14 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 61.52 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 54.45 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 73.44 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 71.13 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 73.02 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' GLU . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 71.24 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 71.01 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 63.53 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 71.53 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 73.12 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 71.3 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 44.44 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 62.11 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 63' ' ' ARG . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.02 109.317 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.25 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 60.04 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 51.2 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 62.01 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 65.33 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 64.44 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 61.05 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 72.52 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HD2' HD23 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 71.44 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 54.45 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 64.34 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 60.24 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 70.5 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HE1' HD12 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 72.44 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 60.11 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 73.23 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 54.04 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.704 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 61.22 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 74.33 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 71.55 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 70.04 109.805 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 32.54 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.53 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.516 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 63.22 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.01 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.718 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 70.33 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 74.32 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 50.34 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.23 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.796 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 60.15 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.25 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 64.22 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 70.35 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.584 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 72.1 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' MET . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 64.53 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.718 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 71.3 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 64.23 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.564 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB1' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.33 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 60.14 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.541 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 64.05 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 45.22 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 62.33 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 63.0 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 64.31 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.925 ' HA ' HG13 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 50.32 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 43.34 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 65.44 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 71.35 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 71.21 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 64.43 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 54.43 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 70.24 111.657 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.561 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 62.14 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.601 HG13 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.624 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 70.15 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.814 ' HB ' ' HB2' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 73.31 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.749 HD12 HD13 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 72.23 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.405 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 72.01 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 42.23 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.749 HD13 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 74.3 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 54.34 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 71.02 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB2' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 71.1 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.41 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 55.43 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 65.34 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 62.21 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 71.31 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 63.31 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.699 -0.482 . . . . 64.34 109.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.572 ' HB ' HE22 ' A' ' 60' ' ' GLN . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 65.43 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 70.53 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 63.53 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.654 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 72.35 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.482 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.715 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 62.52 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 54.01 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 61.32 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 70.13 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.14 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 53.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 65.55 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 64.23 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 71.22 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 60.52 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 65.25 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 64.23 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 54.4 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 24.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 64.3 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 72.33 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 63.41 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 70.34 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 61.03 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 65.53 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 t30 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 44.51 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.572 HE22 ' HB ' ' A' ' 6' ' ' ILE . 45.6 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 72.35 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 70.01 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 71.31 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.594 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 73.03 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 73.51 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 54.33 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.724 ' H ' HG22 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 63.35 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 64.51 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 51.25 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 72.52 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 52.13 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 HG21 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 62.13 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 74.44 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 70.12 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 65.12 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 53.14 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 72.45 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 64.42 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 70.53 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 64.0 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 72.12 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 73.33 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 71.11 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 65.05 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 73.52 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 131' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 64.15 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 72.35 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 34.43 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 51.55 111.735 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.2 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 71.23 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 73.11 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.11 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.24 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.463 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 62.4 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 65.12 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.566 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.14 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 64.31 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 71.12 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.715 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.01 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 54.31 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 72.23 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 61.44 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 63.0 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.509 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 63.4 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.698 ' HB2' HD22 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 72.03 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.24 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 51.23 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 71.1 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 71.32 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.488 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 72.12 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 72.43 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 52.13 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 64.41 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.544 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.626 HG13 ' HA ' ' A' ' 30' ' ' VAL . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 63.21 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 65.23 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.8 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 73.42 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 52.24 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.426 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 74.11 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 64.3 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 186' ' ' LYS . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.11 110.256 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 50.54 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 72.01 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' HG22 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 64.11 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.8 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 51.41 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 65.04 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 63.1 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 73.25 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 70.42 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.689 0.28 . . . . 64.43 111.355 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 63.3 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.9 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.45 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 65.24 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 70.31 110.714 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 78.0 m-20 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 64.2 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 71.23 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 71.51 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 52.24 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.719 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 70.01 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 35.43 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 70.04 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.522 ' HD2' HG12 ' A' ' 153' ' ' VAL . 7.3 t-80 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 72.54 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.463 HD22 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 43.51 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.707 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 74.23 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 64.23 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 62.43 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 61.41 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 62.05 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.703 ' HB3' HD23 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 33.24 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.12 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 62.12 109.503 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 71.01 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 53.52 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 63.41 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 51.32 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 53.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 24.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.24 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 55.41 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 72.41 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 73.42 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 65.0 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.9 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 73.3 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 64.43 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.768 HD13 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 54.42 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 52.32 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 52.41 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.22 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.588 ' H ' HG22 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 62.34 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 31.32 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 74.53 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 73.1 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.12 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 HD13 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 45.13 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 71.12 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 62.45 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.678 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 71.12 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 62.32 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 55.3 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 63.44 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 63.22 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 61.34 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 53.2 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 60.3 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.788 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 45.01 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 72.11 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 72.54 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 110' ' ' GLN . 7.5 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.12 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.568 ' HB3' HD23 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 64.42 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 72.21 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 120' ' ' LEU . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 51.51 109.992 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.41 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 44.21 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 73.42 111.412 -176.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 55.31 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 71.12 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 62.31 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.557 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 64.14 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 72.2 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.855 HD12 ' HB1' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 53.41 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 55.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.788 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 64.14 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 64.5 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 71.12 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 71.52 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 71.34 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.522 HG12 ' HD2' ' A' ' 24' ' ' HIS . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 63.13 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 70.15 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.44 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 62.13 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 55.4 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 71.24 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.59 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.59 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.11 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 55.02 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 74.3 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 70.21 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.532 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 182' ' ' ASP . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 54.44 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.437 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 42.21 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 64.03 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 178' ' ' ILE . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 55.54 111.46 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 65.34 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 44.32 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 61.52 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 33.44 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 71.34 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 72.42 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.537 ' O ' HG12 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 70.11 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 62.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 19.4 mp0 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.056 -0.35 . . . . 53.13 110.056 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 42.32 110.653 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 62.11 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.859 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 43.43 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 73.11 112.082 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 65.35 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 44.41 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 63.22 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 73.42 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.755 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 51.52 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.542 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 71.13 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.751 HG12 HG13 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 71.42 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 63.33 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 72.01 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.02 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 73.15 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 73.32 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 63.11 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 72.45 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 54.54 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 70.45 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.02 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 71.41 111.705 177.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 64.34 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 61.14 111.06 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 64.55 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.859 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 51.44 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 63.45 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 65.13 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 71.31 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.642 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 61.54 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 32.42 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 62.14 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 73.1 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 55.15 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 65.1 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HG2' HD21 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 55.42 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 62.55 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 64.35 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 52.31 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 41.0 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.675 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 54.14 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 62.4 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 63.31 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 63.14 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 61.04 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 73.33 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 60.53 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG3' HD11 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 51.22 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.991 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 73.32 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 61.03 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 30.25 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.853 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 74.12 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 52.21 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 54.34 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 72.11 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 76' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 62.23 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 63.12 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 71.21 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 54.04 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.505 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.991 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 64.0 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.675 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 62.4 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.548 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 64.03 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 71.34 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 73.12 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 71.14 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.22 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 73.32 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 62.14 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 42.1 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 62.11 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 71.23 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 42.53 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.751 HG13 HG12 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 63.22 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 53.14 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 41.21 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 52.55 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD11 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 73.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 70.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 73.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD23 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 71.22 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 60.35 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.535 HD23 ' HG ' ' A' ' 179' ' ' LEU . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 71.04 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 70.33 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.535 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 73.22 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 63.33 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.23 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.33 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.646 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 70.32 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 72.45 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.493 0.187 . . . . 74.11 110.712 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.659 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.881 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 62.14 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 62.32 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 71.51 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB1' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.739 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 41.34 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 24.52 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.739 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 71.13 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 65.03 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.732 ' H ' HG22 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.548 ' OD1' ' HB1' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 73.4 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.796 ' HD1' HG21 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.721 HG12 HG13 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 72.23 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 65.53 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 44.44 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 64.04 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.02 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 72.1 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.34 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 65.02 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 61.31 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 60.33 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.23 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 74.55 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 71.13 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 63.31 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 55.44 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 61.03 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 176' ' ' LEU . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 43.11 111.038 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 1.067 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 55.12 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 74.12 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 54.33 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 63.32 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 71' ' ' MET . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 55.23 112.781 -170.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.4 ' HG2' ' CE2' ' A' ' 70' ' ' PHE . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 73.41 112.716 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.591 HD22 HD22 ' A' ' 73' ' ' LEU . 10.2 t30 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 51.44 112.822 -167.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 78' ' ' ILE . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 71.35 111.355 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 55.42 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 64.34 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' SER . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.21 110.466 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 43.15 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 64.22 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 HD21 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 70.52 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 41.01 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.484 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.784 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 71.41 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.881 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 51.22 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 63.12 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' LYS . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.939 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 65.1 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 65.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 70.14 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 53.11 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.12 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 62.34 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.758 ' HA3' ' HB3' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 64.31 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 73.34 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.839 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 63.03 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.695 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.01 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 61.52 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.02 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 64.53 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 63.01 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 74.42 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 71.34 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.407 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 72.3 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.939 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 74.11 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.839 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 64.04 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 72.14 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 65.24 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.504 HD12 ' HB1' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 74.04 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 62.03 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 71.11 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 71.11 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 51.15 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.468 ' HD2' ' H ' ' A' ' 147' ' ' ASP . 9.7 t60 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 62.3 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.468 ' H ' ' HD2' ' A' ' 145' ' ' HIS . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 53.41 111.709 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 65.21 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 62.41 112.05 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 50.42 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 70.23 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.498 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 44.25 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 63.41 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.847 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 62.23 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 64.34 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.23 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 43.13 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 32.33 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.796 HG21 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 63.43 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 73.34 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.1 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.678 ' HB3' HD12 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.509 HD12 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 73.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 72.15 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 72.24 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 73.15 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 63.43 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.509 HH21 HD12 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 73.04 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 64.14 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.758 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 63.33 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.534 -0.543 . . . . 73.24 109.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 43.41 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 51.11 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 61.04 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.1 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.635 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 70.54 110.511 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 73.22 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 64.32 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.504 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 65.22 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.05 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 61.55 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' GLY . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 73.02 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 72.11 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.58 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 74.23 111.505 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 55.32 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 72.54 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 60.31 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 64.1 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 52.53 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 64.12 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 72.34 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 51.12 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 61.4 112.052 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 62.21 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.811 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 73.51 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 72.22 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 71.12 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 53.4 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 61.13 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 72.34 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 55.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 43.43 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 64.14 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 65.34 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.741 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 61.4 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.21 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.12 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 52.24 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.786 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 64.32 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 74.23 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 61.33 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.645 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.01 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.79 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 62.4 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.771 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 52.21 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 55.23 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 40.11 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 63.31 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 63.25 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 71.11 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 71.12 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 55.31 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 72.41 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 44.12 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 63.12 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.24 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 42.22 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 54.41 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 52.4 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 60.33 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 74.45 111.258 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 71.22 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.79 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 61.4 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 73.21 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.881 HD12 ' HB1' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 54.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 34.32 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 64.11 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 54.11 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 63.44 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.2 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 64.34 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.412 ' OH ' HG23 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 65.11 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 65.31 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 61.33 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.12 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.43 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 73.33 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 64.02 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 54.42 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 65.52 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 55.21 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 53.25 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 45.02 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 62.11 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 74.44 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 61.21 111.208 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 52.02 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.727 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.04 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 172' ' ' SER . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.811 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 62.23 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.94 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 63.52 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 50.55 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 60.03 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.94 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 71.34 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 64.22 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 64.43 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.469 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 62.12 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.983 -0.377 . . . . 71.11 109.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.72 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.12 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.654 ' HG2' HE21 ' A' ' 60' ' ' GLN . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 73.11 113.035 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 61.04 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 70.31 110.306 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 54.24 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 70.21 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 72.51 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 72.34 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 63.23 111.044 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 55.42 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 52.44 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.476 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.571 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 62.53 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.32 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.766 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.745 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.11 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 71.24 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.439 HD22 HD13 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 53.1 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB3' HD23 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 71.23 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 61.53 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.43 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.845 ' HB3' HD12 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 61.12 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 70.22 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 74.41 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 35.24 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 61.5 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 63.12 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 63.11 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 73.5 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.22 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.716 HD11 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 65.21 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.711 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 65.13 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.654 HE21 ' HG2' ' A' ' 7' ' ' LYS . 58.0 tp60 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 HD11 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 72.22 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' HG21 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 62.34 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 53.54 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 53.32 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 64.53 110.925 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 72.12 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.678 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.704 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 54.2 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 53.35 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 54.35 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.767 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 72.34 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.679 ' HB2' HG21 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 63.33 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.03 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 73.23 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 74.24 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 62.44 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 53.12 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 64.43 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.589 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 62.33 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.606 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 64.34 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 54.45 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 52.31 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.72 ' HB3' HD23 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 72.13 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 31.53 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 62.1 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 64.11 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HD2' HD12 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 65.0 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.584 HD12 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 55.14 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.14 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 72.04 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 64.32 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.529 HD22 HD13 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 63.45 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.767 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.59 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.589 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 63.33 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.482 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.766 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 62.14 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 52.02 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 72.4 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.512 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 52.23 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 54.43 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 54.11 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 73.44 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 71.21 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 60.54 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 72.33 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.476 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 71.31 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 62.12 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.736 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 73.51 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 52.52 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.618 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 71.12 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.745 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 62.13 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 64.41 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 54.45 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 63.15 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 64.41 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 54.42 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 45.13 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.725 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 73.45 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 53.35 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 72.35 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 72.25 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 72.35 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 72.12 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 64.0 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 55.22 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.656 -0.868 . . . . 55.13 108.656 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 54.32 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 72.44 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 62.34 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 41.54 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.02 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 23.33 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 63.45 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.25 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 33.44 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HD1' HG21 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.3 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 71.13 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 53.52 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.962 ' HB3' HD12 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 62.24 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 71.54 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 73.21 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 63.33 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.04 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 71.11 109.679 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 70.3 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.3 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 50.52 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.42 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 61.44 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.962 HD12 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 74.2 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 71.42 109.049 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.794 HD12 HD12 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 63.54 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 55.33 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 54.44 110.424 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HD12 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 71.21 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 72.24 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.849 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 63.52 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 54.42 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 61.23 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 55.22 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 45.12 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.23 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 70.44 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.718 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.695 -171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.31 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 64.51 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 64.53 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 74.14 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 50.03 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 71.24 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 54.4 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 60.1 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 70.42 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.748 ' HB2' HD11 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 71.31 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.561 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 65.42 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 23.12 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 44.42 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 62.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 62.44 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.738 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 61.33 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 63.41 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 64.31 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.506 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 72.01 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 41.12 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 55.13 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 51.12 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 52.2 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 42.42 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.561 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 72.31 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 34.33 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 53.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 51.34 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 61.3 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 51.13 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 53.43 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 149' ' ' VAL . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 64.42 112.03 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 72.13 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.785 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 63.34 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.785 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 70.41 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 HD22 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 70.31 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 51.14 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.528 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 64.51 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 65.31 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 62.22 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.718 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.14 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 74.25 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' HD23 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 71.45 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 62.31 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 62.53 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 72.02 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 71.42 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 55.35 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.749 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 71.11 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.14 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 70.14 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 73.35 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HA ' HG22 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 63.14 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.633 HG22 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.0 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 54.24 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 62.24 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 61.01 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 72.32 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 34.31 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 64.43 112.581 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.02 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 71.0 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 24.4 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 54.2 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.79 ' HD1' HG21 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 72.53 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 63.24 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 70.12 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 65.4 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 64.33 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.03 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 55.53 111.404 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 43.14 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 64.03 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.1 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 62.24 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 64.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.964 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.03 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 72.44 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.617 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 71.42 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 72.13 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 71.11 111.681 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 54.25 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 74.41 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 71.53 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 72.21 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 42.4 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 73.34 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 62.31 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 72.33 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 71.02 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 69' ' ' THR . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 65.35 112.942 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 61.32 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.85 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 54.24 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.649 HG12 HG11 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 72.22 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.444 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 40.11 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 65.41 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 71.31 111.124 -175.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HE1' HD12 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.33 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 61.2 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.644 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 72.15 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.775 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 65.45 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 53.24 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 72.24 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 60.25 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 65.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 31.53 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.705 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 45.22 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 53.15 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 53.45 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.62 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.4 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 63.42 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 23.21 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.635 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 44.31 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.31 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 44.34 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 73.34 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 62.13 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 45.23 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.602 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.13 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.05 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.85 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 63.11 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.11 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 53.34 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 54.22 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.03 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 60.25 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.739 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 51.04 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.463 HD13 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 52.15 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 53.54 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 51.54 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 51.41 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 53.22 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.62 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 54.34 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 65.35 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 31.02 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HA ' HG23 ' A' ' 22' ' ' THR . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 73.55 112.945 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 42.11 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 61.12 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.505 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 72.21 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 65.55 111.295 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.23 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.12 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 54.21 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 71.34 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 73.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 62.35 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 62.55 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 61.21 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 60.44 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 62.22 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 60.12 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 53.02 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 62.3 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.05 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 73.4 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 71.14 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 35.51 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 54.11 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 42.13 110.094 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 190' ' ' ARG . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.1 111.196 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' HA3' ' A' ' 183' ' ' GLY . 2.3 mpt? . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.725 0.298 . . . . 75.24 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 184' ' ' LEU . 20.0 m -123.28 144.55 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.894 0.378 . . . . 71.04 110.766 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -83.59 -62.38 1.59 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.561 -0.533 . . . . 72.33 109.561 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -115.8 130.59 24.25 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.388 -0.597 . . . . 65.44 109.388 173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.66 -174.68 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.673 2.249 . . . . 72.23 112.481 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 93' ' ' MET . 2.5 mp -87.29 132.07 33.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.237 -0.438 . . . . 53.33 110.808 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -118.42 6.54 11.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.254 -0.43 . . . . 62.02 110.419 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 81' ' ' LEU . 21.8 tp -168.66 135.13 1.86 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.06 -0.518 . . . . 73.13 110.541 -175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.737 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 7.2 tt -142.54 130.04 21.29 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.045 -0.724 . . . . 71.04 109.045 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG21 HG12 ' A' ' 78' ' ' ILE . 47.7 t -114.41 136.97 49.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 121.035 -0.266 . . . . 73.22 110.838 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -107.73 134.3 12.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.215 -0.517 . . . . 71.05 111.85 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 63.3 mt -118.33 119.24 34.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.867 0.334 . . . . 44.24 111.081 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.705 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -164.28 -168.36 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.524 . . . . 54.23 110.339 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -90.75 110.32 40.75 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.73 -0.471 . . . . 64.31 109.73 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 68' ' ' THR . 72.0 Cg_endo -75.37 155.31 41.24 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 123.11 2.54 . . . . 75.02 112.838 -175.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.44 130.69 1.44 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.684 -0.769 . . . . 74.41 111.536 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 10.5 Cg_endo -53.63 -27.02 39.91 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.056 2.504 . . . . 71.12 112.301 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -57.45 -40.9 79.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.638 -0.71 . . . . 73.23 111.193 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -110.17 -8.2 14.79 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.485 0.659 . . . . 71.15 109.966 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -73.29 -18.33 61.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.829 -1.078 . . . . 63.2 111.059 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.0 -1.58 44.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.592 0.71 . . . . 63.51 110.101 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 ' OG1' ' HE3' ' A' ' 156' ' ' LYS . 91.3 m -87.83 149.79 23.93 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.16 -0.927 . . . . 63.31 109.272 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HG2' HD12 ' A' ' 140' ' ' ILE . 35.5 ttm-85 -54.15 -27.49 33.9 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.44 0.533 . . . . 72.12 112.44 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.445 ' HA ' ' OD1' ' A' ' 97' ' ' ASP . 16.9 t-80 -77.58 37.48 0.22 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.87 -0.605 . . . . 74.42 111.792 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.705 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 p30 -109.38 11.43 25.15 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.62 0.6 . . . . 72.34 112.62 -173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' ASP . . . -52.12 -54.27 32.57 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.632 0.605 . . . . 61.42 112.632 -172.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -59.94 -31.75 73.23 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.739 -0.743 . . . . 50.32 113.227 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.87 -37.38 40.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.916 0.358 . . . . 72.14 111.461 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.719 ' HD1' HG21 ' A' ' 169' ' ' VAL . 8.2 t-105 -62.87 -32.44 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 74.34 111.414 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.679 HG12 HG13 ' A' ' 169' ' ' VAL . 7.3 m -82.08 -28.87 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.853 0.316 . . . . 52.14 111.853 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 71.5 t -66.53 -50.81 63.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.606 0.241 . . . . 54.3 111.517 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -70.67 -26.81 63.61 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.877 -0.329 . . . . 63.54 110.652 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 37' ' ' ILE . 15.0 tp10 -67.78 -38.09 82.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.459 -0.571 . . . . 73.02 109.459 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 91.2 mt -63.58 -41.15 98.39 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.93 0.395 . . . . 63.35 110.23 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.19 -40.03 76.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.686 . . . . 74.24 110.379 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 39.7 ttt180 -72.74 -49.14 32.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 65.11 111.714 -176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 33' ' ' GLU . 44.4 mm -60.31 -47.5 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.38 -0.373 . . . . 53.15 111.903 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.851 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 83.0 t60 -90.81 -12.44 36.38 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.977 -0.289 . . . . 62.53 111.259 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.63 56.28 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.808 0.813 . . . . 71.42 109.483 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.851 ' HB ' ' HD2' ' A' ' 38' ' ' HIS . 9.0 p -106.3 150.0 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.094 -0.957 . . . . 42.32 110.419 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 m -80.96 107.39 13.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.205 0.526 . . . . 63.53 110.725 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD12 ' HG ' ' A' ' 51' ' ' LEU . 1.8 mm? -75.77 109.18 9.16 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.105 -0.702 . . . . 52.32 109.105 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -98.27 128.01 44.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.866 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 14.4 p-10 -91.86 92.74 8.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.332 0.587 . . . . 74.31 109.929 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.55 115.13 65.88 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 70.14 110.927 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.92 -18.06 26.43 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.309 2.673 . . . . 64.14 112.693 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -51.18 -45.28 61.73 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.315 0.578 . . . . 73.13 110.616 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.05 -21.33 13.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.51 -0.922 . . . . 74.12 108.51 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.46 ' HD2' HD13 ' A' ' 73' ' ' LEU . 2.2 t80 65.37 61.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.591 -1.641 . . . . 73.41 109.971 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 44' ' ' ASN . . . -172.05 174.37 45.33 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.601 -1.181 . . . . 65.41 111.212 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 42' ' ' LEU . 19.2 tp -99.32 113.48 25.81 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.919 -0.4 . . . . 52.34 109.919 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.607 ' HB ' HD13 ' A' ' 65' ' ' LEU . 12.7 t -120.74 145.63 47.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 74.02 111.666 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.7 132.71 5.04 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.021 -0.536 . . . . 73.35 111.995 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 4.3 tmm_? -104.42 112.7 25.85 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.95 -0.389 . . . . 72.41 109.95 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 1.3 pt? -127.81 117.85 22.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.186 0.517 . . . . 51.32 112.242 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 8.9 tt -84.63 119.49 25.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.25 110.434 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.9 pt -122.49 138.37 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 54.43 109.666 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 66.66 -66.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.108 0.563 . . . . 74.12 111.28 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.7 p -157.07 -26.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.606 0.241 . . . . 41.31 111.547 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.491 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 6.7 tp60 -102.55 142.28 33.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 62.51 111.03 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 9.5 pt-20 -91.18 116.75 29.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.966 -0.561 . . . . 74.1 110.654 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -89.8 122.62 33.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.989 -0.551 . . . . 53.51 111.339 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.564 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 93.3 mtt180 -104.96 102.71 12.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.894 -0.593 . . . . 73.42 109.968 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.0 p -104.98 141.3 20.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.215 -0.448 . . . . 72.11 110.751 -174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 81' ' ' LEU . 22.5 tp -133.22 135.71 45.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.275 -0.42 . . . . 70.21 110.733 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.5 tt -122.35 115.81 29.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.474 -0.565 . . . . 60.0 109.474 170.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 13.7 Cg_exo -70.15 156.86 61.35 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 123.276 2.651 . . . . 74.42 113.481 -174.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 15' ' ' PRO . 7.4 p -68.11 -47.83 67.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 62.13 111.511 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 25.9 m -117.11 120.29 37.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.176 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 74' ' ' SER . 43.9 p90 -82.33 4.94 21.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.295 0.48 . . . . 74.43 112.295 -173.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' H ' HG22 ' A' ' 69' ' ' THR . 21.3 mmt -95.75 -73.65 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.619 -0.432 . . . . 70.11 111.468 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.42 -46.38 6.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.111 0.481 . . . . 61.2 112.019 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 93.5 mt -72.71 -10.01 59.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.363 0.505 . . . . 74.15 112.363 -172.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 3.2 p -66.02 -55.23 17.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.887 0.375 . . . . 71.43 111.22 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.04 -27.34 66.66 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.416 -0.897 . . . . 75.1 112.483 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -67.77 -34.53 76.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.862 0.363 . . . . 63.43 110.216 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB1' HD21 ' A' ' 65' ' ' LEU . . . -62.69 -47.22 84.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 109.854 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 HG22 ' A' ' 123' ' ' THR . 48.1 mt -64.93 -39.98 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.444 -0.798 . . . . 73.03 110.888 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -54.15 -45.74 72.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.923 -0.58 . . . . 54.22 111.619 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.62 -46.68 30.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.26 -0.427 . . . . 62.23 111.152 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.683 HD22 HD22 ' A' ' 65' ' ' LEU . 31.6 tp -60.93 -50.82 71.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 72.42 111.665 -174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.99 71.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 50.02 110.648 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -65.91 -53.89 33.6 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.972 -0.558 . . . . 63.33 111.459 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -63.77 -43.41 96.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.591 0.71 . . . . 75.1 109.894 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.834 ' HB3' HG12 ' A' ' 87' ' ' ILE . 5.6 m-30 -69.58 -19.44 63.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.727 -1.124 . . . . 75.44 111.677 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.22 32.55 21.92 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.175 0.512 . . . . 62.41 111.027 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.834 HG12 ' HB3' ' A' ' 85' ' ' TYR . 44.8 mm -90.16 129.56 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.667 -0.697 . . . . 72.41 109.99 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 92' ' ' ILE . 12.5 mptt -85.49 162.9 46.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 65.13 111.433 -172.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.437 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 72.4 Cg_exo -50.88 -36.09 51.51 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.662 2.908 . . . . 61.13 115.286 -173.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.28 -12.67 60.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.221 -0.592 . . . . 73.23 110.655 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.576 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 23.6 mt-10 -103.89 0.6 30.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.79 -0.641 . . . . 61.1 109.534 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LEU . 41.2 mm -107.66 115.58 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.513 -0.767 . . . . 72.45 110.311 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 64.4 mtp -115.7 154.63 29.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.068 0.461 . . . . 75.24 111.164 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 135' ' ' ARG . 84.7 t -134.04 129.77 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.965 -0.561 . . . . 64.43 110.57 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -104.84 105.36 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.638 -0.875 . . . . 75.12 108.638 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' ND1' HD11 ' A' ' 120' ' ' LEU . 3.7 p80 -122.02 155.58 35.28 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.842 -0.743 . . . . 73.41 111.956 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 21.5 t70 -64.51 135.17 55.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.402 -1.272 . . . . 51.44 110.697 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 137' ' ' ARG . 8.1 mm-40 -130.73 117.18 19.04 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.714 0.635 . . . . 75.43 112.714 -174.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.0 pt? -93.7 -9.06 39.06 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 72.34 110.21 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.89 -19.1 45.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 55.45 110.669 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 48.0 mt -113.55 145.52 33.51 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 73.23 110.999 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 28.3 Cg_endo -62.65 157.03 49.25 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.29 2.66 . . . . 72.21 112.733 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 24.2 Cg_exo -62.53 124.35 14.04 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.796 2.33 . . . . 62.22 112.394 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.4 32.0 8.55 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.647 -0.787 . . . . 54.11 113.047 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.543 HG12 ' HB2' ' A' ' 195' ' ' LYS . 9.9 m -133.55 148.77 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.966 -0.383 . . . . 63.15 109.966 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.86 163.37 23.08 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.165 -0.47 . . . . 71.14 109.889 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -169.56 132.95 1.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.257 -0.275 . . . . 65.35 110.257 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' N ' HD23 ' A' ' 191' ' ' LEU . 90.0 t80 -87.25 144.47 26.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.117 -0.327 . . . . 75.52 110.117 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.904 ' HE2' ' HA3' ' A' ' 113' ' ' GLY . 0.3 OUTLIER -129.58 122.61 29.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.94 -0.573 . . . . 70.34 109.988 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.608 ' HG3' ' HE1' ' A' ' 134' ' ' TYR . 8.0 tt0 -110.41 140.37 44.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.59 -0.732 . . . . 44.53 109.322 172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.36 -114.59 4.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.41 -0.9 . . . . 54.41 113.106 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -88.36 115.56 4.43 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.075 -0.583 . . . . 74.1 113.11 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.904 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -149.57 64.54 0.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.85 -0.691 . . . . 55.24 112.596 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.25 146.98 50.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.134 0.492 . . . . 74.22 110.782 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.57 -177.21 14.78 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.657 -0.977 . . . . 53.33 110.657 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.69 60.39 2.06 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.061 -0.59 . . . . 61.42 112.727 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -142.68 128.56 19.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.357 -0.609 . . . . 74.15 109.357 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -48.47 -60.59 2.57 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.686 0.616 . . . . 72.4 111.466 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.07 -24.05 34.13 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 116.098 -0.501 . . . . 33.24 114.105 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.454 HD11 ' ND1' ' A' ' 96' ' ' HIS . 4.2 mm? -83.92 -52.72 6.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.118 0.459 . . . . 50.23 111.428 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -83.27 -25.94 31.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.246 0.462 . . . . 74.41 112.246 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' N ' ' HD2' ' A' ' 121' ' ' LYS . 1.6 m-20 -67.56 -21.85 65.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 122.003 -0.436 . . . . 63.24 111.017 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.754 HG22 HD12 ' A' ' 78' ' ' ILE . 70.1 p -56.7 -29.43 62.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.531 0.682 . . . . 74.14 109.366 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.591 ' HA ' HD21 ' A' ' 130' ' ' ASN . 59.6 mt -79.24 -61.4 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.144 -0.935 . . . . 74.32 110.045 173.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 m -58.23 -28.02 64.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.244 0.831 . . . . 73.43 113.244 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 2.5 mmpt? -89.06 -20.43 24.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.573 0.583 . . . . 71.11 112.573 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 79' ' ' ALA . 78.8 mt -96.22 -24.08 16.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.057 0.456 . . . . 64.42 110.136 175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.02 -130.45 5.46 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.89 -0.671 . . . . 65.52 112.83 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -100.94 26.73 6.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.108 0.48 . . . . 72.34 110.237 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.591 HD21 ' HA ' ' A' ' 124' ' ' ILE . 3.5 p-10 -65.71 104.91 1.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.544 0.688 . . . . 74.41 111.586 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 -8.57 16.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.169 0.985 . . . . 51.33 108.58 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 37.9 tt0 -82.74 8.35 12.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.28 -1.327 . . . . 50.22 111.289 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -72.1 141.33 49.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.035 0.445 . . . . 75.03 111.771 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.608 ' HE1' ' HG3' ' A' ' 110' ' ' GLN . 21.9 m-30 -99.4 149.6 23.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.309 -0.405 . . . . 64.24 110.323 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 6.6 ptp180 -168.07 147.78 4.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.378 -0.373 . . . . 72.53 110.755 173.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 pp -111.3 151.55 28.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.942 -0.572 . . . . 72.34 110.681 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.846 ' HB3' ' HG3' ' A' ' 98' ' ' GLU . 75.4 mtt-85 -100.44 132.35 45.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.687 . . . . 71.13 111.078 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 23.9 mt -111.37 107.56 16.85 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.649 -0.5 . . . . 70.45 109.649 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -70.33 120.5 9.34 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 64.14 113.214 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 23' ' ' ARG . 29.8 pt -118.49 -23.26 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.811 0.338 . . . . 74.14 111.244 176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -86.67 125.63 7.51 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 121.106 -0.569 . . . . 42.34 113.044 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -103.16 129.63 25.19 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.662 -0.415 . . . . 60.33 110.043 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.65 114.17 2.81 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.793 2.329 . . . . 61.12 112.827 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.42 -88.85 0.46 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.163 -0.775 . . . . 64.22 111.163 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -105.51 120.21 41.05 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.116 -0.698 . . . . 74.11 109.116 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -64.98 -21.26 66.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 72.22 111.331 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.05 -19.82 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.031 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -113.49 23.42 13.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.303 -0.408 . . . . 72.13 110.874 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.7 m -60.62 -33.95 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 63.31 112.278 -177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.37 -18.69 65.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 73.3 111.214 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.48 -24.37 73.03 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.436 -0.888 . . . . 73.11 112.009 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.7 m-85 -85.07 -45.37 12.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.202 -0.666 . . . . 74.44 109.202 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 149' ' ' VAL . 58.4 t -43.97 -54.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 114.15 -1.386 . . . . 73.25 112.718 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.0 pt? -121.78 39.21 3.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.116 -0.634 . . . . 74.4 111.427 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.99 170.07 30.12 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.192 -1.163 . . . . 44.3 110.192 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.454 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 13.5 mptt -88.08 125.46 34.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 117.704 0.752 . . . . 63.21 110.056 177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.48 125.08 51.01 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 116.401 -0.363 . . . . 70.01 110.131 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 46.8 Cg_exo -56.92 152.98 40.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.625 2.217 . . . . 72.04 111.101 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -50.56 -39.26 48.97 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.247 0.342 . . . . 75.25 111.863 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -63.64 -29.43 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.314 -0.403 . . . . 71.15 111.788 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -89.29 -36.74 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 55.32 110.188 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -22.55 67.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 73.34 111.485 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 39.4 mt-10 -58.93 -30.49 67.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.668 0.27 . . . . 75.33 111.088 174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 51.4 m -66.91 -38.91 87.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.096 0.475 . . . . 75.33 109.977 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.17 -40.89 74.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.309 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.15 -40.46 81.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.292 -0.413 . . . . 65.12 110.621 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.52 93.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.81 -0.632 . . . . 72.22 110.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.64 -53.53 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 25.03 110.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.719 HG21 ' HD1' ' A' ' 29' ' ' TRP . 69.9 t -50.66 -40.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.081 -0.509 . . . . 72.35 111.62 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -56.55 -44.47 80.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 62.23 111.763 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 1.1 pp20? -85.73 -32.37 21.93 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.303 -0.559 . . . . 55.53 110.786 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.4 m -61.16 -30.4 70.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 31.44 111.709 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.88 -32.49 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.743 -0.383 . . . . 72.44 111.416 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.733 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 13.1 ptp180 -84.19 -23.14 30.68 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.123 -0.231 . . . . 74.4 111.582 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.47 ' SG ' HD13 ' A' ' 191' ' ' LEU . 28.3 p -74.59 -21.3 59.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 73.12 110.653 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -58.13 -36.07 72.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.116 0.484 . . . . 72.24 110.326 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -63.85 -46.76 83.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.606 -0.724 . . . . 60.44 110.071 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.2 mt -61.56 -37.67 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 72.42 110.644 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.854 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.6 tt -61.36 -45.95 92.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.826 -0.625 . . . . 74.33 111.009 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 23.4 ptp -84.21 -12.01 55.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.871 0.367 . . . . 74.25 111.287 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -97.87 -54.51 3.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.278 -0.419 . . . . 72.1 111.355 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.628 ' OD2' ' HG2' ' A' ' 186' ' ' LYS . 16.0 t0 -114.1 -7.06 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 72.03 111.547 -173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 1' ' ' MET . . . 125.2 152.04 8.16 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.434 -0.889 . . . . 61.32 112.537 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.854 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -64.22 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.707 0.289 . . . . 75.13 110.838 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -31.49 72.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.288 -0.415 . . . . 62.43 111.038 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.628 ' HG2' ' OD2' ' A' ' 182' ' ' ASP . 1.2 mptm? -71.4 -41.39 69.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.81 0.338 . . . . 75.14 110.283 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.41 92.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.942 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -57.4 -42.19 81.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.653 -0.703 . . . . 74.34 110.969 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -67.45 -22.94 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 62.55 111.798 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -86.98 -46.39 9.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.104 0.478 . . . . 64.52 110.109 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 175' ' ' CYS . 11.2 tp -48.96 -63.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.432 -1.258 . . . . 74.45 112.705 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -85.72 6.62 26.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.51 -0.476 . . . . 64.22 111.993 -174.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.5 m -95.26 -21.62 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.39 0.614 . . . . 62.32 109.456 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -86.78 112.37 21.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.746 -0.835 . . . . 75.15 108.746 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HB2' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.22 149.61 36.65 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 72.11 110.192 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.98 109.82 6.81 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.374 -0.602 . . . . 61.11 109.374 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.376 -0.821 . . . . 71.24 111.093 -177.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.574 -0.528 . . . . 51.2 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.7 143.61 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 74.1 111.717 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.411 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 28.9 m -94.44 5.04 53.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.264 -0.88 . . . . 75.4 110.111 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.704 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 15.7 mm100 -97.6 108.85 47.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.617 . . . . 74.15 110.698 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 3' ' ' SER . 4.8 Cg_exo -80.94 125.01 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.975 2.45 . . . . 70.12 111.65 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -66.1 130.19 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.728 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -86.67 -43.92 12.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.319 0.58 . . . . 74.33 110.83 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pt? -155.74 147.19 22.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.426 -0.806 . . . . 73.3 110.253 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.86 148.66 49.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.748 0.308 . . . . 45.13 110.357 179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 30.7 m -105.6 151.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 75.31 110.911 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.79 141.86 13.25 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.913 -0.661 . . . . 74.52 111.964 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.6 mt -123.55 120.8 33.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.792 0.296 . . . . 65.13 110.767 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.925 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.22 178.07 5.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.89 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 13.6 m120 -62.88 115.53 17.82 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.928 -0.578 . . . . 73.43 111.249 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 6.7 Cg_endo -87.37 104.73 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.431 2.754 . . . . 71.33 112.233 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.6 143.93 4.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.953 -0.641 . . . . 60.01 111.836 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 18.0 Cg_endo -59.01 -29.76 91.54 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.149 2.566 . . . . 75.21 112.412 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.74 -45.99 92.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.65 . . . . 74.23 110.97 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.814 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 2.8 m-85 -98.85 -6.02 29.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.563 0.697 . . . . 71.01 110.123 -173.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -67.19 -13.95 62.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.892 -1.049 . . . . 43.01 112.017 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 8.5 ptpt -96.33 -4.82 41.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.419 0.628 . . . . 75.05 110.263 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 24' ' ' HIS . 5.0 m -81.22 147.99 29.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.196 -0.911 . . . . 73.41 109.199 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 153' ' ' VAL . 56.3 mtt180 -61.0 -29.86 69.95 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.066 0.765 . . . . 73.13 113.066 -171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.547 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 20.5 t-80 -76.27 34.95 0.14 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.141 0.496 . . . . 64.01 111.244 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.925 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 21.3 t-20 -111.27 9.43 21.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.16 -0.473 . . . . 63.14 110.672 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -45.96 -50.24 14.99 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.165 0.802 . . . . 61.52 113.165 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -58.2 -47.12 91.35 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.752 -0.737 . . . . 53.44 113.182 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.04 -35.28 64.32 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.642 0.238 . . . . 54.45 111.642 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -56.39 -43.58 79.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.912 -0.586 . . . . 73.42 111.392 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 169' ' ' VAL . 30.8 m -83.24 -21.89 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.002 0.371 . . . . 73.44 112.002 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 27' ' ' GLY . 54.6 t -71.91 -42.35 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.293 0.568 . . . . 71.13 110.282 176.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -67.39 -24.81 65.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.483 -0.78 . . . . 74.21 110.513 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.2 tp10 -66.6 -39.38 88.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.094 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.571 HD22 HD11 ' A' ' 55' ' ' LEU . 95.6 mt -58.12 -37.77 75.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.27 -0.423 . . . . 73.02 110.822 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -60.45 -38.91 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.721 -0.672 . . . . 72.41 110.752 177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.5 ttp-105 -81.46 -38.83 25.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.445 -0.798 . . . . 74.13 111.256 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 33' ' ' GLU . 40.9 mm -64.14 -48.28 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.781 0.289 . . . . 74.45 111.781 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -95.09 -9.84 32.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.53 0.205 . . . . 64.02 110.816 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 54.11 56.23 7.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.839 0.828 . . . . 71.24 108.952 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 35' ' ' ALA . 14.2 p -107.42 149.12 11.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.005 -0.998 . . . . 71.01 110.119 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -81.39 106.63 13.51 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.057 0.456 . . . . 63.53 111.437 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 35' ' ' ALA . 3.0 mm? -72.88 105.28 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.006 -0.739 . . . . 71.53 109.006 171.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 8.3 mtmp? -97.75 119.42 36.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.529 . . . . 73.12 111.201 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -64.98 119.65 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.568 -0.53 . . . . 74.42 109.568 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -106.34 110.33 63.81 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.128 -0.487 . . . . 73.14 109.784 -177.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 2.9 Cg_exo -78.3 0.16 10.16 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.522 2.815 . . . . 74.44 114.392 -173.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 37.0 mtmm -101.01 -43.04 6.17 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.058 -0.401 . . . . 71.42 110.131 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.42 -11.77 48.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.502 0.668 . . . . 71.3 109.451 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 t80 70.9 21.77 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.926 -1.488 . . . . 71.24 110.757 172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.12 164.09 24.22 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.694 -0.765 . . . . 72.34 112.662 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 23.5 tp -85.58 120.01 26.55 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.019 -0.734 . . . . 73.35 109.019 177.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 65' ' ' LEU . 43.2 p -108.65 149.79 28.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.289 0.478 . . . . 44.44 112.289 -171.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.82 153.67 24.99 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.884 -0.598 . . . . 62.11 111.839 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' HG2' ' A' ' 63' ' ' ARG . 2.4 ttm180 -137.33 109.13 7.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.317 -0.623 . . . . 74.02 109.317 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD11 HD22 ' A' ' 34' ' ' LEU . 1.6 pt? -130.55 118.68 21.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.327 0.584 . . . . 63.31 111.768 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.3 tt -68.67 115.8 8.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 74.25 110.105 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.92 129.3 71.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.41 -0.814 . . . . 64.43 109.348 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.9 t30 70.64 -64.43 0.37 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.727 0.642 . . . . 60.04 111.358 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 t -163.79 0.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.522 0.201 . . . . 72.03 111.334 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 60.3 tp60 -129.96 137.1 50.15 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.86 -0.336 . . . . 71.55 110.104 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 10.1 pt-20 -71.4 110.43 6.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.25 0.548 . . . . 74.23 110.511 177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 tt -93.63 125.02 38.01 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.79 -0.641 . . . . 51.2 110.171 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.754 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 59.6 mtt180 -106.29 152.57 23.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.488 -177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.8 p -139.71 147.91 23.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.041 -0.527 . . . . 62.01 110.529 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 81' ' ' LEU . 9.8 tt -143.23 128.15 18.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 61.43 110.162 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -121.77 116.06 30.5 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.27 -0.423 . . . . 65.33 110.054 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.91 143.25 91.02 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.791 2.328 . . . . 64.44 111.832 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 p -75.92 -3.92 38.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.324 0.583 . . . . 74.13 111.0 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 86.9 m -140.21 100.07 3.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.689 -0.687 . . . . 61.02 109.591 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -86.72 -1.57 57.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.565 . . . . 73.32 111.658 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -91.61 -70.28 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.976 -0.29 . . . . 72.12 111.273 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -96.85 -48.6 5.39 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.03 0.381 . . . . 61.05 112.03 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 95.0 mt -87.32 23.05 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.376 -0.375 . . . . 72.52 111.82 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -72.82 -63.17 1.22 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.788 0.328 . . . . 54.43 111.502 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.24 -27.15 73.85 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.808 -0.711 . . . . 71.13 112.497 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HD2' HD23 ' A' ' 73' ' ' LEU . 96.3 mttt -63.15 -39.84 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 71.44 110.305 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.6 -43.42 89.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.885 -0.598 . . . . 54.45 110.223 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 47.5 mt -66.24 -32.88 60.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.539 -0.755 . . . . 64.34 110.454 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -59.18 -47.59 84.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.57 -0.741 . . . . 53.12 111.819 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.39 76.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.916 0.389 . . . . 60.24 110.832 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HE1' ' A' ' 84' ' ' PHE . 38.7 tp -62.1 -56.58 17.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 75.45 111.529 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.94 67.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.307 -0.406 . . . . 64.51 110.773 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -66.8 -54.73 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 70.5 111.87 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HE1' HD12 ' A' ' 81' ' ' LEU . 8.6 p90 -71.86 -33.87 68.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.466 -0.494 . . . . 72.44 110.646 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -74.32 -22.75 59.11 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 120.639 0.257 . . . . 73.55 111.285 178.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.13 31.09 13.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.954 -0.566 . . . . 74.04 111.677 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 91' ' ' GLU . 47.1 mm -85.98 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.317 -0.623 . . . . 60.11 109.317 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 3.8 mptp? -79.45 159.94 71.15 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.992 -0.549 . . . . 73.23 112.178 -165.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 1.6 Cg_endo -42.89 -50.07 6.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.456 3.437 . . . . 54.04 114.572 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.704 ' HG3' ' HG3' ' A' ' 4' ' ' GLN . 1.4 pm0 -75.14 -3.33 32.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 61.22 111.636 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HB2' HG22 ' A' ' 87' ' ' ILE . 28.8 mt-10 -106.09 -5.07 19.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.178 0.514 . . . . 71.13 109.898 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.13 126.21 53.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.523 -0.762 . . . . 73.12 109.355 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 6.3 tmm? -123.37 133.08 54.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.699 0.285 . . . . 74.33 110.297 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 135' ' ' ARG . 39.1 t -113.6 110.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.931 0.396 . . . . 71.55 111.29 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.93 110.1 21.79 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.805 -0.442 . . . . 70.04 109.805 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 98' ' ' GLU . 3.7 p80 -132.31 154.04 50.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.165 -0.614 . . . . 74.23 111.43 -175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 11.3 t70 -67.79 123.97 22.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.152 -0.931 . . . . 74.02 110.414 175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 137' ' ' ARG . 31.1 tt0 -142.35 120.23 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 74.41 110.919 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.8 pp -76.08 13.68 0.84 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.55 0.574 . . . . 73.23 112.55 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.49 -27.09 62.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.022 0.439 . . . . 32.54 111.12 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.53 ' HB2' ' HA2' ' A' ' 139' ' ' GLY . 96.0 mt -109.01 147.6 36.23 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.799 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.516 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 33.2 Cg_exo -63.1 151.12 86.38 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.946 2.43 . . . . 55.51 111.751 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 19.2 Cg_endo -59.06 113.87 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.076 2.517 . . . . 73.15 113.258 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.561 ' HA3' ' HB3' ' A' ' 164' ' ' CYS . . . 119.13 -10.37 11.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.454 -0.879 . . . . 53.15 114.194 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 195' ' ' LYS . 22.5 m -107.67 166.55 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.63 0.715 . . . . 63.22 111.12 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.86 159.46 41.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.445 -0.343 . . . . 71.01 110.229 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -160.92 133.73 6.3 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.772 0.32 . . . . 74.41 110.982 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.54 173.75 12.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.998 -0.546 . . . . 71.23 111.504 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.718 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -159.19 121.19 3.44 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 70.33 110.093 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -111.01 128.02 55.72 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.765 -0.828 . . . . 75.32 108.765 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.21 -124.02 5.6 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.393 -0.908 . . . . 73.12 112.186 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.51 112.74 5.0 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 121.372 -0.442 . . . . 71.21 112.753 -172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.584 ' HA3' ' CZ ' ' A' ' 133' ' ' PHE . . . -103.04 21.54 39.7 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.511 -0.852 . . . . 75.11 113.586 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -75.99 146.52 39.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.236 0.518 . . . . 74.32 110.025 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.83 11.49 8.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.4 112.468 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 9.2 79.02 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.136 -0.554 . . . . 51.2 113.408 176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -142.52 152.55 42.76 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.585 -0.524 . . . . 73.3 109.585 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -45.65 -42.31 11.31 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.791 0.682 . . . . 75.02 112.774 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.71 -48.74 49.49 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.236 -0.507 . . . . 73.04 113.284 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.95 -32.17 25.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.246 0.545 . . . . 75.24 110.548 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -69.49 -32.24 71.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 73.42 111.5 -175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.89 -36.5 84.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.711 0.291 . . . . 50.34 110.683 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.5 m -61.3 -39.87 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.099 0.476 . . . . 75.31 110.019 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 48.6 mm -69.2 -34.74 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.527 0.68 . . . . 74.23 110.437 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 t -74.27 -33.82 63.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.8 -0.636 . . . . 73.33 111.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 79' ' ' ALA . 23.0 tttp -92.55 -50.71 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 71.15 111.596 -173.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.796 HD11 ' HA ' ' A' ' 79' ' ' ALA . 91.3 mt -120.53 19.66 11.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 60.15 111.077 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 124' ' ' ILE . . . -73.94 6.3 20.61 Favored Glycine 0 CA--C 1.516 0.147 0 C-N-CA 121.114 -0.565 . . . . 74.43 113.561 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.12 -31.31 69.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.07 -0.715 . . . . 71.12 109.07 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -103.28 96.13 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.531 -0.758 . . . . 74.25 109.502 171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -83.21 -11.85 57.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.158 -0.928 . . . . 64.22 110.581 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -79.19 39.4 0.38 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 70.35 112.441 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.584 ' CZ ' ' HA3' ' A' ' 113' ' ' GLY . 47.3 p90 -106.99 149.06 27.93 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.245 0.545 . . . . 72.1 111.336 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 93' ' ' MET . 46.5 m-85 -89.09 149.82 23.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.618 -0.719 . . . . 64.53 111.309 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.718 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 7.5 ppt_? -161.77 128.41 3.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.846 -0.615 . . . . 71.3 110.172 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.71 152.07 24.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 64.23 109.848 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.564 ' HG3' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -130.5 156.25 45.11 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.523 -0.471 . . . . 74.1 110.378 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD12 ' HB1' ' A' ' 26' ' ' ALA . 80.9 mt -103.46 146.64 28.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.609 -0.723 . . . . 73.33 109.797 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -75.99 116.6 4.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.953 -0.641 . . . . 60.14 112.169 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.541 HG13 ' OD2' ' A' ' 97' ' ' ASP . 44.0 mm -120.77 -30.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.202 0.525 . . . . 64.05 111.033 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.41 133.11 11.53 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.791 -0.719 . . . . 45.22 112.863 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -103.12 134.57 19.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.349 . . . . 62.33 110.75 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 24.2 Cg_exo -64.77 122.51 10.37 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.041 2.494 . . . . 75.53 112.271 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.25 -114.6 0.3 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.091 -0.576 . . . . 63.0 112.065 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 132.91 53.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.187 -0.301 . . . . 64.31 110.187 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.925 ' HA ' HG13 ' A' ' 149' ' ' VAL . 9.8 mptt -78.61 -20.2 50.98 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.883 0.327 . . . . 65.11 111.883 -174.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.72 -27.32 62.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -127.32 29.98 5.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.603 -0.271 . . . . 72.21 111.357 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.925 HG13 ' HA ' ' A' ' 146' ' ' LYS . 3.3 m -51.64 -54.61 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 121.234 -0.186 . . . . 50.32 111.278 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.618 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -58.04 -31.15 66.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.632 -0.258 . . . . 43.34 111.151 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.29 -52.59 51.76 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.042 -0.526 . . . . 74.3 113.051 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 11.7 p90 -85.72 -26.79 25.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 120.082 -0.647 . . . . 65.44 111.913 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 37.1 t -63.11 -46.22 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.862 0.319 . . . . 71.35 111.862 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.8 pp -109.64 12.78 24.11 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.102 -0.639 . . . . 71.21 111.548 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -79.53 176.29 54.74 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.211 -1.155 . . . . 34.11 110.211 170.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -78.94 143.71 35.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.337 0.569 . . . . 64.43 110.041 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 23' ' ' ARG . . . -82.66 124.67 77.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 75.44 110.725 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.3 147.99 67.04 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.244 1.963 . . . . 74.13 110.78 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.25 -42.43 51.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.922 0.341 . . . . 54.43 111.922 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.29 -43.58 74.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.356 0.41 . . . . 73.21 111.899 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.14 -30.48 18.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.279 0.561 . . . . 72.33 111.071 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -22.88 60.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 70.24 111.657 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -27.22 68.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 73.14 110.68 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.561 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . 61.1 m -66.99 -40.03 87.27 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.549 -0.538 . . . . 72.14 109.549 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 68.8 tp -68.5 -44.35 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.716 . . . . 62.14 110.525 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.69 -38.19 80.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.54 -0.754 . . . . 70.43 111.215 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.7 -35.76 60.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 64.52 111.208 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.7 69.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.275 -0.421 . . . . 75.14 111.639 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.601 HG13 HG12 ' A' ' 30' ' ' VAL . 46.4 t -51.44 -41.06 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.14 -0.482 . . . . 74.34 111.976 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 21.9 t70 -58.22 -60.29 3.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.196 -0.298 . . . . 75.54 110.196 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 191' ' ' LEU . 8.7 tp10 -59.36 -31.29 69.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.786 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 51.2 m -56.63 -48.19 78.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.996 -0.547 . . . . 72.13 111.091 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.5 m -83.94 -22.16 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.483 -0.487 . . . . 74.14 111.445 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 33.4 mmt180 -66.94 -40.22 87.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.869 -0.15 . . . . 73.55 111.37 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.624 ' HA ' ' HB1' ' A' ' 187' ' ' ALA . 30.0 p -59.0 -38.42 79.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 70.15 110.749 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.52 -36.47 71.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 72.13 110.187 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -64.36 -51.35 63.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 74.23 110.467 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.814 ' HB ' ' HB2' ' A' ' 187' ' ' ALA . 48.2 mm -64.06 -33.34 61.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.0 -0.545 . . . . 73.31 110.762 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.749 HD12 HD13 ' A' ' 184' ' ' LEU . 8.2 tt -52.97 -44.12 66.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 72.23 110.777 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.405 ' SD ' ' HB3' ' A' ' 60' ' ' GLN . 20.0 ptt? -100.44 3.69 43.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 75.24 111.392 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 178' ' ' ILE . 17.8 ttmm -101.63 -59.16 1.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.973 0.416 . . . . 72.01 110.964 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.32 -8.91 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.933 -0.576 . . . . 65.31 111.529 -170.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.44 138.0 4.98 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.674 -0.774 . . . . 42.23 112.841 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.749 HD13 HD12 ' A' ' 179' ' ' LEU . 61.8 tp -56.57 -38.46 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.499 0.32 . . . . 74.3 111.781 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.7 m -56.75 -36.28 69.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.983 0.421 . . . . 54.34 111.488 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -76.36 -35.98 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 71.02 110.428 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB2' ' HB ' ' A' ' 178' ' ' ILE . . . -66.04 -39.29 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 71.1 110.087 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -57.96 -32.95 68.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.179 -0.918 . . . . 74.5 111.563 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.83 -31.53 64.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 73.41 110.618 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -82.43 -51.51 7.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.682 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 171' ' ' GLU . 23.6 tp -53.35 -39.42 64.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.308 -0.86 . . . . 55.43 112.521 -173.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -83.29 -23.61 32.55 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.789 0.292 . . . . 65.34 111.789 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.2 m -92.22 -21.39 20.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.715 0.293 . . . . 73.02 111.509 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -78.22 110.04 12.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.087 0.47 . . . . 72.24 111.089 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -147.68 154.84 41.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.677 -0.692 . . . . 62.21 109.534 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.33 90.69 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.909 0.385 . . . . 71.31 109.999 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.515 -0.755 . . . . 63.31 110.53 -175.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.438 -0.578 . . . . 72.43 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -140.23 123.06 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.548 -0.751 . . . . 75.24 109.806 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 t -70.53 -23.97 62.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 61.11 110.128 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.97 116.35 59.8 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.083 -0.508 . . . . 64.34 109.699 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.3 127.72 19.82 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.766 2.311 . . . . 74.31 112.076 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.572 ' HB ' HE22 ' A' ' 60' ' ' GLN . 1.9 mp -64.78 129.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.213 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 87' ' ' ILE . 3.7 ttmp? -80.2 -63.68 1.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.345 -0.843 . . . . 65.43 111.429 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 8.5 tt -168.87 148.31 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.267 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.702 HD12 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -113.86 139.71 48.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.282 0.563 . . . . 74.33 110.558 175.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HG12 ' A' ' 78' ' ' ILE . 44.4 t -110.53 126.77 67.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.591 -0.731 . . . . 73.34 110.645 -175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.5 133.63 11.41 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.81 -0.709 . . . . 52.43 111.594 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 58.4 mt -108.56 112.77 25.3 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.723 -0.281 . . . . 70.53 110.54 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -154.04 -165.67 2.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.487 -0.324 . . . . 65.32 111.472 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.654 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 17.8 m120 -97.47 101.0 9.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.819 -0.628 . . . . 64.03 110.205 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 6.3 Cg_exo -82.09 37.69 0.7 Allowed 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.835 3.023 . . . . 63.53 112.469 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 19' ' ' TYR . . . -137.24 139.22 10.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.477 -0.649 . . . . 54.54 111.477 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 53.1 Cg_exo -53.04 -42.01 67.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.377 2.718 . . . . 72.52 113.375 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.45 -19.61 59.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.053 0.454 . . . . 63.42 110.777 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.654 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 29.6 m-85 -100.79 -14.74 17.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.976 -0.557 . . . . 70.21 110.799 -175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.95 64.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.667 0.618 . . . . 71.14 112.667 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -77.3 -2.26 33.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.22 0.452 . . . . 71.44 112.22 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.2 m -78.75 154.08 30.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.676 -0.238 . . . . 64.13 110.473 -178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 152' ' ' TYR . 11.9 tpt180 -53.74 -32.76 53.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.173 0.589 . . . . 72.35 111.785 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.482 ' HD1' ' CG ' ' A' ' 97' ' ' ASP . 85.6 t60 -74.81 36.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.962 -1.017 . . . . 72.11 110.978 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -86.15 -27.08 24.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.902 -0.59 . . . . 73.12 112.197 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.715 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -44.18 -48.74 9.25 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.889 1.07 . . . . 62.52 113.889 -167.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -57.63 -32.36 65.04 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 121.012 -0.613 . . . . 54.01 113.663 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.07 -37.34 26.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.226 0.513 . . . . 72.13 111.152 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 169' ' ' VAL . 11.3 t-105 -65.05 -36.14 83.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 61.32 110.384 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 169' ' ' VAL . 14.2 m -74.57 -35.99 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.667 -0.242 . . . . 70.13 111.398 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 66' ' ' ILE . 46.9 t -62.41 -47.81 91.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 72.14 111.019 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -74.54 -22.2 59.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 72.02 110.85 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 36' ' ' ARG . 10.0 tp10 -62.74 -41.03 98.98 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.028 -0.36 . . . . 53.33 110.028 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 4.1 mm? -60.06 -40.58 89.94 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.421 . . . . 65.55 110.694 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -57.44 -39.48 76.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.092 0.472 . . . . 64.23 110.734 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 18.9 ttt180 -68.13 -29.95 68.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.64 -0.709 . . . . 71.22 111.413 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 33' ' ' GLU . 51.5 mm -66.2 -55.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.007 0.373 . . . . 60.52 112.007 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -112.54 7.09 18.79 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.988 -0.685 . . . . 75.23 111.305 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 58.41 31.9 21.47 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.744 0.783 . . . . 65.25 110.661 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.32 136.7 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.642 -0.873 . . . . 64.23 108.642 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 19.7 m -79.7 116.35 19.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.028 0.442 . . . . 54.4 110.461 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.6 mm? -65.34 117.04 7.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.791 . . . . 24.21 109.624 175.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 41' ' ' THR . 6.9 mtmp? -114.48 131.65 56.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 73.13 111.472 -169.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -71.3 118.7 14.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.092 0.472 . . . . 70.52 110.355 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -106.32 107.51 60.04 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.053 -0.521 . . . . 73.33 109.689 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_exo -71.92 -4.6 15.42 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 123.425 2.75 . . . . 70.32 114.492 -172.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 37.9 mtmm -85.58 -32.71 21.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.213 -0.595 . . . . 64.3 110.65 177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 2.3 m-85 -98.42 -25.27 14.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.638 -0.875 . . . . 72.33 108.638 174.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 68.96 55.97 0.42 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.656 -1.611 . . . . 73.34 110.09 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.77 163.71 30.95 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.305 -0.861 . . . . 63.41 111.932 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 15.4 tp -85.15 116.05 23.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.997 -0.742 . . . . 70.34 108.997 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 44.9 p -119.42 144.15 47.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.155 0.428 . . . . 74.0 112.155 -171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.0 132.74 3.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.017 -0.611 . . . . 74.53 111.962 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 10.6 ttm180 -91.14 105.78 18.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.834 -0.432 . . . . 64.13 109.834 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 34' ' ' LEU . 4.2 mm? -104.14 106.95 17.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.163 0.506 . . . . 72.04 111.614 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.4 tt -87.11 118.22 26.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.793 -0.64 . . . . 61.03 109.976 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' SD ' ' A' ' 180' ' ' MET . 30.5 pt -132.21 154.85 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.74 -0.664 . . . . 65.53 109.416 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 t30 62.71 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.311 0.382 . . . . 44.51 110.619 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.3 m -157.88 9.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.872 0.368 . . . . 74.42 110.336 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.572 HE22 ' HB ' ' A' ' 6' ' ' ILE . 45.6 tt0 -131.16 145.59 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.493 -176.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.6 pt-20 -85.15 128.79 34.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.124 -0.489 . . . . 65.32 110.332 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -119.38 110.33 16.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.04 0.448 . . . . 72.35 110.046 176.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.501 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.6 mtt180 -87.17 142.96 27.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.115 -0.493 . . . . 73.03 109.876 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.0 p -122.33 145.53 28.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.56 -0.291 . . . . 70.01 110.598 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' A' ' 8' ' ' LEU . 7.1 tt -139.91 138.39 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.414 . . . . 71.31 110.042 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.594 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.9 tt -141.39 116.95 7.19 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.898 0.38 . . . . 73.03 110.091 172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HG2' ' HA ' ' A' ' 74' ' ' SER . 2.6 Cg_exo -76.07 147.84 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.101 2.534 . . . . 73.51 112.037 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 15' ' ' PRO . 31.6 p -73.68 -47.21 41.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.312 0.577 . . . . 54.33 110.84 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 72' ' ' ASN . 44.7 m -86.14 92.36 8.72 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.158 -0.474 . . . . 64.31 109.961 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -73.36 1.18 10.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.663 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -96.74 -57.52 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.384 -0.371 . . . . 74.24 110.645 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.724 ' H ' HG22 ' A' ' 69' ' ' THR . 27.6 t-20 -96.54 -45.4 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.698 0.629 . . . . 63.35 112.698 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.29 -6.1 59.36 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.691 0.626 . . . . 64.51 112.691 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.581 ' HA ' ' HG2' ' A' ' 67' ' ' PRO . 16.5 m -51.49 -53.27 39.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.06 0.393 . . . . 74.42 112.06 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.62 -27.79 23.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.989 -1.101 . . . . 51.25 112.582 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 58.5 mtpt -65.84 -37.53 86.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.63 0.252 . . . . 72.52 110.873 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.18 -43.76 98.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 52.13 109.894 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 HG21 ' A' ' 10' ' ' VAL . 60.3 mt -65.19 -42.26 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.375 -0.829 . . . . 72.31 110.401 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.31 -51.11 71.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.486 -0.779 . . . . 72.4 111.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.56 92.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 72.04 110.677 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' HD22 ' A' ' 8' ' ' LEU . 16.2 tp -53.68 -62.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.67 -0.695 . . . . 62.13 111.527 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.4 -35.16 76.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.171 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -66.89 -49.86 64.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.44 0.533 . . . . 65.35 112.44 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 8.9 m-85 -66.82 -38.44 86.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.686 0.755 . . . . 74.44 109.737 -177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -69.73 -18.97 63.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.691 -1.14 . . . . 74.33 111.248 176.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 67.27 15.93 10.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.375 0.67 . . . . 70.12 112.124 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 7' ' ' LYS . 10.4 mt -102.51 150.54 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 110.114 -0.328 . . . . 74.44 110.114 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 12.2 mptt -59.75 167.93 2.28 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.791 -0.641 . . . . 73.04 112.635 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 55.8 Cg_endo -71.71 -24.99 21.01 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.633 2.222 . . . . 72.12 113.779 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 132' ' ' GLU . 29.4 tt0 -53.12 -49.21 66.97 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.275 0.842 . . . . 65.12 113.275 -168.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -87.81 23.7 1.95 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 53.14 111.773 -177.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 27.2 mm -88.96 104.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.966 -1.124 . . . . 72.45 107.966 166.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.35 115.96 29.56 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.644 -0.422 . . . . 64.42 111.196 -174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 48.1 t -98.17 131.87 44.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.599 -0.273 . . . . 70.53 110.58 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -131.11 131.36 44.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.773 -0.194 . . . . 71.42 110.555 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 4.8 p80 -160.77 -178.83 7.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.564 0.697 . . . . 73.34 111.99 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' CG ' ' HD1' ' A' ' 24' ' ' HIS . 19.2 p-10 -75.75 128.88 36.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.123 -1.399 . . . . 75.41 112.072 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 29.9 mt-10 -140.37 120.6 13.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.367 0.603 . . . . 64.0 110.466 172.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 152' ' ' TYR . 4.0 pp -82.45 6.13 18.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.264 -0.88 . . . . 72.12 112.536 -171.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.46 -16.84 55.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.279 0.561 . . . . 73.33 110.359 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 72.1 mt -111.59 143.57 28.81 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.577 -0.738 . . . . 72.44 110.577 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 32.2 Cg_exo -59.34 155.77 39.13 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.47 2.78 . . . . 71.53 112.514 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 30.8 Cg_exo -61.5 112.2 1.37 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.955 2.437 . . . . 73.33 113.013 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 97.62 48.5 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.94 -0.648 . . . . 74.32 113.126 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 16.7 m -140.57 143.94 28.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.555 -0.535 . . . . 71.11 109.555 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.25 158.56 22.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.044 0.45 . . . . 71.21 111.47 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -166.65 134.33 2.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.144 -0.48 . . . . 71.33 110.764 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -91.2 172.3 8.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.235 0.54 . . . . 65.05 111.327 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.1 OUTLIER -157.18 134.72 10.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.169 -0.923 . . . . 75.54 109.363 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 54.5 tt0 -124.96 136.74 54.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.941 -0.762 . . . . 73.52 108.941 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' HZ2' ' A' ' 109' ' ' LYS . . . 127.98 -99.11 0.5 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.308 -0.948 . . . . 71.01 112.056 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 131' ' ' LYS . . . -150.53 -118.24 0.85 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.871 -0.68 . . . . 72.04 112.395 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.08 65.29 1.49 Allowed Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.094 -0.574 . . . . 64.15 113.537 173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.62 121.85 44.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.011 0.405 . . . . 74.42 110.979 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.7 172.04 51.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 35.34 112.421 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.45 66.09 3.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.264 -0.494 . . . . 74.31 112.556 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -135.2 139.0 44.18 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.117 -0.697 . . . . 73.02 109.117 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -40.53 -58.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.073 0.858 . . . . 72.35 112.75 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.03 -45.78 61.95 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.402 -0.428 . . . . 61.3 113.835 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 120' ' ' LEU . 4.0 mm? -83.41 -29.74 27.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.905 0.335 . . . . 34.43 111.905 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 21.6 mmtp -80.66 -30.71 36.52 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.93 -0.308 . . . . 51.55 111.735 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.02 -33.57 76.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.974 -0.38 . . . . 73.51 109.974 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m -55.66 -47.17 77.14 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.922 -0.581 . . . . 73.2 110.256 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.67 -43.38 83.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.47 -0.786 . . . . 71.23 110.098 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -59.97 -32.89 71.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 74.35 111.542 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -67.99 -35.73 78.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.347 . . . . 74.43 111.154 177.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 88.6 mt -100.48 -2.06 34.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.386 . . . . 73.11 111.386 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.99 -104.38 3.02 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.981 -0.628 . . . . 75.1 112.126 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -102.68 -5.27 23.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.839 0.352 . . . . 73.11 110.867 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.717 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 44.9 m-80 -68.33 111.37 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.487 0.661 . . . . 74.24 111.798 -174.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' HD3' ' HA3' ' A' ' 112' ' ' GLY . 8.9 ptpp? -117.41 3.57 12.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.007 -0.997 . . . . 62.4 109.319 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 3.5 tt0 -71.32 48.94 0.14 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.497 -1.229 . . . . 74.33 113.737 -167.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' PRO . 5.7 p90 -131.12 157.45 43.08 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.241 0.543 . . . . 65.12 111.101 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -78.57 147.57 33.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.486 -0.779 . . . . 74.34 110.537 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.566 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -141.09 137.23 32.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 74.14 110.019 169.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' ALA . 3.3 pp -121.43 139.24 53.72 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.419 -0.956 . . . . 64.31 108.419 175.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -114.23 145.86 41.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.642 -0.423 . . . . 71.12 110.002 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.715 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.0 mt -99.56 128.08 45.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.053 -0.521 . . . . 72.33 109.799 176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -63.3 104.04 0.76 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.877 -0.678 . . . . 64.01 111.432 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 97' ' ' ASP . 2.9 pp -125.33 7.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.645 0.26 . . . . 74.31 111.154 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.19 157.51 14.92 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -1.012 . . . . 71.52 112.852 -175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 1.9 p-80 -125.96 134.32 25.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.856 -0.424 . . . . 74.11 109.856 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 31.7 Cg_exo -58.89 131.94 44.74 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.125 2.55 . . . . 54.31 112.759 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -171.64 -149.61 6.69 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.56 -0.616 . . . . 71.11 111.56 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.47 110.11 14.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.003 -0.74 . . . . 72.23 109.003 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -70.36 -9.17 55.46 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.224 0.824 . . . . 61.44 113.224 -166.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -80.0 -14.61 58.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.309 0.576 . . . . 73.44 109.52 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -92.26 25.08 3.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 63.0 109.547 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.509 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 10.3 p -52.85 -27.59 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.216 -0.902 . . . . 63.4 112.175 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.13 71.67 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.735 0.302 . . . . 72.22 111.27 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.0 -24.15 76.48 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.684 -0.769 . . . . 54.33 112.409 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.698 ' HB2' HD22 ' A' ' 99' ' ' LEU . 3.8 m-85 -86.09 -35.28 20.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.975 0.417 . . . . 72.03 110.179 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -84.78 -45.03 17.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.576 -0.738 . . . . 74.23 112.628 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 pp -126.49 8.44 7.07 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.751 -0.593 . . . . 65.1 111.806 -175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -74.89 133.04 14.54 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.557 -0.83 . . . . 75.24 111.386 177.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 11.8 mptt -72.16 136.3 46.42 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.636 -0.505 . . . . 75.24 109.636 -178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -95.53 139.78 22.09 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-O 120.721 0.296 . . . . 51.23 111.49 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 23.9 Cg_exo -65.15 163.24 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.677 2.252 . . . . 75.14 111.079 173.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -58.37 -42.46 87.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.405 -0.361 . . . . 71.1 111.919 -173.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -61.1 -35.56 77.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 71.32 111.373 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.488 ' CD ' HH22 ' A' ' 23' ' ' ARG . 39.2 tt0 -85.32 -24.92 27.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 72.12 110.414 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -72.44 -20.75 61.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.91 175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 46.6 mt-10 -63.06 -37.45 87.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 73.52 110.099 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 71.5 m -70.74 -28.48 64.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.058 -0.519 . . . . 74.22 110.457 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.17 -52.13 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.435 -0.58 . . . . 72.43 109.435 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.35 -37.73 84.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.805 -0.634 . . . . 52.13 110.957 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.91 99.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 64.41 111.123 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.544 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -64.4 -27.43 69.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.351 0.596 . . . . 73.52 110.77 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.626 HG13 ' HA ' ' A' ' 30' ' ' VAL . 70.6 t -74.55 -39.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.796 -0.638 . . . . 63.21 110.956 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 15.1 t70 -61.52 -51.8 67.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.402 -0.363 . . . . 74.12 110.025 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 14.9 pt-20 -60.21 -29.44 68.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.64 0.257 . . . . 75.44 111.045 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 67.9 m -62.38 -47.53 83.74 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.703 -0.226 . . . . 65.23 111.226 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.8 m -72.0 -21.86 20.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.118 -0.633 . . . . 75.32 110.643 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 20.8 mmt180 -70.5 -46.3 63.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.433 -0.349 . . . . 73.15 110.138 176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.8 ' HB3' ' HG ' ' A' ' 191' ' ' LEU . 28.6 p -67.97 -29.09 68.05 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.98 -0.288 . . . . 75.25 111.245 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 172' ' ' SER . 98.3 mt -64.91 -38.78 92.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 73.42 109.817 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -67.5 -49.48 63.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.537 -0.756 . . . . 63.05 110.107 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 174' ' ' ARG . 51.4 mm -56.76 -44.55 81.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.916 -0.584 . . . . 52.24 110.735 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 7.8 tt -55.58 -49.27 73.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.639 -0.709 . . . . 73.34 111.101 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.426 ' SD ' HG13 ' A' ' 57' ' ' ILE . 21.2 ptp -82.58 -15.92 50.42 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.188 0.44 . . . . 72.42 112.188 -173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.542 ' HD2' ' HB2' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -101.8 -25.92 13.65 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.965 -0.694 . . . . 74.11 111.891 -178.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 181' ' ' LYS . 14.1 t0 -135.66 -9.14 2.15 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.595 0.591 . . . . 74.23 112.595 -175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 179' ' ' LEU . . . 114.5 162.15 13.98 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.023 -1.084 . . . . 73.51 112.016 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 179' ' ' LEU . 3.4 pp -83.4 -16.29 46.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.943 0.349 . . . . 73.21 111.943 -173.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 -35.4 71.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.767 0.284 . . . . 64.3 111.767 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 186' ' ' LYS . 11.8 mptt -64.53 -34.67 78.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.11 110.256 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.637 ' HA ' HD23 ' A' ' 191' ' ' LEU . . . -64.49 -40.42 95.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 50.54 111.361 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -57.03 -44.12 82.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.179 0.514 . . . . 72.01 110.769 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -78.08 -48.56 15.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.271 -0.877 . . . . 72.5 111.453 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.43 ' O ' HG22 ' A' ' 193' ' ' THR . 28.9 mmt180 -78.41 -29.93 47.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.9 0.704 . . . . 64.11 112.9 -170.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.8 ' HG ' ' HB3' ' A' ' 175' ' ' CYS . 4.5 mm? -84.9 -31.91 23.44 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.792 0.664 . . . . 74.51 112.792 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -77.38 -8.22 57.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.21 -0.596 . . . . 73.11 111.122 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 190' ' ' ARG . 14.8 t -93.31 -2.67 54.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.297 0.57 . . . . 51.41 109.786 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -89.83 130.9 36.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.711 -0.677 . . . . 65.04 109.522 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -145.09 133.03 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.064 -0.347 . . . . 63.1 110.064 169.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.24 84.16 4.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.108 0.48 . . . . 73.25 110.052 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 C--O 1.253 1.284 0 CA-C-N 115.332 -0.849 . . . . 70.42 109.498 -176.412 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.807 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 21.6 ttt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.283 -0.636 . . . . 73.41 109.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.807 ' H ' ' HG2' ' A' ' 1' ' ' MET . 37.5 t 76.14 -88.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 123.394 0.677 . . . . 72.23 109.835 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 7.7 t 171.91 -63.16 0.01 OUTLIER 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.587 0.555 . . . . 72.21 110.273 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 3' ' ' SER . 19.6 mp0 -99.21 132.83 22.7 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.219 -0.446 . . . . 64.43 111.355 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -66.27 106.06 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.433 2.089 . . . . 70.43 109.849 165.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 91' ' ' GLU . 15.8 tt -63.89 154.26 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.726 -0.67 . . . . 63.3 112.509 -168.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HG2' HG13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -82.02 -75.45 0.3 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.92 -0.582 . . . . 64.34 112.544 -174.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.9 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 1.5 pp -142.57 155.8 45.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.45 112.036 -171.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.647 HD12 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -123.26 144.36 49.45 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.855 -0.794 . . . . 65.24 108.855 168.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 65' ' ' LEU . 27.7 m -107.25 147.78 12.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.864 -0.334 . . . . 73.25 110.913 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -117.9 133.18 10.29 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.843 -0.694 . . . . 74.44 111.607 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 40.9 mt -113.34 112.03 22.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.981 0.391 . . . . 75.53 110.925 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -168.14 -166.53 0.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.049 -0.523 . . . . 70.31 110.714 177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.719 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 78.0 m-20 -62.84 134.56 95.6 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 64.2 111.988 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 68' ' ' THR . 82.4 Cg_endo -86.36 -2.09 8.5 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.19 2.594 . . . . 71.23 114.289 -174.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.39 148.63 20.45 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.122 -1.037 . . . . 71.51 112.566 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.88 -33.28 96.83 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.328 2.685 . . . . 75.04 112.775 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 34.5 mt-10 -63.36 -27.94 69.66 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.076 0.465 . . . . 52.24 110.948 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.719 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.5 m-85 -97.01 -29.45 13.64 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.457 -0.572 . . . . 70.01 109.457 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.07 66.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 35.43 112.183 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 46.0 pttt -80.08 47.6 0.91 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.329 0.585 . . . . 75.21 111.422 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 19' ' ' TYR . 6.9 t -140.44 -170.42 2.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 70.04 109.531 175.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 14.0 tpt180 -80.57 -35.51 34.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 75.23 111.848 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.522 ' HD2' HG12 ' A' ' 153' ' ' VAL . 7.3 t-80 -79.35 35.74 0.28 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.044 -0.525 . . . . 72.54 111.925 -170.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.463 HD22 ' HE3' ' A' ' 29' ' ' TRP . 58.2 t30 -111.7 22.44 14.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.687 0.28 . . . . 71.32 111.622 -172.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.855 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -55.69 -53.73 53.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.699 0.629 . . . . 64.13 112.699 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.77 -30.11 71.88 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.065 -0.588 . . . . 62.3 113.618 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -84.1 -37.78 21.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.032 0.416 . . . . 43.51 111.174 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.707 ' CD1' HG21 ' A' ' 169' ' ' VAL . 7.6 t-105 -59.96 -34.75 73.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.338 -0.392 . . . . 72.44 110.654 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 169' ' ' VAL . 15.4 m -77.46 -34.21 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 112.131 0.419 . . . . 74.23 112.131 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 28' ' ' ALA . 27.9 m -77.71 -33.54 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.582 -0.447 . . . . 73.13 111.418 -176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.86 -23.02 55.62 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.919 -0.312 . . . . 64.23 110.781 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.21 -46.07 85.51 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.263 -0.643 . . . . 75.42 109.263 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' HB3' HD22 ' A' ' 55' ' ' LEU . 96.7 mt -58.11 -40.09 80.3 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.924 -0.58 . . . . 62.43 110.39 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.72 -44.14 85.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.611 -0.722 . . . . 74.41 111.011 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -76.28 -41.75 47.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 61.41 111.38 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -69.67 -48.71 63.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.037 0.384 . . . . 62.05 112.037 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.703 ' HB3' HD23 ' A' ' 55' ' ' LEU . 30.7 t60 -93.88 -15.89 24.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.795 -0.362 . . . . 75.43 111.168 -174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 64.61 29.51 13.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.535 0.683 . . . . 33.24 110.679 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 p -73.59 148.97 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.529 . . . . 71.12 109.799 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 23.0 m -82.12 106.1 13.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.835 0.35 . . . . 75.22 110.546 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' HD21 ' A' ' 51' ' ' LEU . 3.8 mm? -67.64 110.29 3.65 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.503 -0.555 . . . . 62.12 109.503 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' THR . 48.6 mtmt -111.44 122.59 48.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.028 -0.533 . . . . 71.01 111.169 -172.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -71.15 136.69 48.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.085 -0.507 . . . . 53.52 110.505 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -124.82 102.6 31.72 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.053 -0.721 . . . . 64.2 109.053 176.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.05 -24.13 72.06 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.784 2.989 . . . . 63.41 114.536 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB2' ' OE2' ' A' ' 45' ' ' GLU . 38.7 mtpt -72.18 -31.33 65.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.985 0.421 . . . . 51.32 110.708 -178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -90.39 -31.28 16.93 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.328 -0.99 . . . . 53.31 108.328 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 t80 74.7 23.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.386 -1.734 . . . . 75.42 109.682 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.87 173.46 16.63 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.284 -0.871 . . . . 24.13 111.676 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 66' ' ' ILE . 28.0 tp -96.98 122.37 39.9 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.166 -0.679 . . . . 71.24 109.166 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 HD12 ' A' ' 65' ' ' LEU . 77.3 p -111.31 151.58 28.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.217 0.532 . . . . 55.41 111.936 -173.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -152.5 162.81 30.09 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.002 -0.839 . . . . 63.54 111.002 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 2.1 tmm_? -145.3 109.38 4.84 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 72.41 109.238 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 38' ' ' HIS . 1.7 mp -118.71 130.19 55.68 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 116.253 -0.43 . . . . 73.03 111.259 -172.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -87.99 116.15 25.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.18 -0.464 . . . . 73.42 109.857 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.26 115.65 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.93 -0.396 . . . . 73.42 109.93 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.4 t30 66.35 -73.29 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.884 0.74 . . . . 71.32 111.569 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 p -139.19 -24.45 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.391 -0.368 . . . . 65.0 111.387 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -105.34 130.1 53.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.052 0.453 . . . . 71.33 110.821 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.939 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.71 129.87 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.785 -0.643 . . . . 74.41 110.401 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 HD12 ' A' ' 9' ' ' LEU . 3.4 tt -124.02 137.9 54.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.789 -0.641 . . . . 70.2 111.846 -172.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.9 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 1.4 mpt_? -93.48 154.94 17.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.09 -0.505 . . . . 73.3 110.736 -177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 p -140.5 141.3 32.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.622 -0.717 . . . . 64.43 109.282 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.768 HD13 HD22 ' A' ' 81' ' ' LEU . 10.5 tt -141.8 127.96 19.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.896 0.379 . . . . 54.42 110.23 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 51' ' ' LEU . 6.6 tt -116.87 110.43 41.94 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 121.161 0.505 . . . . 75.02 110.022 174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.21 129.12 17.6 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.84 2.36 . . . . 52.32 111.054 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 13.0 p -57.38 -63.01 1.37 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.236 0.541 . . . . 75.33 110.816 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.588 HG22 ' H ' ' A' ' 72' ' ' ASN . 40.2 m -83.15 83.16 7.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.307 0.575 . . . . 52.41 109.92 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -69.39 -3.44 14.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.354 -0.839 . . . . 73.22 111.214 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 92.2 mmm -85.97 -64.18 1.2 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.72 -0.673 . . . . 61.04 110.861 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.588 ' H ' HG22 ' A' ' 69' ' ' THR . 15.8 m120 -97.76 -48.29 5.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.505 0.557 . . . . 65.31 112.505 -176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 69.5 mt -87.65 7.86 28.0 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.954 0.724 . . . . 65.52 112.954 -167.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 p -59.83 -53.05 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.763 0.316 . . . . 62.34 111.774 -174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.58 -29.04 58.42 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.447 -0.883 . . . . 31.32 112.151 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HD2' ' HA ' ' A' ' 73' ' ' LEU . 60.0 mttm -62.48 -31.58 72.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.019 0.438 . . . . 74.53 110.888 177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.03 -42.8 65.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.232 0.539 . . . . 75.33 110.238 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.649 HD12 HG22 ' A' ' 123' ' ' THR . 50.2 mt -72.38 -29.01 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 74.21 110.936 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -57.46 7.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.757 -0.656 . . . . 73.1 111.949 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.73 68.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 74.12 111.415 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 HD13 ' A' ' 65' ' ' LEU . 49.6 tp -60.58 -53.69 54.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 45.13 111.19 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.48 -23.33 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 71.12 110.517 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.19 -60.81 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.979 -0.555 . . . . 62.45 111.769 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 81' ' ' LEU . 20.1 p90 -69.71 -24.76 63.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 73.13 110.359 -175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.678 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -76.58 -13.0 60.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 71.12 111.355 175.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 4.6 pp0? 48.87 28.59 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.094 0.958 . . . . 62.32 111.445 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 7' ' ' LYS . 36.4 mm -92.39 134.4 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.789 -0.641 . . . . 74.32 110.707 -176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB3' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mptt -89.45 171.3 9.06 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.187 -0.915 . . . . 55.3 110.098 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' A' ' 88' ' ' LYS . 10.3 Cg_endo -50.62 -25.11 14.05 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.411 2.741 . . . . 73.14 112.798 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.665 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 9.3 pt-20 -60.25 -21.18 61.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.592 -0.731 . . . . 73.22 112.373 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.696 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 45.4 mt-10 -127.46 21.03 6.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.758 0.313 . . . . 70.24 110.966 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.95 114.71 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.314 -0.403 . . . . 63.44 110.277 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 71.2 mtm -113.23 152.1 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.015 0.436 . . . . 63.22 111.877 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 46.3 t -129.26 129.57 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.872 -0.604 . . . . 61.34 110.675 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -124.42 131.58 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.156 -0.683 . . . . 53.2 109.156 174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 8.5 p80 -161.43 170.76 19.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.847 -1.141 . . . . 64.41 112.971 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 7.8 t70 -64.8 117.82 8.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.944 -1.48 . . . . 71.02 110.226 174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.96 107.8 5.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.075 0.464 . . . . 60.3 109.908 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 3.0 pp -73.25 9.83 1.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.059 0.763 . . . . 74.1 113.059 -173.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.06 -31.76 68.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.95 0.405 . . . . 55.45 110.871 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 55.4 mt -102.11 153.87 37.75 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.317 -0.401 . . . . 75.24 111.561 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 18.3 Cg_endo -59.73 164.49 11.51 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.397 2.731 . . . . 74.31 112.378 176.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.788 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 61.2 Cg_endo -72.19 112.8 3.52 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.554 2.169 . . . . 45.01 112.696 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.01 46.41 2.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.629 -0.796 . . . . 64.32 112.792 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 194' ' ' PHE . 32.0 m -143.68 134.61 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.256 -0.646 . . . . 73.1 109.256 172.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -118.89 138.32 52.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.911 0.386 . . . . 72.31 110.478 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -137.89 132.75 32.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.041 0.448 . . . . 72.11 110.733 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -92.99 134.58 34.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.423 -0.808 . . . . 72.54 110.27 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.557 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -123.85 124.53 42.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.711 -177.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 110' ' ' GLN . 7.5 tt0 -105.14 112.45 25.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.968 -0.753 . . . . 62.01 108.968 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.75 -123.31 2.97 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.992 -1.099 . . . . 63.33 113.359 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 -119.05 3.54 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 120.896 -0.669 . . . . 75.14 113.103 -169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.39 64.72 1.95 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.568 -0.825 . . . . 75.53 113.896 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -83.3 126.45 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.852 -0.425 . . . . 74.12 109.852 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.09 12.25 70.04 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.834 -0.698 . . . . 42.13 113.416 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.53 62.09 6.52 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 121.136 -0.554 . . . . 64.21 113.012 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.568 ' HB3' HD23 ' A' ' 120' ' ' LEU . 44.7 t-80 -141.38 139.94 33.6 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.011 -0.737 . . . . 54.43 109.011 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -47.26 -45.51 23.87 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.615 0.572 . . . . 64.42 110.687 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.77 93.6 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.384 -0.825 . . . . 71.53 113.404 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.1 mm? -77.81 -25.55 48.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.086 0.47 . . . . 74.13 110.981 -175.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -76.14 -47.84 22.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.8 -0.444 . . . . 72.21 109.8 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.55 -37.36 83.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.658 -0.246 . . . . 73.21 111.432 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 78' ' ' ILE . 19.3 p -57.33 -38.89 74.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 75.23 110.41 176.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 120' ' ' LEU . 40.3 mm -75.02 -40.04 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 51.51 109.992 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.0 m -62.99 -28.91 70.42 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.481 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.1 mmpt? -87.4 -35.18 18.46 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.264 0.468 . . . . 75.41 112.264 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 78' ' ' ILE . 77.5 mt -92.38 -24.65 18.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.907 0.384 . . . . 72.12 111.491 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.8 153.43 8.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.604 -0.998 . . . . 44.21 110.604 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -78.71 12.53 2.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.231 0.516 . . . . 73.42 111.412 -176.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.76 111.6 1.34 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 55.31 111.168 174.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -80.15 36.04 0.34 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.579 -0.737 . . . . 71.12 111.667 -177.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.68 -1.67 34.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.297 0.57 . . . . 74.13 110.595 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -70.44 148.97 47.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.328 0.585 . . . . 62.31 111.159 -175.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.69 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 15.2 m-85 -103.32 146.08 29.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.019 -0.537 . . . . 73.1 109.709 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.557 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -148.57 130.44 15.2 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.183 -0.607 . . . . 64.14 110.645 172.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.644 ' H ' HD23 ' A' ' 136' ' ' LEU . 0.9 OUTLIER -103.29 114.53 28.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.573 -0.899 . . . . 74.32 108.573 172.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.97 140.14 31.14 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.435 -0.802 . . . . 72.2 109.913 -172.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.855 HD12 ' HB1' ' A' ' 26' ' ' ALA . 20.7 mt -104.59 125.72 51.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.082 -0.34 . . . . 73.5 110.082 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.05 111.93 3.52 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.826 -0.702 . . . . 53.41 112.692 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -118.36 0.31 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.055 0.455 . . . . 55.44 110.685 176.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -92.73 121.19 6.41 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.5 -0.857 . . . . 61.32 111.931 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.788 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 1.1 p-80 -100.89 165.25 14.58 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.838 -0.43 . . . . 64.14 109.838 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.46 98.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.242 1.962 . . . . 74.53 111.337 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.67 175.9 19.99 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.623 -0.799 . . . . 63.41 112.269 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -87.34 136.13 33.05 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.308 -0.256 . . . . 75.22 110.308 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -47.0 -43.92 19.8 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.065 0.765 . . . . 64.5 113.065 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.471 -0.331 . . . . 71.12 111.871 -175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -118.77 19.27 13.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.726 -0.216 . . . . 71.52 111.224 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.3 p -54.15 -47.35 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.242 -0.436 . . . . 75.23 111.89 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.65 -18.28 62.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.766 0.317 . . . . 65.2 111.386 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.36 59.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.036 -0.602 . . . . 71.34 112.916 -175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -85.5 -16.25 40.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.007 0.373 . . . . 74.24 112.007 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.522 HG12 ' HD2' ' A' ' 24' ' ' HIS . 72.3 t -78.88 -36.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.917 0.34 . . . . 63.13 111.917 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.84 12.75 5.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.389 -0.524 . . . . 75.43 112.095 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.62 160.59 26.69 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.149 -0.78 . . . . 74.51 111.149 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 13.4 mptt -70.78 109.34 4.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.179 0.514 . . . . 73.23 110.623 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -92.27 142.62 26.33 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.445 -0.798 . . . . 75.24 110.138 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.79 172.07 16.58 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.431 2.087 . . . . 72.15 111.44 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.61 -30.59 68.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 70.15 110.678 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -50.88 -45.54 60.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.298 -0.865 . . . . 71.44 110.971 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -89.07 -45.46 9.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.584 -0.734 . . . . 62.13 111.193 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -59.49 -18.73 42.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.139 0.792 . . . . 55.4 113.139 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -56.66 -29.2 62.05 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.068 -0.253 . . . . 71.24 110.909 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.2 -27.55 56.92 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.723 0.297 . . . . 72.03 110.298 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.03 -49.92 66.02 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.315 0.578 . . . . 72.44 109.989 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.2 -32.99 74.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.238 -0.892 . . . . 53.12 110.95 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.91 96.5 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.113 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.59 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -65.72 -30.29 70.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.534 0.683 . . . . 74.45 110.562 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.707 HG21 ' CD1' ' A' ' 29' ' ' TRP . 77.9 t -71.98 -39.42 66.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.812 -0.631 . . . . 74.2 110.994 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.747 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 14.3 t70 -58.63 -51.56 69.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.265 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.59 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 16.2 pt-20 -62.54 -36.25 82.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.653 -0.249 . . . . 63.11 111.098 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 72.8 m -60.15 -50.74 72.49 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.348 -0.387 . . . . 55.02 111.519 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.08 -20.89 23.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.026 0.38 . . . . 72.21 112.026 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 16.4 mmt180 -74.64 -44.8 48.69 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.95 -0.3 . . . . 74.3 110.571 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 30.9 p -66.53 -28.4 68.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.453 -0.339 . . . . 73.54 111.315 -174.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.97 -38.53 91.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.792 0.329 . . . . 70.21 110.945 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' HG2' ' HE3' ' A' ' 181' ' ' LYS . 10.1 tt0 -67.01 -46.92 73.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.45 0.643 . . . . 75.52 110.268 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 182' ' ' ASP . 51.2 mm -67.91 -45.37 84.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.269 -0.878 . . . . 72.21 111.321 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 184' ' ' LEU . 10.4 tt -49.06 -44.08 41.44 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.663 0.602 . . . . 54.44 112.222 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.437 ' HG3' ' HG3' ' A' ' 181' ' ' LYS . 20.7 ptp -75.27 -54.78 6.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.595 0.591 . . . . 42.21 112.595 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -102.22 -18.35 15.54 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.153 1.168 . . . . 64.03 114.153 -169.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HB2' HG23 ' A' ' 178' ' ' ILE . 26.7 m-20 -112.05 -10.58 13.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.297 -0.561 . . . . 55.54 111.46 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 1' ' ' MET . . . 105.03 141.27 10.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.388 -0.91 . . . . 52.51 112.273 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 2' ' ' VAL . 2.6 pt? -66.65 -29.08 69.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.461 0.172 . . . . 65.34 111.314 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.7 p -63.8 -33.49 75.79 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.343 0.497 . . . . 44.32 112.343 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.71 -46.29 86.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.374 0.606 . . . . 74.42 109.929 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -69.69 -45.3 68.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.402 -0.817 . . . . 75.42 111.144 -178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 17.6 mm-40 -51.84 -48.2 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.307 0.379 . . . . 73.54 111.527 -178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -60.48 -46.52 89.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.808 0.337 . . . . 61.52 110.967 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 190' ' ' ARG . 4.0 tmt_? -73.33 -39.56 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.964 -0.562 . . . . 33.44 110.646 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 106' ' ' ALA . 31.0 tp -66.14 -45.39 81.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.041 -0.527 . . . . 71.34 111.229 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -76.65 -8.41 57.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.435 . . . . 75.14 111.635 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -107.11 7.1 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.07 0.462 . . . . 72.42 110.556 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.537 ' O ' HG12 ' A' ' 105' ' ' VAL . 46.1 t80 -90.34 122.81 33.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.256 -0.429 . . . . 74.42 110.246 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -145.57 154.75 42.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.866 -0.607 . . . . 70.11 109.59 173.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.023 0.749 . . . . 71.44 113.023 -171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.415 -0.812 . . . . 62.41 109.122 170.096 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 111.321 0.119 . . . . 74.55 111.321 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.563 ' CG1' ' HG ' ' A' ' 184' ' ' LEU . 7.9 m -142.68 148.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 61.33 111.496 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 m -87.3 -32.57 19.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.563 -0.744 . . . . 75.34 110.083 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 19.4 mp0 -104.69 125.43 33.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.537 -0.756 . . . . 53.13 110.056 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.2 Cg_exo -74.76 114.96 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.424 2.083 . . . . 42.32 110.653 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.4 tp -50.28 133.01 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.023 0.439 . . . . 62.11 110.813 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -90.03 -71.09 0.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.315 -0.402 . . . . 74.22 111.163 -174.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.859 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.6 pt? -154.8 155.33 34.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.32 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -114.74 147.39 39.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 72.25 109.644 174.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.756 HG12 ' HB3' ' A' ' 65' ' ' LEU . 28.8 m -108.87 145.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 120.885 0.374 . . . . 75.04 110.602 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.79 135.11 11.74 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.77 -0.728 . . . . 70.04 111.868 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.39 128.77 55.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.985 0.421 . . . . 74.42 110.817 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -136.78 -144.08 0.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.575 -0.739 . . . . 54.34 109.514 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 65.7 m-20 -91.14 151.92 43.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.273 -0.269 . . . . 43.43 110.273 173.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CE1' ' A' ' 70' ' ' PHE . 87.3 Cg_endo -77.94 29.3 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.062 2.508 . . . . 71.04 113.657 -168.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -179.61 149.79 8.89 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.73 -0.747 . . . . 73.44 112.29 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 32.0 Cg_exo -59.69 -25.76 80.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.117 2.545 . . . . 73.11 112.082 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.82 -31.19 71.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.805 -0.634 . . . . 65.35 110.871 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -105.85 -5.07 20.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.738 . . . . 44.41 109.345 -174.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.6 -10.04 48.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.805 -1.089 . . . . 63.22 111.739 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.76 -10.49 59.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.287 0.565 . . . . 73.42 110.506 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.8 m -79.03 146.86 33.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 72.42 110.473 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 12.3 ttm180 -62.75 -11.18 15.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -173.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.755 ' H ' HG22 ' A' ' 22' ' ' THR . 81.8 t60 -80.95 27.98 0.37 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.693 0.758 . . . . 75.1 109.826 177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 35.5 p-10 -107.36 10.73 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.594 -0.73 . . . . 74.13 111.092 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -48.85 -44.5 39.71 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.409 0.522 . . . . 51.52 112.409 -175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -61.43 -42.12 99.7 Favored Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.597 -0.811 . . . . 71.33 112.709 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.91 -33.24 51.9 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.889 0.329 . . . . 75.43 111.889 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.542 ' HD1' HG21 ' A' ' 169' ' ' VAL . 23.5 t-105 -63.41 -36.93 85.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.513 . . . . 71.13 111.554 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.751 HG12 HG13 ' A' ' 169' ' ' VAL . 5.9 m -80.39 -24.23 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.646 -0.252 . . . . 71.42 111.5 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 27' ' ' GLY . 70.4 t -71.94 -46.83 58.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 75.11 110.958 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -68.56 -27.0 65.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 63.33 109.997 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 37' ' ' ILE . 11.8 tp10 -63.83 -47.3 81.35 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.417 -0.586 . . . . 75.44 109.417 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.18 -41.34 88.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.062 -0.517 . . . . 73.01 110.68 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 40' ' ' VAL . . . -57.84 -41.54 82.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 72.01 110.776 177.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 33' ' ' GLU . 24.7 ttp-105 -73.06 -45.23 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.666 -0.697 . . . . 75.42 111.563 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 33' ' ' GLU . 45.4 mm -63.28 -47.54 91.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 70.33 112.343 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -104.28 -2.84 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.512 -0.475 . . . . 74.02 111.653 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.4 t30 59.04 45.85 14.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.708 0.766 . . . . 74.01 109.937 -177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 35' ' ' ALA . 8.2 p -82.41 145.23 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.571 -0.74 . . . . 62.53 110.37 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 p -81.32 96.55 7.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.23 0.538 . . . . 73.15 111.778 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 51' ' ' LEU . 3.4 mm? -74.37 100.76 3.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 73.1 109.404 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 38.6 mtmt -104.13 127.97 51.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.054 -0.521 . . . . 74.21 111.39 -173.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -82.31 95.59 7.65 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 64.43 109.559 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.11 138.15 19.46 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.376 -0.375 . . . . 73.32 111.041 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.88 171.02 7.87 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.838 2.359 . . . . 75.33 111.509 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 47' ' ' LYS . 42.0 mtmt 72.77 -46.24 0.64 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.188 0.595 . . . . 73.33 111.106 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.4 -23.06 28.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.834 -0.802 . . . . 63.11 108.834 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 57.83 32.76 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.416 -1.265 . . . . 72.45 112.003 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.72 -176.6 30.95 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.47 -0.871 . . . . 54.54 112.502 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 42' ' ' LEU . 9.3 mp -91.34 126.3 36.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.057 -0.349 . . . . 70.45 110.057 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.2 p -108.35 147.17 31.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.958 -0.564 . . . . 71.02 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 63' ' ' ARG . . . -147.78 161.66 28.59 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.164 -0.774 . . . . 44.12 111.164 174.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 3.1 tmm_? -152.99 119.2 5.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -130.53 119.94 23.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.667 0.746 . . . . 71.41 111.705 177.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.5 tt -78.22 103.02 7.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.29 -0.868 . . . . 75.41 109.615 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.74 143.57 20.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.893 -0.594 . . . . 64.34 109.779 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 63.08 -83.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.726 -0.67 . . . . 73.52 110.777 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -148.24 6.92 0.78 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 74.35 111.416 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -131.68 136.1 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.736 0.303 . . . . 61.14 111.06 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.2 pt-20 -72.2 100.81 2.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.101 0.477 . . . . 70.21 110.019 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 176' ' ' LEU . 9.0 tt -93.29 118.01 30.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.945 -0.57 . . . . 64.55 110.039 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.859 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 19.6 mtt180 -101.67 172.46 6.94 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.166 0.508 . . . . 75.24 111.303 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.441 HG21 HG22 ' A' ' 31' ' ' VAL . 7.6 p -149.07 148.39 15.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.362 -0.835 . . . . 63.13 109.361 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.756 ' HB3' HG12 ' A' ' 10' ' ' VAL . 5.5 tt -143.49 129.99 20.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.618 -0.512 . . . . 51.44 109.618 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 51' ' ' LEU . 4.3 tt -125.71 107.31 26.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.051 0.453 . . . . 75.34 110.557 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.09 150.3 72.12 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.081 2.521 . . . . 73.43 112.048 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.9 p -70.31 -72.68 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 63.45 111.428 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 72' ' ' ASN . 30.7 m -78.54 97.08 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.287 -0.415 . . . . 65.13 110.056 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE1' ' HD3' ' A' ' 15' ' ' PRO . 10.8 p90 -72.81 -7.15 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 71.03 112.117 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 118' ' ' ASN . 17.8 mmt -96.19 -52.42 4.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.792 0.329 . . . . 71.31 111.584 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.642 ' H ' HG22 ' A' ' 69' ' ' THR . 20.1 m120 -95.22 -46.38 6.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.165 0.431 . . . . 71.42 112.165 -174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -87.16 -10.11 53.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.185 0.439 . . . . 61.54 112.185 -171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 78' ' ' ILE . 8.7 p -53.64 -63.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.776 0.658 . . . . 32.42 112.776 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.9 66.01 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.466 -0.873 . . . . 62.14 113.342 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HG2' ' HE3' ' A' ' 126' ' ' LYS . 32.8 mtmm -68.45 -27.15 65.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.173 0.486 . . . . 73.1 110.982 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.29 -48.9 66.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.276 -0.638 . . . . 72.45 109.276 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 74' ' ' SER . 66.8 mt -64.28 -38.22 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.159 -0.928 . . . . 73.52 110.798 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.09 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.928 -0.578 . . . . 72.05 111.092 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.99 98.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.481 . . . . 55.15 110.211 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 8' ' ' LEU . 47.2 tp -57.15 -58.22 9.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.213 -0.903 . . . . 75.34 111.521 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.64 72.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.952 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.96 -53.22 33.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.186 -0.461 . . . . 64.52 111.797 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -71.81 -33.63 68.7 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.421 -0.512 . . . . 74.02 110.28 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -21.74 58.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.126 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 58.71 19.91 7.3 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.827 -0.624 . . . . 75.11 110.638 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.559 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 mm -85.25 141.3 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.286 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -77.66 153.06 80.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.07 -0.514 . . . . 65.1 111.164 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.706 ' HG2' HD21 ' A' ' 130' ' ' ASN . 50.8 Cg_exo -56.74 -20.42 35.11 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.234 2.622 . . . . 55.42 112.95 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 8.4 pt-20 -71.34 -15.71 62.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.925 -0.579 . . . . 62.55 110.829 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 15.2 mt-10 -111.33 4.91 19.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.895 -0.593 . . . . 64.35 109.725 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.67 114.78 45.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.326 -0.852 . . . . 73.13 109.461 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.546 ' HE2' HD23 ' A' ' 136' ' ' LEU . 86.3 mtp -115.91 146.08 42.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.648 -0.251 . . . . 64.43 110.859 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 10' ' ' VAL . 7.6 p -128.24 134.79 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.877 0.37 . . . . 75.34 111.081 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 136' ' ' LEU . . . -98.93 146.09 26.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.403 -0.362 . . . . 52.31 111.125 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.7 -179.88 8.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.316 0.579 . . . . 63.21 112.183 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -94.46 142.54 27.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.561 -1.2 . . . . 41.0 110.643 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.675 ' HG2' ' CG ' ' A' ' 137' ' ' ARG . 0.5 OUTLIER -114.54 134.72 54.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.287 0.565 . . . . 74.52 112.058 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.747 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.5 pt? -109.11 -7.36 15.33 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.173 -0.921 . . . . 54.14 108.996 171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.71 -15.84 47.16 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.094 -0.957 . . . . 62.4 110.096 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.891 HD11 ' HG3' ' A' ' 107' ' ' LYS . 92.3 mt -117.63 149.94 45.91 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 63.31 111.234 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.8 162.96 32.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.929 2.42 . . . . 63.14 111.042 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 12.2 Cg_exo -69.57 109.34 2.25 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.092 . . . . 61.04 112.535 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 195' ' ' LYS . . . 117.06 42.53 0.65 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 71.25 113.398 175.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 4.7 m -147.06 155.07 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.959 -0.386 . . . . 73.33 109.959 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.04 141.49 51.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.683 0.277 . . . . 60.53 110.97 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.891 ' HG3' HD11 ' A' ' 101' ' ' LEU . 49.3 mtmt -113.94 131.22 56.39 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.881 0.372 . . . . 51.22 110.905 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HB3' ' OE1' ' A' ' 188' ' ' GLN . 88.0 t80 -97.17 111.7 23.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.425 -0.807 . . . . 72.42 109.229 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.991 ' HE3' ' HG2' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -114.75 121.94 44.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.046 0.451 . . . . 73.32 111.189 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -105.64 139.79 39.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.421 -0.809 . . . . 61.03 109.443 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.07 -114.15 4.33 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 70.42 113.347 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -85.51 122.22 5.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.896 -0.668 . . . . 30.25 113.16 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.853 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . -175.88 57.92 0.11 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.385 -0.912 . . . . 64.42 112.89 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -117.14 133.08 56.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.864 0.364 . . . . 73.23 110.311 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -95.13 -0.5 63.44 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.701 -0.762 . . . . 74.12 113.201 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.16 88.5 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.975 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.08 148.57 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.467 -0.568 . . . . 75.15 109.467 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.475 ' HB2' ' SD ' ' A' ' 71' ' ' MET . 2.8 m-20 -39.16 -51.06 1.93 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.9 0.88 . . . . 52.21 113.291 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.67 -60.28 4.93 Favored Glycine 0 CA--C 1.522 0.482 0 O-C-N 123.484 0.49 . . . . 54.34 113.883 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.482 ' O ' HG12 ' A' ' 124' ' ' ILE . 3.1 mm? -84.64 -23.05 29.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.583 -0.363 . . . . 75.11 110.687 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -72.15 -40.27 68.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.849 0.314 . . . . 73.35 111.849 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.52 -36.14 83.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.209 -0.663 . . . . 74.4 109.209 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.5 m -59.75 -48.73 80.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.506 -0.77 . . . . 75.3 109.817 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 120' ' ' LEU . 36.8 mm -57.57 -41.99 80.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 CA-C-N 115.742 -0.663 . . . . 72.11 110.585 175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.5 m -63.54 -39.35 94.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.014 -0.539 . . . . 71.43 111.605 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 76' ' ' LYS . 3.2 mmmp? -85.12 -0.31 54.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.708 0.289 . . . . 62.23 111.281 -177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 130' ' ' ASN . 88.4 mt -111.6 -22.83 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.119 0.485 . . . . 63.12 110.043 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.61 -113.33 4.7 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.545 -0.752 . . . . 71.21 111.842 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -101.64 3.6 39.98 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.309 0.576 . . . . 74.31 109.521 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.706 HD21 ' HG2' ' A' ' 89' ' ' PRO . 41.7 t-20 -61.04 114.57 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.4 -0.818 . . . . 72.23 111.6 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -117.49 34.92 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.035 -0.984 . . . . 74.4 110.601 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 5.1 tp10 -92.39 -17.77 24.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 73.04 111.212 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -59.32 139.86 56.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.44 0.638 . . . . 54.04 112.15 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.505 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 4.2 m-85 -91.75 147.33 23.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 74.44 110.565 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.991 ' HG2' ' HE3' ' A' ' 109' ' ' LYS . 21.7 ptt180 -140.89 141.65 34.56 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.833 -0.432 . . . . 73.1 109.833 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 4.1 pp -118.86 133.69 55.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.926 -1.139 . . . . 64.0 107.926 171.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.675 ' CG ' ' HG2' ' A' ' 98' ' ' GLU . 25.5 ttt180 -127.86 126.13 41.03 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.416 -0.513 . . . . 62.4 110.803 -169.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.548 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.4 mt -91.31 115.37 27.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.529 -0.76 . . . . 64.03 111.172 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -62.07 114.08 6.42 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.554 -0.618 . . . . 62.11 111.554 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HB ' ' HD3' ' A' ' 23' ' ' ARG . 2.8 pp -126.43 -10.14 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.772 0.32 . . . . 71.34 111.598 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -87.76 161.77 32.36 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.679 -0.772 . . . . 55.01 112.08 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.84 149.6 50.37 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.749 -0.463 . . . . 62.31 109.749 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.98 115.73 2.7 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.817 2.345 . . . . 73.13 112.321 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.89 -120.1 0.99 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.954 -0.859 . . . . 64.4 110.954 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -86.84 131.75 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 73.12 109.756 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.15 -45.67 90.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.624 -0.716 . . . . 71.14 112.566 -169.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.1 -29.51 26.71 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.527 -0.469 . . . . 74.43 110.934 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.77 17.19 15.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.114 -0.494 . . . . 73.53 111.462 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 14.3 p -62.69 -26.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.236 0.541 . . . . 71.2 110.0 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.733 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -61.2 -34.92 75.85 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.591 -0.731 . . . . 61.22 110.742 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.41 -23.11 66.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.957 -0.639 . . . . 70.11 112.334 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 3.1 m-85 -85.73 -46.39 10.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.116 0.484 . . . . 73.32 109.753 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 150' ' ' ALA . 20.0 m -68.62 -28.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.177 -0.92 . . . . 62.14 111.991 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.733 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 3.6 pp -114.2 17.54 17.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.435 0.636 . . . . 75.22 110.631 175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.03 167.95 24.29 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.409 -1.076 . . . . 73.44 110.409 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 10.0 mptt -87.34 145.9 26.14 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.086 -0.709 . . . . 72.43 109.086 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -102.47 136.33 19.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 C-N-CA 120.84 -0.344 . . . . 73.1 110.66 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.1 Cg_exo -70.46 160.83 48.17 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.725 2.283 . . . . 72.33 111.022 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.47 -36.8 35.19 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.376 0.423 . . . . 73.41 111.732 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -42.86 93.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.153 -0.476 . . . . 42.1 111.384 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -88.89 -24.56 22.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.025 0.441 . . . . 71.43 111.4 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 157' ' ' ALA . 10.3 mm100 -63.66 -20.26 65.55 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.487 0.551 . . . . 74.44 112.487 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -18.27 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 62.11 110.473 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 69.9 m -79.14 -35.69 41.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.007 -0.542 . . . . 71.23 109.976 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.0 tp -67.3 -42.81 83.12 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.959 0.409 . . . . 64.21 110.179 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.67 -31.13 72.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.853 -0.612 . . . . 72.42 110.994 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.94 -30.98 65.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 65.21 111.04 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.41 -15.46 62.36 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.93 -0.577 . . . . 42.53 111.479 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.751 HG13 HG12 ' A' ' 30' ' ' VAL . 91.8 t -89.52 -30.39 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.999 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.12 -59.91 4.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.914 0.339 . . . . 63.22 111.914 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.637 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -71.36 -35.09 71.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.48 -0.327 . . . . 74.32 110.968 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -53.58 -50.15 66.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.337 -0.392 . . . . 72.01 111.893 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.8 -30.73 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.78 -0.368 . . . . 53.14 111.934 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 10.0 ptm180 -84.2 -22.72 30.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.726 -0.39 . . . . 41.21 111.54 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 19.8 p -71.94 -22.11 61.51 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.182 -0.207 . . . . 52.55 110.957 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.444 ' HB3' HD11 ' A' ' 62' ' ' LEU . 98.8 mt -62.13 -35.69 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 73.33 111.185 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.62 -43.78 58.71 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.251 -0.648 . . . . 70.53 109.251 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -61.54 -40.48 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.257 -0.883 . . . . 73.33 110.979 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.535 ' HG ' HD23 ' A' ' 184' ' ' LEU . 9.8 tt -52.07 -44.68 64.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.629 -0.714 . . . . 71.22 112.377 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.8 ptp -80.38 -37.03 33.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.39 0.515 . . . . 70.24 112.39 -172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -18.52 15.66 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.462 0.541 . . . . 60.35 112.462 -172.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -111.93 -11.47 13.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 63.0 111.003 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.33 15.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.625 -0.797 . . . . 75.05 113.422 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.563 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 81.1 mt -59.19 -46.89 87.22 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.155 0.502 . . . . 71.04 111.211 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.1 m -70.21 -31.41 68.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.961 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 182' ' ' ASP . 3.1 tppp? -60.4 -50.71 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.047 0.451 . . . . 70.33 110.061 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.97 83.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.765 -0.652 . . . . 73.24 110.517 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.535 ' OE1' ' HB3' ' A' ' 108' ' ' PHE . 4.7 tp60 -53.38 -46.11 69.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.5 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -65.64 -37.39 86.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.422 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -85.83 -32.04 21.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.287 0.477 . . . . 73.22 112.287 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.07 -64.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.806 0.443 . . . . 73.42 112.158 -173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -75.92 8.26 3.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.932 0.345 . . . . 63.33 111.932 -176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 49.4 m -94.46 -19.82 20.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.244 0.545 . . . . 75.23 109.599 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -87.32 112.47 22.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.176 -0.676 . . . . 74.33 109.176 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.646 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 8.3 pttp -145.27 149.79 35.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.374 -0.376 . . . . 70.32 111.624 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.18 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 75.34 110.224 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.694 -0.67 . . . . 72.45 109.992 -177.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.753 0.311 . . . . 35.4 111.036 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.5 t -123.48 106.56 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.385 . . . . 74.53 110.871 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.4 t -80.5 -57.35 3.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 75.01 110.402 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 53.2 mt-30 -134.31 123.78 16.81 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.712 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 4' ' ' GLN . 3.0 Cg_exo -76.56 130.96 12.12 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.852 2.368 . . . . 74.43 111.14 174.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.659 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -58.97 141.92 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 123.451 0.469 . . . . 74.42 111.221 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.881 ' HD2' HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -71.93 -67.4 0.54 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.376 -0.375 . . . . 62.14 111.739 177.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.067 ' HB3' ' HB2' ' A' ' 63' ' ' ARG . 2.7 pt? -143.73 155.25 44.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.123 0.487 . . . . 73.41 112.023 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -113.99 147.29 38.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.628 -0.714 . . . . 62.32 110.161 173.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 59.3 t -103.01 126.14 57.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.11 -0.495 . . . . 73.34 110.349 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.24 138.51 14.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.926 -0.654 . . . . 71.52 111.815 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -99.91 146.04 27.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.668 0.234 . . . . 71.51 110.393 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB1' ' OD1' ' A' ' 25' ' ' ASN . . . -159.0 -165.95 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 73.34 111.193 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.739 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 3.9 m-20 -96.21 145.09 28.96 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.926 -0.579 . . . . 65.43 110.72 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.11 81.06 2.9 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.713 2.275 . . . . 41.34 113.136 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.28 149.7 7.25 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.79 -0.719 . . . . 24.52 112.604 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.49 -23.96 77.47 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.048 2.498 . . . . 73.4 112.663 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.07 -35.58 80.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.382 . . . . 75.23 110.797 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.739 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 10.4 m-85 -101.69 -7.02 23.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 74.55 109.961 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.44 -10.33 24.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 73.24 112.593 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 3.9 ptpt -92.24 3.16 55.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.436 0.636 . . . . 71.13 110.558 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 24' ' ' HIS . 1.7 m -80.51 145.91 31.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.23 -0.896 . . . . 65.03 109.117 170.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 153' ' ' VAL . 16.5 ttt180 -70.68 -8.41 51.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.005 0.431 . . . . 75.12 111.991 -171.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.732 ' H ' HG22 ' A' ' 22' ' ' THR . 83.5 t60 -74.9 -8.71 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.473 0.654 . . . . 74.04 110.351 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.548 ' OD1' ' HB1' ' A' ' 13' ' ' ALA . 5.8 t30 -90.23 21.52 3.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.757 -0.656 . . . . 73.3 110.417 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -65.41 -35.03 79.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.258 -0.428 . . . . 61.01 111.218 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.39 -32.19 83.36 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 120.871 -0.681 . . . . 73.4 112.555 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -74.79 -30.7 61.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.062 0.393 . . . . 73.25 112.062 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.796 ' HD1' HG21 ' A' ' 169' ' ' VAL . 9.8 t-105 -69.52 -38.56 77.61 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.93 -0.308 . . . . 71.24 111.112 -173.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.721 HG12 HG13 ' A' ' 169' ' ' VAL . 29.0 m -68.15 -25.32 31.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.841 0.353 . . . . 72.23 110.488 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 27' ' ' GLY . 57.6 t -72.12 -50.31 37.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 74.44 110.404 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.62 -33.66 75.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.643 -0.708 . . . . 72.43 111.67 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 37' ' ' ILE . 10.2 tp10 -60.67 -46.34 90.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.887 -0.412 . . . . 71.52 109.887 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 30' ' ' VAL . 95.4 mt -56.73 -36.84 70.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.107 -0.497 . . . . 65.53 111.34 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.2 -36.5 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.017 -0.538 . . . . 44.44 111.383 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 36' ' ' ARG . 8.1 mpt_? -85.84 -23.16 27.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.531 -0.304 . . . . 71.42 111.035 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.2 mm -66.34 -50.94 63.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 64.04 111.109 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 45.4 t-80 -109.07 -2.71 17.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.78 -0.368 . . . . 74.13 111.715 -174.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 60.06 57.06 3.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 122.094 0.95 . . . . 70.02 109.689 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.773 HG11 ' HB3' ' A' ' 55' ' ' LEU . 16.9 m -103.83 145.2 13.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.463 -0.789 . . . . 72.1 110.002 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.04 101.52 10.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.217 0.532 . . . . 63.34 111.885 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 35' ' ' ALA . 3.4 mm? -72.29 100.65 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 65.02 109.361 172.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.76 158.37 42.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 72.54 110.643 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -72.5 151.76 42.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 53.24 111.233 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -123.36 106.92 32.61 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.093 -0.706 . . . . 74.33 109.093 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.13 -16.01 47.7 Favored 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.046 2.498 . . . . 73.44 112.714 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -76.49 -28.41 56.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.011 -0.541 . . . . 61.31 110.972 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' HE1' ' HD2' ' A' ' 84' ' ' PHE . 16.0 m-85 -110.78 -33.12 6.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.207 0.527 . . . . 71.32 110.092 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.3 t80 80.09 77.53 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.519 -1.673 . . . . 72.13 110.423 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 171.92 177.7 41.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.029 -0.987 . . . . 73.35 111.058 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 66' ' ' ILE . 16.5 tp -93.6 129.63 39.79 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.962 -0.755 . . . . 60.33 108.962 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -135.87 158.08 45.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.236 0.541 . . . . 74.23 111.85 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.74 168.73 27.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.229 -0.896 . . . . 64.14 110.943 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.649 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -154.24 110.67 3.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.525 -0.546 . . . . 74.54 109.525 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HB3' HG11 ' A' ' 40' ' ' VAL . 1.4 pt? -135.21 119.53 17.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.45 0.643 . . . . 74.55 112.24 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.63 121.34 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.35 -0.841 . . . . 72.33 109.866 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.1 pt -122.71 131.73 72.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 71.13 109.941 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB3' ' SD ' ' A' ' 180' ' ' MET . 49.7 t30 60.25 -85.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.572 -0.74 . . . . 63.31 111.599 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.4 m -137.93 11.23 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.77 0.319 . . . . 55.44 111.393 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -138.31 133.03 32.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.63 -0.259 . . . . 73.21 110.984 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 4.6 pt-20 -80.71 103.12 10.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.505 -0.554 . . . . 61.03 109.505 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 176' ' ' LEU . 8.3 tt -93.31 125.89 38.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.999 -0.546 . . . . 43.11 111.038 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 1.067 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 83.4 mtt180 -106.25 168.86 8.86 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 71.2 110.001 -177.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 31' ' ' VAL . 14.6 p -150.17 149.42 14.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.753 -0.462 . . . . 73.45 109.753 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 8.7 tt -144.85 138.32 26.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.812 0.339 . . . . 55.12 110.548 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 13' ' ' ALA . 7.8 tt -133.46 121.13 16.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 74.12 109.656 174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 8.7 Cg_exo -71.58 152.59 59.78 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.927 2.418 . . . . 64.22 112.252 -177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.2 p -72.32 -38.11 68.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.158 0.504 . . . . 54.33 110.781 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 18.1 m -112.95 107.75 16.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.88 -0.6 . . . . 63.32 109.543 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 71' ' ' MET . 38.2 p90 -70.6 -21.67 62.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.781 0.659 . . . . 55.23 112.781 -170.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HG2' ' CE2' ' A' ' 70' ' ' PHE . 19.6 mmt -97.84 -71.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.716 0.636 . . . . 73.41 112.716 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.591 HD22 HD22 ' A' ' 73' ' ' LEU . 10.2 t30 -76.39 -49.5 16.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.822 0.675 . . . . 51.44 112.822 -167.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.5 mm? -87.87 5.24 41.33 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.157 -0.339 . . . . 61.04 111.891 -175.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' HG13 ' A' ' 78' ' ' ILE . 24.1 t -71.1 -58.02 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.7 0.286 . . . . 71.35 111.355 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.22 -34.38 89.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.591 -0.814 . . . . 55.42 113.481 -173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -66.16 -35.01 79.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.428 0.614 . . . . 64.34 110.674 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.64 -43.74 88.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.157 0.503 . . . . 75.14 109.823 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' SER . 55.3 mt -66.8 -38.95 82.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.496 -0.774 . . . . 75.21 110.466 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.48 82.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.605 -0.725 . . . . 43.15 111.214 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.06 96.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.185 -0.461 . . . . 64.22 109.955 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.575 HD21 HD21 ' A' ' 8' ' ' LEU . 18.5 tp -49.6 -59.18 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.408 -0.815 . . . . 70.52 111.176 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' CE1' ' A' ' 85' ' ' TYR . . . -66.13 -43.58 86.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.025 -0.534 . . . . 41.01 111.728 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -58.99 -38.25 78.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 71.12 111.37 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.484 ' HD2' ' HE1' ' A' ' 48' ' ' PHE . 11.5 m-30 -78.26 -55.02 5.58 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 120.694 -0.402 . . . . 73.35 110.549 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.784 ' CE1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -69.91 -15.68 63.1 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.572 -0.851 . . . . 71.41 113.144 -171.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' N ' ' HD1' ' A' ' 85' ' ' TYR . 37.3 tt0 72.04 -15.74 0.45 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.063 0.545 . . . . 75.12 112.45 171.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.881 HG21 ' HD2' ' A' ' 7' ' ' LYS . 33.4 mt -58.81 150.0 5.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.355 -0.384 . . . . 51.22 110.286 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.782 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.94 128.63 21.46 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.824 -0.626 . . . . 63.12 112.291 -171.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 88' ' ' LYS . 25.2 Cg_exo -64.13 -10.58 23.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.338 2.692 . . . . 75.1 112.478 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.782 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 8.9 pt-20 -73.88 -20.96 60.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 71.35 109.71 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.53 9.56 15.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 72.02 110.817 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 82' ' ' ALA . 29.7 mm -82.62 101.46 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.149 -0.685 . . . . 75.4 109.149 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.939 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 79.0 mtp -105.59 138.1 42.34 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.086 -0.246 . . . . 65.1 110.642 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.49 126.84 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.88 0.372 . . . . 71.53 110.582 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -116.62 126.03 52.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.442 -0.344 . . . . 74.34 110.263 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.69 -179.38 8.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.912 -0.715 . . . . 73.42 112.002 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 140' ' ' ILE . 18.3 p-10 -81.36 132.8 35.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.279 -1.328 . . . . 52.42 112.047 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -140.69 169.06 18.35 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 110.35 -0.241 . . . . 65.43 110.35 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.582 HD23 HG21 ' A' ' 153' ' ' VAL . 2.0 pp -122.38 9.95 9.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.978 1.103 . . . . 70.14 113.978 -164.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -97.32 8.58 44.28 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.931 -0.481 . . . . 53.11 111.288 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -131.04 155.69 81.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.283 -0.417 . . . . 74.12 110.415 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HG2' ' CG2' ' A' ' 105' ' ' VAL . 6.7 Cg_endo -51.53 153.45 10.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.952 2.435 . . . . 71.05 111.516 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.91 32.43 0.23 Allowed 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.476 2.784 . . . . 62.34 114.722 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.758 ' HA3' ' HB3' ' A' ' 196' ' ' ALA . . . -173.87 44.6 0.15 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.297 -0.477 . . . . 61.23 112.375 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.726 HG22 ' HA ' ' A' ' 195' ' ' LYS . 41.6 t -143.3 132.44 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 110.22 -0.289 . . . . 71.24 110.22 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' A' ' 191' ' ' LEU . . . -102.11 179.4 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 64.31 111.398 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 57.7 tttm -165.43 141.29 5.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.344 -0.389 . . . . 73.34 110.803 175.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -90.3 147.06 23.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 73.45 111.007 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.839 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.8 OUTLIER -136.56 130.94 33.14 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.739 -0.664 . . . . 63.03 109.473 174.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.695 ' HG3' ' CE1' ' A' ' 134' ' ' TYR . 60.0 tt0 -122.3 123.52 41.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 74.12 109.622 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 102.43 -111.3 3.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.465 -0.874 . . . . 70.53 112.625 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -92.35 134.84 12.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.017 -0.611 . . . . 62.01 112.474 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HE2' ' A' ' 109' ' ' LYS . . . 154.84 65.56 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.477 -0.868 . . . . 61.52 112.13 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -86.45 171.58 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.534 0.683 . . . . 73.35 111.437 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.13 124.7 7.76 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.187 -1.565 . . . . 62.02 109.187 166.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.58 52.11 1.17 Allowed Glycine 0 CA--C 1.513 -0.091 0 C-N-CA 121.226 -0.511 . . . . 64.53 112.111 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -142.02 156.84 45.44 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 122.473 0.309 . . . . 72.42 110.305 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -46.29 -58.66 3.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.036 0.835 . . . . 75.51 112.78 -173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -53.33 -46.47 63.85 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.461 -0.399 . . . . 63.01 113.767 -174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.62 -50.66 14.85 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.696 -0.296 . . . . 72.4 111.153 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.68 -44.57 93.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.474 -0.33 . . . . 74.42 111.008 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.94 -33.74 73.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 74.5 110.687 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -59.04 -51.49 69.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.046 -0.524 . . . . 73.22 110.039 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.77 -36.67 77.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.778 -0.646 . . . . 71.34 110.45 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.6 m -64.56 -41.47 96.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 73.34 111.334 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' HE3' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -71.73 -31.63 66.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.857 0.361 . . . . 74.33 110.673 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 91.8 mt -81.61 -10.1 59.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.556 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.89 -111.14 3.23 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.95 -0.568 . . . . 64.04 112.545 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.407 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -101.27 24.89 8.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.612 0.227 . . . . 53.53 111.612 -177.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 127' ' ' LEU . 25.0 m-80 -81.85 100.82 9.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.325 0.583 . . . . 73.03 110.928 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.33 18.35 22.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.349 -0.841 . . . . 71.53 109.458 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.72 8.02 45.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.449 -0.796 . . . . 72.3 111.461 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -69.82 142.54 53.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.164 0.507 . . . . 74.25 111.072 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.939 ' HB2' ' HG2' ' A' ' 93' ' ' MET . 19.0 m-30 -100.15 159.04 15.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.092 -0.503 . . . . 74.11 109.917 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.839 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -153.57 150.93 29.19 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.864 -0.334 . . . . 64.04 110.144 174.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 2.7 pp -128.36 120.96 28.05 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 72.14 108.53 170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -92.21 131.18 37.64 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.836 -0.62 . . . . 65.24 110.515 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.504 HD12 ' HB1' ' A' ' 26' ' ' ALA . 27.3 mt -93.6 113.9 26.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.145 -0.687 . . . . 74.04 109.145 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.78 103.16 0.79 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.944 -0.862 . . . . 70.14 110.944 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.832 HD11 HG13 ' A' ' 153' ' ' VAL . 2.4 pp -125.38 -27.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.104 0.478 . . . . 62.03 110.791 -177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -84.41 111.22 3.45 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.618 -0.801 . . . . 61.04 112.495 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -102.71 119.45 55.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.039 -0.726 . . . . 71.11 109.039 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.99 141.28 20.97 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.068 2.512 . . . . 71.11 114.266 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.92 -77.57 0.39 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.94 -1.027 . . . . 51.15 110.641 173.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.468 ' HD2' ' H ' ' A' ' 147' ' ' ASP . 9.7 t60 -105.37 131.3 52.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.018 -0.734 . . . . 72.43 109.018 173.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -58.72 -26.93 64.4 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.58 0.585 . . . . 62.3 112.58 -171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.468 ' H ' ' HD2' ' A' ' 145' ' ' HIS . 4.0 m-20 -83.73 -16.71 43.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.578 -0.283 . . . . 53.41 111.709 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -125.4 24.58 7.29 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.096 -0.241 . . . . 65.21 110.839 -173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 153' ' ' VAL . 15.3 m -60.04 -34.7 57.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.05 0.389 . . . . 62.41 112.05 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.497 ' O ' ' HG ' ' A' ' 154' ' ' LEU . . . -67.04 -20.89 65.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 71.43 111.226 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.7 -27.93 71.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.926 -0.654 . . . . 74.23 112.431 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.46 -19.56 31.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.804 0.811 . . . . 75.55 109.012 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.832 HG13 HD11 ' A' ' 140' ' ' ILE . 78.2 t -75.93 -52.78 17.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.251 -1.34 . . . . 50.42 110.86 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 150' ' ' ALA . 2.9 pp -101.95 16.71 25.14 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.925 -0.31 . . . . 70.23 111.72 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.02 163.17 37.71 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.477 -0.868 . . . . 64.34 111.496 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.498 ' HE3' ' OG1' ' A' ' 22' ' ' THR . 11.3 mptt -89.17 115.47 26.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.947 0.403 . . . . 44.25 109.931 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.16 154.43 66.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.847 -0.615 . . . . 61.44 110.65 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.55 157.13 48.23 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.363 2.042 . . . . 63.41 110.935 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.18 -43.14 70.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.039 0.385 . . . . 75.4 112.039 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.847 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -67.18 -28.87 68.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 72.14 111.453 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -81.58 -23.43 37.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.343 0.592 . . . . 71.14 109.766 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -74.39 -22.02 59.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.537 -0.756 . . . . 74.13 110.701 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -62.58 -32.39 73.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.349 . . . . 62.23 110.712 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 10.4 m -64.41 -49.14 72.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.245 0.545 . . . . 64.34 109.634 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.3 -46.65 79.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.295 -0.866 . . . . 74.13 111.346 176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.93 -35.5 81.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 70.23 111.217 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.23 71.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.564 -0.289 . . . . 43.13 111.024 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 171' ' ' GLU . . . -64.56 -39.63 94.09 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 121.056 0.455 . . . . 32.33 110.416 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.796 HG21 ' HD1' ' A' ' 29' ' ' TRP . 90.3 t -53.33 -31.04 18.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.951 -0.568 . . . . 63.43 111.793 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.744 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 13.2 t70 -65.73 -59.62 3.72 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.233 -0.284 . . . . 72.1 110.233 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -61.25 -31.01 70.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.655 0.264 . . . . 74.51 111.186 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 61.1 m -62.29 -47.2 85.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.187 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.06 -21.95 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 120.577 -0.449 . . . . 73.34 111.288 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.744 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 30.8 mmt180 -63.11 -51.32 67.03 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.856 0.36 . . . . 74.1 110.432 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.678 ' HB3' HD12 ' A' ' 191' ' ' LEU . 23.7 p -60.82 -28.7 68.99 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.885 -0.598 . . . . 72.21 112.079 -171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 86.4 mt -62.94 -38.29 90.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.899 0.38 . . . . 70.03 111.058 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 180' ' ' MET . 35.2 tt0 -85.24 -35.4 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.059 0.457 . . . . 72.14 109.974 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.509 HD12 HH21 ' A' ' 190' ' ' ARG . 43.3 mm -62.66 -44.59 99.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 73.34 110.891 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.48 -37.65 62.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.857 -0.611 . . . . 72.15 112.212 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.6 ptp -78.83 -36.26 42.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.156 0.428 . . . . 72.24 112.156 -173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 -23.41 13.91 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 72.24 112.317 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.88 -9.24 12.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.888 0.375 . . . . 75.43 111.169 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 96.59 151.49 28.04 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.401 -0.904 . . . . 75.13 112.102 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -67.54 -29.11 68.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.84 0.352 . . . . 73.15 110.884 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.9 p -71.51 -43.4 66.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 70.33 111.296 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -60.24 -42.24 94.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 64.02 110.105 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.34 -51.65 66.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.741 -0.663 . . . . 62.31 110.696 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -53.79 -46.56 71.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.776 0.322 . . . . 63.43 111.135 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -66.04 -46.59 77.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.267 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.509 HH21 HD12 ' A' ' 178' ' ' ILE . 20.7 mtm180 -80.99 -17.65 49.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.944 0.35 . . . . 73.32 111.944 -175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 175' ' ' CYS . 8.5 tt -81.6 -56.7 3.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.021 -0.362 . . . . 73.04 110.021 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -67.31 -15.02 63.45 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.361 -0.381 . . . . 75.3 111.763 -172.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 15.0 t -73.89 -16.4 61.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.93 0.395 . . . . 70.15 110.069 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -86.21 136.55 33.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.772 -0.649 . . . . 72.4 110.253 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.726 ' HA ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -144.32 116.33 8.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.313 -0.403 . . . . 64.14 110.544 171.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.758 ' HB3' ' HA3' ' A' ' 104' ' ' GLY . . . -73.48 89.79 1.69 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.76 -0.655 . . . . 63.33 109.966 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.508 -0.769 . . . . 74.41 109.061 -176.105 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.657 0.265 . . . . 73.04 110.718 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 m -105.66 108.93 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.273 0.559 . . . . 73.23 111.023 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -70.08 -51.71 29.65 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.363 -0.835 . . . . 71.02 110.739 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -115.96 97.71 49.76 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.775 -0.648 . . . . 73.24 109.534 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.92 166.74 22.97 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.325 2.683 . . . . 43.41 112.807 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' HA ' ' A' ' 91' ' ' GLU . 2.4 mp -58.27 134.61 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.472 -0.786 . . . . 51.11 110.459 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' HG2' HD13 ' A' ' 87' ' ' ILE . 0.8 OUTLIER -84.36 -56.61 3.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.608 -174.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.0 pt? -127.02 150.47 49.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.161 0.505 . . . . 73.54 111.914 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -133.02 142.23 48.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.722 -0.672 . . . . 61.04 109.31 170.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 94' ' ' VAL . 30.6 m -111.19 154.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.413 -0.358 . . . . 73.41 110.981 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.68 134.57 11.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.657 -0.782 . . . . 73.24 112.608 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 96' ' ' HIS . 59.5 mt -104.75 124.92 50.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 75.51 109.622 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.68 163.03 35.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.094 0.473 . . . . 72.1 111.748 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.635 ' HB3' ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -74.26 119.18 75.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.185 -0.916 . . . . 70.3 110.358 175.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -82.65 -8.03 11.43 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.184 2.589 . . . . 74.22 113.649 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.71 143.18 18.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.545 -0.836 . . . . 72.35 111.713 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.95 -40.5 75.73 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 123.173 2.582 . . . . 72.22 112.817 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 45.1 mt-10 -75.38 -22.7 57.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.24 0.543 . . . . 64.52 110.667 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.635 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . 9.4 m-85 -96.05 -7.54 35.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.639 0.733 . . . . 75.14 109.475 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . . . -73.43 -39.24 65.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.556 -1.202 . . . . 70.54 110.511 173.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 49.2 pttt -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.391 0.615 . . . . 73.22 109.839 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 52.4 m -71.54 146.93 48.17 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.065 -0.97 . . . . 64.32 108.466 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 140' ' ' ILE . 18.5 ttt180 -72.6 -5.77 39.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.375 0.88 . . . . 74.21 113.375 -166.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.504 ' CD2' ' HB3' ' A' ' 154' ' ' LEU . 86.0 m-70 -85.71 34.18 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.86 -0.336 . . . . 70.14 111.086 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HA ' ' HB1' ' A' ' 13' ' ' ALA . 16.9 t-20 -115.29 12.11 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.512 0.672 . . . . 74.33 109.901 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.881 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -58.83 -37.24 75.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.75 -0.659 . . . . 65.22 111.638 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -64.22 -29.22 74.37 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.833 -0.698 . . . . 71.34 112.975 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.63 23.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.929 0.365 . . . . 72.5 110.868 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.483 ' CD1' HG21 ' A' ' 169' ' ' VAL . 2.5 t-105 -56.95 -44.94 83.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.777 -0.647 . . . . 73.05 110.817 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 169' ' ' VAL . 6.2 m -69.8 -37.74 74.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.572 -0.285 . . . . 61.55 111.497 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 27' ' ' GLY . 74.5 t -68.4 -46.0 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.8 0.333 . . . . 75.35 111.304 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -68.03 -36.04 79.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.339 -0.391 . . . . 73.02 110.408 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -62.54 -38.83 91.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.936 -0.394 . . . . 71.02 109.936 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.63 -42.44 92.75 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.811 0.339 . . . . 72.11 110.334 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.58 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -61.14 -43.53 98.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 72.43 110.661 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 36' ' ' ARG . 13.3 ttm180 -70.77 -49.18 49.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.182 -0.917 . . . . 74.23 111.505 -176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.08 -52.27 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 55.32 111.593 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -85.88 -7.74 58.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.6 -0.273 . . . . 75.22 110.836 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.3 t30 58.89 57.42 3.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.684 0.754 . . . . 74.31 110.321 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 35' ' ' ALA . 7.2 p -117.06 136.77 53.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.527 177.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -81.49 104.13 11.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.359 0.599 . . . . 74.15 111.658 -176.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 35' ' ' ALA . 1.1 mm? -66.53 101.44 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.43 -0.805 . . . . 72.54 109.6 174.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 25.3 mtmm -94.51 135.11 36.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.814 -0.63 . . . . 75.4 111.086 -172.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -74.2 123.22 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.204 0.526 . . . . 70.22 110.107 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.0 tm-20 -113.32 114.4 48.1 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.278 -0.638 . . . . 71.44 109.278 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 21.1 Cg_exo -66.85 -21.05 51.23 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.122 2.548 . . . . 60.31 113.89 -174.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -90.15 -26.1 20.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.618 0.247 . . . . 64.1 111.274 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 6.5 m-85 -105.17 -0.2 26.75 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 122.02 0.914 . . . . 73.54 108.827 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 58.77 27.88 16.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 74.34 112.4 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.68 178.58 31.35 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.239 -0.981 . . . . 52.53 112.813 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 9.5 mp -94.08 126.32 39.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.135 -0.32 . . . . 64.12 110.135 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.8 t -113.19 145.59 40.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.263 0.554 . . . . 72.34 111.617 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.65 137.46 6.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.468 -0.787 . . . . 51.12 111.651 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 1.4 tmm_? -117.85 106.08 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.649 -0.871 . . . . 71.21 108.649 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.2 pt? -125.99 116.84 22.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.219 0.533 . . . . 61.4 112.052 -175.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.5 tt -78.38 112.1 15.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.683 -0.69 . . . . 62.21 109.619 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 29.0 pt -110.41 137.62 41.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.278 -0.419 . . . . 64.25 109.951 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.811 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 6.5 t30 61.71 -77.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.961 0.788 . . . . 71.24 110.892 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.8 p -155.05 12.26 0.37 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.014 0.435 . . . . 65.41 110.988 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.08 129.34 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.995 -0.372 . . . . 73.51 109.995 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 2.3 pt-20 -72.97 112.31 8.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.041 0.448 . . . . 74.44 110.703 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 9' ' ' LEU . 9.4 tt -94.76 129.23 41.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.089 0.471 . . . . 72.22 111.081 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 75.9 mtt85 -104.29 126.34 51.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.827 -0.624 . . . . 70.3 110.826 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 12.3 p -129.64 144.75 37.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.534 -0.303 . . . . 71.12 110.329 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 81' ' ' LEU . 8.8 tt -151.19 133.71 15.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.902 -0.407 . . . . 53.4 109.902 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.1 tt -119.93 111.05 36.0 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-O 120.99 0.424 . . . . 74.41 110.496 177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' ILE . 12.9 Cg_exo -69.75 139.39 40.14 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.929 2.419 . . . . 61.13 111.976 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.4 p -65.61 -44.45 86.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.357 0.598 . . . . 72.23 111.057 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 28.7 m -94.51 96.88 9.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.134 -0.484 . . . . 75.52 110.412 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -80.26 1.08 29.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.887 -0.597 . . . . 72.34 111.169 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 94.2 mmm -97.17 -71.08 0.69 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.262 -0.426 . . . . 55.55 112.015 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -96.59 -49.48 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.854 0.687 . . . . 44.01 112.854 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 89.9 mt -86.9 10.6 15.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.728 0.64 . . . . 72.55 112.728 -169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 78' ' ' ILE . 2.7 m -65.82 -60.64 2.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.675 0.274 . . . . 43.43 111.643 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.37 73.87 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.603 -0.808 . . . . 71.24 113.032 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 39.2 mtpt -69.52 -40.58 76.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -60.35 -48.0 83.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.483 -0.781 . . . . 64.14 109.985 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 74' ' ' SER . 56.7 mt -65.23 -39.13 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.154 -0.93 . . . . 65.34 110.763 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.741 ' HA ' HD21 ' A' ' 127' ' ' LEU . . . -59.0 -50.77 72.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 72.32 111.027 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -58.89 -47.19 85.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.681 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 65' ' ' LEU . 27.6 tp -61.65 -52.47 64.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.818 -0.628 . . . . 75.23 111.128 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 -20.28 63.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.077 -0.51 . . . . 61.4 111.655 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 65.7 t30 -78.2 -53.12 7.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.807 -0.179 . . . . 73.52 111.44 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.501 ' HE1' HD12 ' A' ' 81' ' ' LEU . 13.2 p90 -72.54 -21.96 61.09 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.295 -0.562 . . . . 72.21 110.206 -177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 4.0 m-85 -83.44 -19.27 36.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 74.12 110.7 172.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 38.15 69.39 0.25 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.01 0.924 . . . . 52.24 112.355 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.786 HD13 ' HG2' ' A' ' 7' ' ' LYS . 21.5 mt -114.81 148.6 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.26 -0.882 . . . . 64.32 109.507 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 92' ' ' ILE . 37.8 mttt -58.91 152.64 48.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 74.23 111.406 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 50.3 Cg_exo -57.48 -32.5 94.33 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 74.11 110.958 171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.53 ' HA ' ' HE1' ' A' ' 134' ' ' TYR . 30.0 mt-10 -60.13 -31.21 69.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.85 -1.068 . . . . 61.33 111.359 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.645 ' HB3' ' H ' ' A' ' 7' ' ' LYS . 75.4 mt-10 -103.19 19.83 18.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.036 -0.529 . . . . 74.01 110.604 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 88' ' ' LYS . 49.2 mm -108.51 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.39 -0.823 . . . . 75.03 109.085 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 36.9 mtt -110.25 150.98 27.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 73.5 111.56 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.79 HG13 ' HB2' ' A' ' 135' ' ' ARG . 4.0 p -134.92 136.83 51.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.751 -0.659 . . . . 62.4 110.229 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.1 144.04 49.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.584 -0.28 . . . . 65.01 110.564 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' CB ' ' HB2' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -169.33 175.98 5.34 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.252 0.549 . . . . 73.42 111.696 176.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.771 ' HB2' HD13 ' A' ' 140' ' ' ILE . 1.1 p-10 -64.73 134.58 54.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.662 -1.153 . . . . 73.13 110.701 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 137' ' ' ARG . 2.3 tp10 -126.98 138.08 53.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 64.12 110.974 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -88.41 0.86 55.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 74.02 110.504 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.81 -14.12 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 52.21 111.389 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.79 149.73 63.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.584 -0.28 . . . . 55.23 111.226 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 35.4 Cg_endo -65.88 158.3 54.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.985 2.457 . . . . 40.11 111.801 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 17.3 Cg_exo -65.91 115.12 3.26 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.867 2.378 . . . . 63.31 112.818 -175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.77 -27.36 4.38 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.417 -0.896 . . . . 63.25 113.031 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 195' ' ' LYS . 30.6 m -100.4 147.59 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.243 0.544 . . . . 71.11 111.767 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.46 169.21 9.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.806 -0.813 . . . . 71.44 108.806 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -171.48 157.1 4.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.252 -0.647 . . . . 71.12 109.252 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -94.88 166.11 12.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.329 0.585 . . . . 55.31 110.896 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.647 ' HB3' ' HG2' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -140.55 116.59 10.47 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.127 -1.064 . . . . 72.41 108.127 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -110.93 134.2 52.76 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.758 -0.831 . . . . 72.13 108.758 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.94 -112.8 3.43 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.181 -1.009 . . . . 75.23 112.286 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.18 -117.07 2.0 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.389 -0.91 . . . . 60.44 113.088 -170.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.92 64.86 2.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.883 -0.675 . . . . 72.51 112.839 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -59.71 127.04 30.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.985 0.393 . . . . 73.35 110.725 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -85.04 40.78 3.01 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.93 -0.652 . . . . 44.12 113.588 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.66 20.49 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 123.557 0.21 . . . . 63.12 113.553 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.11 131.51 25.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.847 -0.427 . . . . 74.24 109.847 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.09 -38.37 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.653 0.596 . . . . 74.3 111.727 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' HA2' ' HB2' ' A' ' 74' ' ' SER . . . -56.0 -45.37 87.03 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.673 . . . . 72.02 112.956 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 mt -76.27 -39.03 55.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.916 0.389 . . . . 75.12 110.972 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -69.99 -41.86 73.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.034 -0.53 . . . . 42.22 111.553 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -62.45 -33.0 73.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.978 0.418 . . . . 74.03 110.192 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 39.3 m -62.17 -46.71 87.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.903 -0.59 . . . . 73.34 110.2 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -58.14 -41.51 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.643 -0.708 . . . . 73.53 110.222 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.4 m -70.06 -56.64 6.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.155 -0.93 . . . . 54.41 112.283 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' HG2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -62.39 -47.94 81.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 73.04 112.047 -170.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 79' ' ' ALA . 85.5 mt -80.31 -17.96 50.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 75.0 111.511 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 33.8 63.52 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.377 -0.916 . . . . 52.4 110.859 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 89' ' ' PRO . 24.5 t-20 -62.39 -32.29 73.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.946 -0.627 . . . . 60.33 111.857 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.3 -107.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.68 -0.691 . . . . 73.03 110.732 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -120.62 24.62 10.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.376 0.131 . . . . 74.45 111.258 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -117.95 48.82 1.32 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.479 -0.488 . . . . 74.23 111.793 -171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -122.97 137.42 54.96 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.102 -0.639 . . . . 71.22 110.927 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.53 ' HE1' ' HA ' ' A' ' 90' ' ' GLU . 17.6 m-85 -99.82 137.22 38.59 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.233 -0.894 . . . . 72.4 109.338 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.79 ' HB2' HG13 ' A' ' 94' ' ' VAL . 2.3 ptt180 -142.11 134.55 28.01 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.028 -0.669 . . . . 61.4 110.554 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 pp -103.09 137.75 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.037 -0.727 . . . . 73.35 109.037 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 2.7 ptp180 -115.19 138.57 50.77 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.526 -0.761 . . . . 73.21 111.395 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.881 HD12 ' HB1' ' A' ' 26' ' ' ALA . 34.2 mt -102.82 116.55 32.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.943 -0.571 . . . . 54.15 109.622 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -67.18 115.72 7.41 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.813 -0.708 . . . . 62.43 112.36 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 97' ' ' ASP . 46.9 pt -119.62 -4.01 9.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.956 0.408 . . . . 74.52 111.028 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -98.41 116.94 5.69 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.244 -0.979 . . . . 34.32 113.115 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.534 ' HB3' ' HG2' ' A' ' 103' ' ' PRO . 2.6 p-80 -102.11 138.63 19.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.371 -0.603 . . . . 73.52 109.371 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -52.54 129.08 30.47 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.652 2.235 . . . . 72.32 112.184 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.41 -170.94 20.12 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.354 -0.698 . . . . 64.11 111.354 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -73.23 127.2 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.541 -0.54 . . . . 72.55 109.541 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 146' ' ' LYS . 19.1 ptmt -54.82 -35.36 63.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.803 0.668 . . . . 72.3 112.803 -172.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.34 -19.8 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 54.11 111.367 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.7 mmtt -119.21 29.27 7.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 73.33 110.51 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 7.4 p -56.77 -41.77 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.876 -0.602 . . . . 63.44 111.352 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -17.91 64.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.7 0.286 . . . . 64.2 111.586 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.81 -49.92 72.89 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.087 -0.506 . . . . 64.34 113.058 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.412 ' OH ' HG23 ' A' ' 149' ' ' VAL . 41.1 p90 -84.64 -16.5 41.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.212 0.506 . . . . 74.15 111.009 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 149' ' ' VAL . 91.8 t -70.8 -47.47 63.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.716 -0.674 . . . . 65.11 111.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 24' ' ' HIS . 1.8 pp -134.67 24.56 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.494 0.553 . . . . 65.31 112.494 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -91.0 162.09 28.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.121 -1.038 . . . . 61.33 111.018 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -81.58 97.68 7.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.036 0.446 . . . . 74.31 109.946 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 158' ' ' PRO . . . -68.98 131.1 91.03 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.824 -0.625 . . . . 64.12 110.296 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 27.3 Cg_exo -64.23 174.24 4.34 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.877 2.385 . . . . 73.43 112.315 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.86 -44.66 82.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.25 112.032 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -64.46 -23.56 67.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.134 0.42 . . . . 73.33 112.134 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' A' ' 23' ' ' ARG . 44.2 tp10 -89.74 -40.28 12.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.94 0.4 . . . . 64.02 110.77 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.525 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 8.7 mm-40 -75.52 -19.43 59.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.544 0.572 . . . . 54.42 112.544 -175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -20.36 63.72 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.635 -0.426 . . . . 65.52 110.051 173.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 61.9 m -75.19 -29.97 60.51 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.02 -0.536 . . . . 55.21 110.098 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 55.5 tp -70.96 -48.69 51.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 53.25 109.833 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -58.66 -39.5 80.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.656 -0.702 . . . . 71.43 110.872 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.78 -48.55 81.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 45.02 110.792 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.22 87.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.68 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 30' ' ' VAL . 50.1 t -58.24 -48.27 85.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 62.11 112.028 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -65.38 -35.56 81.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.772 0.32 . . . . 74.44 110.904 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' A' ' 174' ' ' ARG . 14.9 tp10 -71.59 -40.6 69.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.09 0.472 . . . . 75.5 109.965 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.4 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 69.2 m -57.96 -42.35 84.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 61.21 111.208 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.45 -29.7 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.798 0.296 . . . . 52.02 111.798 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 171' ' ' GLU . 6.0 ptp180 -74.15 -34.8 63.96 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.879 -0.329 . . . . 75.22 110.622 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.727 ' HB2' ' HB1' ' A' ' 187' ' ' ALA . 18.4 p -70.51 -22.46 62.63 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.478 -0.328 . . . . 75.04 111.179 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 172' ' ' SER . 86.4 mt -60.68 -38.43 84.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.653 0.263 . . . . 73.33 111.501 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.811 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 35.3 tt0 -72.3 -40.31 67.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 62.23 110.413 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.12 -39.65 79.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.966 -0.561 . . . . 75.33 110.493 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.94 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 10.4 tt -56.4 -41.16 75.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.58 -0.737 . . . . 74.33 111.798 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 23.7 ptp -74.31 -40.98 61.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.144 0.424 . . . . 63.52 112.144 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -27.91 12.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.801 0.667 . . . . 73.31 112.801 -170.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.29 -9.44 16.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 50.55 111.217 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 117.19 138.54 6.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.249 -0.977 . . . . 60.03 111.882 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.94 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 1.7 pt? -66.51 -32.16 73.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.955 0.407 . . . . 75.34 110.299 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 9.3 p -73.52 -31.31 63.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 74.35 111.149 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -63.33 -48.9 76.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.107 0.479 . . . . 73.45 110.21 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.727 ' HB1' ' HB2' ' A' ' 175' ' ' CYS . . . -72.1 -42.99 65.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.899 -0.591 . . . . 73.01 111.163 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.2 -34.22 73.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.311 -0.404 . . . . 71.34 111.575 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -67.16 -25.17 66.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.597 0.221 . . . . 72.04 111.597 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -87.94 -46.11 9.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.421 0.629 . . . . 64.22 109.38 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -48.39 -56.83 7.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.165 -1.38 . . . . 73.51 112.758 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.4 8.84 20.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.723 0.638 . . . . 64.43 112.723 -175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 11.9 m -118.73 -5.23 10.68 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.496 -0.482 . . . . 62.51 110.947 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -89.3 111.11 21.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.894 0.378 . . . . 73.41 110.221 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.469 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -146.19 153.19 40.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.038 -0.528 . . . . 73.42 109.92 175.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.5 88.22 5.07 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.351 -0.611 . . . . 62.12 109.351 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.477 -0.773 . . . . 73.32 110.571 -175.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.759 0.314 . . . . 74.22 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 m -128.73 103.76 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.461 0.648 . . . . 75.31 111.945 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -90.79 -44.38 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.145 -0.934 . . . . 63.43 109.532 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -117.34 92.9 41.53 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.05 -0.977 . . . . 71.11 109.983 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.77 157.08 18.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.828 2.352 . . . . 71.53 111.428 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.72 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -61.05 128.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.594 -0.521 . . . . 71.12 109.594 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.654 ' HG2' HE21 ' A' ' 60' ' ' GLN . 23.5 mtmm -101.39 -14.87 17.4 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.035 0.754 . . . . 73.11 113.035 -172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.36 151.79 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.322 -0.551 . . . . 61.04 111.727 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.519 ' HB3' ' HE3' ' A' ' 93' ' ' MET . 0.0 OUTLIER -140.78 141.41 34.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 74.42 109.873 174.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 24.1 m -109.58 134.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.987 -0.551 . . . . 74.35 110.823 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 95' ' ' ALA . . . -105.23 133.17 11.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.665 -0.779 . . . . 53.34 111.404 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 61.6 mt -106.31 130.23 54.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.736 0.268 . . . . 70.31 110.306 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.14 -171.46 3.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 54.24 110.421 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 77.7 m-20 -83.47 133.32 47.33 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.682 -0.69 . . . . 74.01 111.025 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.78 87.04 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.093 2.529 . . . . 72.44 113.313 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 134.74 144.67 5.06 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.527 -0.844 . . . . 54.31 112.379 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 31.9 Cg_exo -58.81 -25.45 76.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.043 2.495 . . . . 70.21 112.314 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 37.5 mt-10 -71.84 -27.44 62.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 72.51 111.066 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 22' ' ' THR . 3.7 m-85 -106.29 -12.0 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 72.34 109.201 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . . . -79.07 -9.26 59.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.824 -1.08 . . . . 63.23 111.044 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 18' ' ' GLU . 18.8 ptpt -89.36 13.63 13.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.177 -0.465 . . . . 55.42 111.365 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 19' ' ' TYR . 7.3 t -114.72 -173.79 2.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.896 -0.321 . . . . 52.44 110.296 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.476 HH22 ' CD ' ' A' ' 161' ' ' GLU . 15.9 ttt180 -75.76 -21.08 57.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.49 . . . . 72.34 112.065 -170.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.571 ' H ' HG23 ' A' ' 22' ' ' THR . 48.6 t-80 -88.06 38.11 0.84 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.4 0.619 . . . . 62.53 110.428 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -111.87 11.36 20.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.353 -0.385 . . . . 74.32 111.702 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.766 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -53.54 -46.79 70.3 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.271 0.471 . . . . 65.14 112.271 -174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -62.48 -31.03 78.21 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.913 -0.66 . . . . 61.13 113.128 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 66' ' ' ILE . . . -83.62 -37.0 23.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.001 0.4 . . . . 73.44 111.261 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.745 ' HD1' HG21 ' A' ' 169' ' ' VAL . 13.3 t-105 -64.13 -36.45 84.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.844 -175.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 169' ' ' VAL . 15.9 m -76.07 -27.06 17.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.94 0.348 . . . . 72.21 111.94 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 27' ' ' GLY . 76.1 t -66.76 -51.35 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.714 0.292 . . . . 73.11 111.211 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -68.19 -37.96 81.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.418 -0.355 . . . . 74.11 110.483 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.563 ' O ' HG12 ' A' ' 37' ' ' ILE . 14.0 tp10 -63.99 -41.22 97.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.433 -0.349 . . . . 71.24 110.161 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.439 HD22 HD13 ' A' ' 55' ' ' LEU . 3.4 tt -61.32 -46.36 90.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 53.1 109.968 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HA ' HD21 ' A' ' 55' ' ' LEU . . . -59.98 -36.53 77.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.26 0.552 . . . . 71.05 110.776 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -69.14 -22.79 63.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 75.43 111.164 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 33' ' ' GLU . 46.5 mm -67.57 -51.1 55.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 73.41 111.725 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.487 ' HB3' HD23 ' A' ' 55' ' ' LEU . 36.2 t60 -112.76 7.02 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.388 -0.525 . . . . 73.34 111.775 -173.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 64.48 58.35 1.07 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.594 0.711 . . . . 73.42 111.346 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG11 HD11 ' A' ' 55' ' ' LEU . 4.0 p -98.97 151.7 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.111 -0.495 . . . . 71.23 109.742 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.2 m -80.27 100.92 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.381 -0.6 . . . . 72.54 109.381 173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.66 99.98 5.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.673 -0.862 . . . . 61.53 108.673 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -117.21 162.24 18.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 72.43 111.005 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.845 ' HB3' HD12 ' A' ' 51' ' ' LEU . 14.6 p30 -108.52 135.11 50.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.353 0.597 . . . . 73.43 111.814 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' OE1' ' HD3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -103.32 117.01 61.22 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.593 -0.73 . . . . 62.01 109.496 171.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.44 -15.07 46.16 Favored 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 122.853 2.368 . . . . 61.12 111.969 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -66.48 -35.08 79.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.564 -0.744 . . . . 70.22 110.593 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -104.54 -26.15 12.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.768 -0.827 . . . . 74.41 108.768 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.8 t80 71.6 61.82 0.15 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.935 -1.484 . . . . 65.01 110.218 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.37 169.58 42.42 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.875 -1.057 . . . . 35.24 111.275 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.845 HD12 ' HB3' ' A' ' 44' ' ' ASN . 8.3 mp -85.55 142.78 28.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.726 0.298 . . . . 61.5 110.288 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -146.22 145.23 30.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.474 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.9 132.74 3.35 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.791 -0.524 . . . . 63.12 111.791 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 63' ' ' ARG . 3.4 tmm_? -102.36 108.98 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.858 -0.423 . . . . 63.11 109.858 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 35' ' ' ALA . 5.1 mp -113.81 109.19 18.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 112.348 0.499 . . . . 73.5 112.348 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 7.6 tt -74.74 103.29 4.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.696 -0.853 . . . . 74.22 108.696 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.716 HD11 HD12 ' A' ' 62' ' ' LEU . 35.7 pt -115.78 142.43 29.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.84 -0.618 . . . . 65.21 109.65 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.711 ' HB2' ' HG3' ' A' ' 177' ' ' GLU . 26.8 t-20 65.91 -66.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.875 0.735 . . . . 65.13 110.954 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 p -162.8 -28.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.214 -0.448 . . . . 71.02 111.184 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.654 HE21 ' HG2' ' A' ' 7' ' ' LYS . 58.0 tp60 -99.8 147.15 25.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.305 . . . . 74.33 110.366 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 12.2 pt-20 -86.81 123.16 31.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.991 0.424 . . . . 71.12 110.698 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.716 HD12 HD11 ' A' ' 57' ' ' ILE . 9.7 mt -109.54 116.32 31.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.531 0.682 . . . . 73.11 111.601 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.622 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 76.9 mtt180 -96.52 116.96 29.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.297 -0.865 . . . . 72.22 110.036 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' THR . 9.8 p -105.27 139.62 25.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.879 -0.415 . . . . 73.42 109.879 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 5.8 tt -143.87 129.79 19.47 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.129 -0.693 . . . . 72.02 109.129 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' HG21 ' A' ' 31' ' ' VAL . 8.1 tt -112.98 108.29 53.47 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 121.063 0.458 . . . . 62.34 110.639 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 127.83 18.56 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.93 2.42 . . . . 70.53 111.388 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -60.53 -63.37 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.332 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 73' ' ' LEU . 15.2 m -84.7 90.1 7.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 75.31 110.582 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -65.97 -9.56 31.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.54 -0.755 . . . . 63.12 112.124 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 13.7 tpt -96.38 -61.25 1.46 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.871 0.367 . . . . 73.35 111.664 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.632 ' H ' HG22 ' A' ' 69' ' ' THR . 25.1 t-20 -95.42 -49.3 5.49 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.442 0.534 . . . . 74.23 112.442 -171.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' ' HB ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -87.38 3.96 44.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.658 0.266 . . . . 74.31 111.586 -170.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.6 t -49.06 -54.23 16.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.854 -0.612 . . . . 53.54 112.191 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.51 -26.58 35.31 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.199 -1.001 . . . . 53.32 113.192 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -64.27 -33.57 76.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.649 0.724 . . . . 64.53 110.925 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.39 92.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 72.04 109.928 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.494 HD12 HG22 ' A' ' 123' ' ' THR . 63.5 mt -73.48 -32.98 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.234 -0.894 . . . . 72.12 111.078 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.15 74.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.704 -0.68 . . . . 74.25 111.855 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.55 -40.3 80.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.231 -0.44 . . . . 62.55 110.92 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.678 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 10.5 tp -63.01 -57.17 11.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.954 -0.566 . . . . 73.35 110.843 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -57.67 -38.33 74.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 71.55 111.153 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -58.79 -44.73 90.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.474 -0.785 . . . . 72.43 112.025 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' CE2' ' HA ' ' A' ' 81' ' ' LEU . 6.4 p90 -80.55 -22.02 41.2 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.032 -0.667 . . . . 75.01 112.262 -173.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.796 ' CZ ' ' HA ' ' A' ' 82' ' ' ALA . 1.5 p90 -95.87 -13.18 24.18 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 119.109 -1.037 . . . . 73.42 111.604 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 46.67 29.53 0.97 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.558 1.143 . . . . 73.34 113.814 171.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.704 ' H ' ' HD1' ' A' ' 85' ' ' TYR . 34.8 mt -80.52 150.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.401 -0.592 . . . . 54.2 109.401 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.541 ' HD2' ' HG2' ' A' ' 90' ' ' GLU . 11.8 tmtt? -49.35 132.3 17.74 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.257 0.623 . . . . 53.35 111.476 -173.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -39.78 -35.84 1.1 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 124.871 3.714 . . . . 54.35 116.274 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.767 ' HB2' ' HE1' ' A' ' 134' ' ' TYR . 14.1 pt-20 -73.3 5.68 3.43 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.312 0.486 . . . . 70.33 112.312 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 6' ' ' ILE . 11.1 tp10 -77.53 -10.55 59.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.512 0.672 . . . . 72.34 110.408 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mm -82.94 103.92 10.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.708 . . . . 75.44 110.183 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.679 ' HB2' HG21 ' A' ' 6' ' ' ILE . 47.1 ttp -105.4 131.52 52.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.896 0.379 . . . . 63.33 110.374 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 135' ' ' ARG . 40.8 t -112.69 140.94 29.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.213 -0.449 . . . . 74.03 110.901 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . -131.98 124.79 30.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 70.2 109.488 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.9 p80 -159.46 -179.44 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.75 . . . . 75.35 112.721 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.454 ' HB2' HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -78.12 126.32 30.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.722 -1.581 . . . . 71.25 112.584 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 20.0 mt-10 -138.69 122.07 17.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.206 0.527 . . . . 73.23 110.243 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.6 pt? -83.25 10.98 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.778 -0.646 . . . . 74.24 111.783 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.29 -22.18 60.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.369 0.604 . . . . 62.44 109.842 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.517 ' HB3' HG21 ' A' ' 105' ' ' VAL . 96.7 mt -117.55 150.57 46.95 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.74 . . . . 74.54 110.854 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 36.4 Cg_endo -64.98 156.57 61.83 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.03 2.487 . . . . 74.24 112.301 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 36.3 Cg_endo -65.13 108.61 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.716 2.277 . . . . 75.23 112.896 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.68 39.9 0.81 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.631 -0.795 . . . . 53.12 112.898 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 195' ' ' LYS . 33.7 m -144.2 145.49 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.607 -0.516 . . . . 71.54 109.607 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 191' ' ' LEU . . . -126.94 139.08 53.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.08 0.467 . . . . 74.54 110.523 173.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -138.89 139.01 37.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 64.43 111.099 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.589 ' HD1' ' HB3' ' A' ' 136' ' ' LEU . 55.4 t80 -102.15 139.54 37.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.97 -175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -123.55 128.07 49.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.008 -0.542 . . . . 62.33 110.312 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.606 ' HG3' ' CE2' ' A' ' 134' ' ' TYR . 58.7 tt0 -111.38 117.03 31.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 74.34 109.818 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.16 -111.58 3.38 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.537 -0.839 . . . . 72.43 112.954 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -102.0 142.79 15.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 72.11 112.521 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.66 64.79 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.381 -0.914 . . . . 64.34 112.882 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -76.41 130.34 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.937 -0.394 . . . . 75.44 109.937 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.33 54.97 5.01 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.11 -0.566 . . . . 54.45 114.042 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 46.32 41.29 11.67 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 114.707 0.643 . . . . 52.31 114.707 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.72 ' HB3' HD23 ' A' ' 120' ' ' LEU . 13.7 t-80 -143.47 136.02 27.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.171 0.485 . . . . 72.13 110.365 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -55.54 -37.12 67.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.507 -0.315 . . . . 31.53 111.056 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.76 -27.34 68.2 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.924 -0.655 . . . . 62.1 112.605 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.72 HD23 ' HB3' ' A' ' 117' ' ' HIS . 4.4 mm? -81.77 -30.4 32.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.098 0.475 . . . . 64.11 109.963 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HD2' HD12 ' A' ' 124' ' ' ILE . 3.0 mmmp? -81.78 -23.18 36.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 74.11 112.161 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.75 -35.13 78.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.856 0.36 . . . . 74.34 110.79 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.494 HG22 HD12 ' A' ' 78' ' ' ILE . 81.8 p -63.93 -46.53 84.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.231 0.539 . . . . 65.0 109.84 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.584 HD12 ' HD2' ' A' ' 121' ' ' LYS . 66.7 mt -61.63 -40.56 87.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-N 115.365 -0.834 . . . . 55.14 110.325 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m -61.37 -28.78 69.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 75.41 111.756 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' NZ ' ' HA ' ' A' ' 126' ' ' LYS . 2.8 mmpm? -82.16 -20.58 37.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.913 0.387 . . . . 75.14 110.874 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 130' ' ' ASN . 81.5 mt -106.59 1.88 25.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.065 0.46 . . . . 72.04 110.978 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.06 -119.67 5.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.156 -0.545 . . . . 62.43 112.94 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.73 26.49 6.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.629 0.728 . . . . 64.32 109.787 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.529 HD22 HD13 ' A' ' 127' ' ' LEU . 47.0 t30 -66.95 117.11 8.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 63.45 111.457 -177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -116.66 16.89 15.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.215 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 92.4 mt-10 -97.11 12.63 32.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.775 -0.648 . . . . 74.24 111.51 -175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -80.65 132.14 35.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.573 0.701 . . . . 72.23 111.179 -173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.767 ' HE1' ' HB2' ' A' ' 90' ' ' GLU . 3.1 m-85 -93.13 144.37 25.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 74.1 109.269 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.59 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -154.98 138.53 15.99 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.123 -0.631 . . . . 70.34 111.261 178.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.589 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.8 pp -113.32 138.05 50.61 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.394 -0.965 . . . . 63.33 108.394 171.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.482 ' HD3' ' NH2' ' A' ' 135' ' ' ARG . 35.5 ptt180 -115.59 142.98 46.01 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.48 -0.488 . . . . 74.43 110.956 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.766 HD12 ' HB1' ' A' ' 26' ' ' ALA . 21.4 mt -95.21 125.15 39.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.552 -0.749 . . . . 62.14 109.872 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.55 116.12 6.77 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.812 -0.915 . . . . 52.02 110.812 175.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 165' ' ' LEU . 45.2 pt -117.5 -30.29 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 112.33 0.493 . . . . 72.4 112.33 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -99.0 152.31 19.63 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.232 -0.985 . . . . 73.12 113.888 -166.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.512 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 3.6 p-80 -115.22 130.59 24.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 52.23 109.433 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 4.3 Cg_exo -75.14 87.56 1.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.777 2.318 . . . . 71.44 112.538 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.49 -85.28 1.59 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 110.852 -0.899 . . . . 71.13 110.852 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 148' ' ' LYS . 34.2 m80 -96.59 123.77 40.36 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.2 -40.06 73.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.767 -0.652 . . . . 74.2 112.04 -171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -87.73 -16.58 33.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.302 -0.408 . . . . 75.44 111.259 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 145' ' ' HIS . 27.9 mmtp -109.91 20.48 17.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.369 -175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.477 ' HA ' ' CD2' ' A' ' 152' ' ' TYR . 16.9 m -61.74 -23.28 30.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.804 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' A' ' 153' ' ' VAL . . . -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 54.43 111.083 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.85 -30.81 55.39 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.481 -0.866 . . . . 74.23 111.866 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 149' ' ' VAL . 2.1 m-85 -85.57 -44.59 12.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.846 0.355 . . . . 54.11 110.227 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 150' ' ' ALA . 12.4 p -56.03 -32.03 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.122 -0.945 . . . . 74.03 112.731 -172.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 pp -124.15 19.98 9.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.964 0.411 . . . . 73.44 110.992 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -96.15 149.28 19.27 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 111.046 -0.822 . . . . 61.35 111.046 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -74.05 107.3 6.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 71.21 110.129 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -75.19 147.55 83.16 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 65.41 111.326 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.67 164.28 35.04 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.643 2.229 . . . . 60.54 111.757 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.14 76.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.378 -0.374 . . . . 72.33 111.413 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -61.64 -33.5 74.06 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.093 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.476 ' CD ' HH22 ' A' ' 23' ' ' ARG . 24.7 tt0 -89.07 -37.76 14.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.992 0.425 . . . . 74.25 111.207 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 7.7 mm100 -67.57 -22.36 65.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.5 0.556 . . . . 71.31 112.5 -176.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -27.22 68.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 74.05 110.285 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 55.7 m -76.91 -38.98 52.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.998 -0.547 . . . . 62.12 109.758 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.736 HD11 HG22 ' A' ' 140' ' ' ILE . 29.0 tp -70.02 -34.99 73.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 73.51 110.821 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.06 -29.75 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.584 . . . . 72.35 110.571 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.1 89.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 52.52 110.975 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.618 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -61.21 -34.67 75.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.395 0.617 . . . . 71.12 110.661 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.745 HG21 ' HD1' ' A' ' 29' ' ' TRP . 68.1 t -70.04 -38.08 74.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.778 -0.647 . . . . 62.13 111.054 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' A' ' 174' ' ' ARG . 12.6 t70 -65.13 -53.2 48.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.031 -0.359 . . . . 64.41 110.031 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.618 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 15.2 pt-20 -58.61 -32.22 68.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.604 -0.271 . . . . 74.32 110.949 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 65.8 m -54.68 -52.08 63.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.382 -0.372 . . . . 73.31 111.208 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.28 -21.97 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.996 -0.282 . . . . 54.45 111.515 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 170' ' ' ASP . 26.1 mmt180 -78.16 -45.52 22.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 63.15 110.469 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.9 p -64.45 -31.57 72.84 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.276 -0.42 . . . . 75.01 111.716 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.2 -35.29 80.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.693 0.283 . . . . 64.41 111.075 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 58' ' ' ASN . 41.7 tt0 -70.42 -43.28 70.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 74.44 109.987 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 mm -61.28 -39.17 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 74.12 110.518 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 9.0 tt -60.79 -41.48 95.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.346 -0.843 . . . . 74.24 111.442 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 58' ' ' ASN . 23.4 ptp -83.04 -21.26 33.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.035 0.383 . . . . 70.32 112.035 -173.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -41.17 10.77 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.432 0.53 . . . . 54.42 112.432 -174.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 186' ' ' LYS . 53.0 m-20 -120.67 -2.69 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.264 0.468 . . . . 45.13 112.264 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.43 157.47 11.92 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.326 -0.94 . . . . 53.11 112.871 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.725 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -67.41 -19.63 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 73.45 111.231 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.8 p -65.8 -37.11 85.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.996 0.427 . . . . 53.35 111.202 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 182' ' ' ASP . 75.0 mmtt -66.79 -42.51 85.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 72.35 109.658 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.13 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.43 -0.805 . . . . 73.31 111.006 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -55.39 -53.33 57.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.54 -0.3 . . . . 74.51 111.327 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.59 -40.23 95.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.769 0.319 . . . . 65.15 111.259 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' O ' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER -68.17 -46.54 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.396 -0.366 . . . . 72.44 111.404 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 106' ' ' ALA . 13.9 tp -70.59 -41.07 72.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.097 -0.501 . . . . 72.25 111.149 -174.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -72.69 -5.66 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.118 0.414 . . . . 72.35 112.118 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 190' ' ' ARG . 2.8 t -110.83 2.94 18.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.054 0.454 . . . . 72.12 110.608 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -96.56 115.31 27.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.579 -0.526 . . . . 75.52 109.579 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.607 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -145.72 142.23 28.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.822 0.344 . . . . 75.01 110.984 177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.33 114.05 27.89 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.971 -0.559 . . . . 64.0 109.806 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 119.013 -0.518 . . . . 55.22 110.85 -177.116 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 109.861 -0.422 . . . . 63.05 109.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -91.17 137.12 22.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.545 -0.539 . . . . 71.21 109.545 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t -82.02 -43.08 18.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.654 -0.869 . . . . 74.14 108.654 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 27.2 mp0 -107.42 119.49 50.55 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.656 -0.868 . . . . 55.13 108.656 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' MET . 19.1 Cg_exo -66.76 173.52 7.94 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.543 2.162 . . . . 54.32 112.307 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 9' ' ' LEU . 7.4 tt -63.52 141.92 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.048 -0.524 . . . . 72.44 111.221 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -98.45 -61.79 1.33 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.032 0.444 . . . . 62.34 111.457 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 81' ' ' LEU . 7.6 tt -134.84 138.78 44.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 41.54 110.285 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -123.84 143.03 50.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.125 -0.489 . . . . 75.13 109.763 174.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 65' ' ' LEU . 26.4 m -113.5 146.56 17.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.011 0.434 . . . . 75.12 111.358 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.82 132.98 9.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.755 -0.736 . . . . 72.02 111.434 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.68 131.35 44.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.745 -0.465 . . . . 74.43 109.745 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 25' ' ' ASN . . . -159.61 -156.73 0.52 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.779 0.323 . . . . 73.42 111.574 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 14.1 m120 -99.36 145.66 30.43 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.757 -0.656 . . . . 64.34 110.942 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.34 108.09 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.632 2.221 . . . . 71.44 112.708 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.98 149.12 24.69 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.536 -0.84 . . . . 23.33 112.797 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 24.7 Cg_endo -61.73 -21.38 72.01 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.782 2.322 . . . . 74.44 112.423 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.74 -31.77 73.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.924 -0.58 . . . . 73.21 110.723 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.594 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 60.1 m-85 -109.34 -4.97 16.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 72.31 109.844 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' CG ' ' A' ' 25' ' ' ASN . . . -66.08 -10.98 45.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.607 -0.724 . . . . 74.14 111.651 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.27 3.61 54.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.268 0.556 . . . . 63.45 110.339 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 24' ' ' HIS . 65.7 m -86.07 148.32 25.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.567 -0.742 . . . . 75.23 110.122 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HD3' ' HB2' ' A' ' 157' ' ' ALA . 20.2 tpt180 -62.36 -18.73 62.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.07 0.396 . . . . 73.05 112.07 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 22' ' ' THR . 77.0 t60 -76.59 -15.09 59.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.136 0.493 . . . . 71.25 110.62 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' CG ' ' HA ' ' A' ' 20' ' ' ALA . 7.4 t30 -89.22 49.46 1.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.417 0.627 . . . . 73.4 110.878 -174.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 140' ' ' ILE . . . -83.87 -40.93 18.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.204 -0.453 . . . . 71.22 110.638 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -65.29 -24.35 70.56 Favored Glycine 0 C--O 1.223 -0.562 0 CA-C-N 115.879 -0.6 . . . . 72.04 113.028 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -81.41 -24.14 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.038 0.419 . . . . 33.44 111.785 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HD1' HG21 ' A' ' 169' ' ' VAL . 5.2 t-105 -70.38 -36.46 74.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.915 0.388 . . . . 74.03 110.482 -173.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG12 HG13 ' A' ' 169' ' ' VAL . 12.3 m -73.49 -24.89 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 73.13 110.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 27' ' ' GLY . 81.2 t -64.35 -55.05 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.855 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -69.71 -23.03 63.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.486 -0.325 . . . . 73.3 110.808 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 37' ' ' ILE . 12.0 tp10 -65.53 -45.2 84.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.603 -0.517 . . . . 71.14 109.603 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HB3' ' HG ' ' A' ' 55' ' ' LEU . 96.3 mt -63.04 -43.93 97.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.0 0.429 . . . . 64.43 110.122 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -54.62 -40.48 68.96 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.511 -0.768 . . . . 71.13 110.836 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 33' ' ' GLU . 43.4 ttt180 -69.9 -48.99 56.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.158 -0.928 . . . . 75.52 111.899 -178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 33' ' ' GLU . 37.0 mm -68.17 -37.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.802 0.667 . . . . 53.52 112.802 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.962 ' HB3' HD12 ' A' ' 55' ' ' LEU . 29.3 t60 -109.05 -7.52 15.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.866 -0.734 . . . . 72.24 111.325 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 56.24 45.41 23.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.24 0.543 . . . . 74.21 111.378 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HB ' HD13 ' A' ' 55' ' ' LEU . 7.7 p -71.24 149.8 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.067 -0.716 . . . . 62.24 109.067 169.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 68.9 m -81.96 106.87 14.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.693 -0.484 . . . . 71.54 109.693 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 35' ' ' ALA . 2.4 mm? -66.27 123.69 20.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.72 -0.673 . . . . 73.21 109.802 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 41' ' ' THR . 41.1 mtmt -123.34 129.53 51.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.163 -0.471 . . . . 74.53 110.613 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 8.3 p30 -82.72 130.41 35.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.016 0.436 . . . . 63.33 110.139 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.65 106.8 58.86 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.046 -0.524 . . . . 61.04 109.939 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.79 -10.65 23.29 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.244 2.629 . . . . 60.4 112.411 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -64.99 -44.27 89.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 71.11 109.679 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' HB3' ' HA ' ' A' ' 77' ' ' ALA . 1.7 m-85 -104.85 -15.67 15.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.238 -0.892 . . . . 70.3 108.781 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.1 t80 71.32 23.47 3.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 113.774 -1.557 . . . . 72.3 110.186 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.82 159.44 14.43 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.899 -0.667 . . . . 50.52 112.543 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 28.6 tp -90.77 126.66 36.07 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.155 -0.683 . . . . 74.42 109.155 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 7.1 t -123.47 156.76 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.246 0.546 . . . . 61.44 111.722 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.48 132.15 3.41 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.017 -0.833 . . . . 70.1 111.017 174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -96.23 104.62 16.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.214 0.531 . . . . 74.31 110.534 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.962 HD12 ' HB3' ' A' ' 38' ' ' HIS . 3.2 mm? -92.57 154.42 18.43 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.699 -0.682 . . . . 74.2 110.178 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 9.8 tt -125.53 115.18 19.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.049 -0.722 . . . . 71.42 109.049 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.794 HD12 HD12 ' A' ' 62' ' ' LEU . 61.9 mt -122.2 132.05 71.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.073 -0.512 . . . . 63.54 110.063 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 64.2 -79.8 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.705 0.628 . . . . 61.31 111.535 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -154.98 12.03 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.112 0.482 . . . . 73.54 110.772 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.566 ' HG2' ' HB2' ' A' ' 5' ' ' PRO . 49.5 tp60 -129.73 145.39 51.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.081 -0.509 . . . . 55.33 109.649 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' LEU . 8.5 pt-20 -87.07 129.94 34.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.11 0.481 . . . . 54.44 110.424 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.794 HD12 HD12 ' A' ' 57' ' ' ILE . 78.1 mt -113.59 108.72 17.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.686 -0.688 . . . . 73.31 109.838 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 50.2 mtt180 -92.4 127.88 38.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.894 -0.594 . . . . 71.21 109.665 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' THR . 12.5 p -109.91 143.92 19.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 110.051 -0.352 . . . . 70.54 110.051 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 10' ' ' VAL . 8.2 tt -142.94 135.44 27.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.879 0.371 . . . . 72.33 110.148 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.76 114.58 26.8 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.073 -0.512 . . . . 71.43 110.568 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.14 117.39 4.12 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.033 2.489 . . . . 71.53 111.28 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.1 p -65.75 -45.2 83.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 72.24 111.114 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.849 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 29.9 m -80.38 87.11 5.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.213 0.53 . . . . 63.52 109.643 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -74.04 5.6 4.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.789 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.46 -72.07 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.59 0.234 . . . . 54.42 111.364 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -95.38 -49.65 5.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.237 0.541 . . . . 73.01 111.465 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.849 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 87.2 mt -82.32 17.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.021 -0.536 . . . . 61.23 111.166 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.3 t -77.06 -64.4 1.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.146 -0.479 . . . . 55.22 109.882 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.35 -26.72 58.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.484 -0.865 . . . . 45.12 112.335 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.51 -35.7 81.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.702 0.287 . . . . 74.23 110.457 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' PHE . . . -59.35 -45.16 92.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.345 0.593 . . . . 70.44 109.87 174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.5 mt -71.84 -33.61 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.109 -0.951 . . . . 75.32 111.048 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' HD11 ' A' ' 127' ' ' LEU . . . -58.34 -58.24 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.73 -0.668 . . . . 75.14 111.989 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.8 -34.44 76.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 75.22 110.305 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 8' ' ' LEU . 29.7 tp -59.75 -62.2 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.117 -0.947 . . . . 65.32 111.504 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.69 -33.83 75.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 61.44 110.955 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.14 -49.82 58.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 71.1 111.955 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -76.14 -22.91 54.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.287 -0.565 . . . . 65.03 110.704 -175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.718 ' HB3' HG12 ' A' ' 87' ' ' ILE . 8.6 m-85 -78.51 -20.72 50.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.887 -0.325 . . . . 74.54 110.377 173.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 54.01 39.23 30.34 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.454 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.718 HG12 ' HB3' ' A' ' 85' ' ' TYR . 42.7 mm -101.79 129.95 52.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.333 -0.849 . . . . 73.22 109.641 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -75.13 159.66 82.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.695 -171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.07 -24.85 34.42 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.367 2.712 . . . . 73.34 113.47 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 91' ' ' GLU . 13.1 pt-20 -70.17 -17.39 63.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.986 0.422 . . . . 75.14 111.007 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.835 ' HG3' ' HG3' ' A' ' 90' ' ' GLU . 10.2 mt-10 -114.63 8.28 16.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 75.45 110.216 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mm -121.96 125.34 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.79 -0.641 . . . . 73.31 109.881 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 54.0 ttp -128.72 146.93 50.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 64.51 111.186 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG13 HG23 ' A' ' 10' ' ' VAL . 23.2 t -120.57 143.4 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.14 -0.482 . . . . 64.53 110.467 177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -125.49 133.54 52.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.514 -0.55 . . . . 72.13 109.514 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 98' ' ' GLU . 3.6 p80 -161.59 -179.03 6.97 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.126 -0.629 . . . . 72.24 112.419 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -81.3 125.07 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.623 -1.171 . . . . 63.33 112.049 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG3' ' CE1' ' A' ' 96' ' ' HIS . 36.0 mt-10 -141.21 114.57 8.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.264 0.554 . . . . 64.45 110.537 171.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -76.1 2.22 13.51 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.427 -0.806 . . . . 74.14 112.277 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.2 -22.4 62.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.082 0.468 . . . . 50.03 110.234 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 107' ' ' LYS . 89.8 mt -104.64 140.57 21.21 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.767 -0.651 . . . . 71.24 110.55 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 105' ' ' VAL . 24.4 Cg_exo -64.09 158.06 49.97 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.003 2.469 . . . . 70.2 111.816 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.0 Cg_exo -61.81 120.16 7.65 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.687 2.258 . . . . 54.4 113.036 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.32 -12.48 19.16 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.646 -0.788 . . . . 60.1 113.775 173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 102' ' ' PRO . 30.0 m -103.64 162.76 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 117.541 0.671 . . . . 70.42 111.866 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.488 -0.778 . . . . 61.43 109.864 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.748 ' HB2' HD11 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -143.32 132.85 23.57 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.744 0.306 . . . . 72.51 111.011 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -89.77 150.59 22.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.123 -0.49 . . . . 71.31 110.136 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.561 ' CE ' ' HG3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -148.6 132.13 16.74 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.879 0.371 . . . . 75.25 110.694 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 56.7 tt0 -116.26 139.58 50.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.651 -0.704 . . . . 65.42 109.483 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.2 -105.03 1.25 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.963 -1.113 . . . . 72.33 112.774 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.51 -120.3 2.13 Favored Glycine 0 C--O 1.227 -0.3 0 C-N-CA 120.585 -0.817 . . . . 23.12 112.795 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.65 64.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 44.42 113.159 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -64.35 118.49 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 62.41 110.482 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -68.1 149.74 50.44 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.264 -0.735 . . . . 62.44 111.264 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.4 64.13 0.41 Allowed Glycine 0 C--N 1.332 0.309 0 N-CA-C 111.614 -0.594 . . . . 71.03 111.614 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.738 ' HB2' HD23 ' A' ' 120' ' ' LEU . 2.4 m-70 -142.07 145.02 33.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.144 -0.528 . . . . 61.33 110.025 -175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.68 -45.38 81.77 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.6 0.562 . . . . 74.32 110.936 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -57.73 -44.75 94.0 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 121.028 -0.606 . . . . 71.52 113.023 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.738 HD23 ' HB2' ' A' ' 117' ' ' HIS . 3.3 mm? -68.42 -35.37 77.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.781 0.324 . . . . 63.41 110.257 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 0.7 OUTLIER -55.63 -54.9 38.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.783 174.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.48 -29.59 70.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 73.14 111.048 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.2 m -61.78 -41.31 97.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.206 -0.452 . . . . 64.31 109.982 173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.506 ' HA ' ' HA3' ' A' ' 128' ' ' GLY . 48.3 mm -69.29 -34.84 64.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.125 0.488 . . . . 72.01 110.347 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 m -60.72 -40.04 90.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.013 -0.539 . . . . 41.12 111.22 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.9 mmpt? -93.79 -50.93 5.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.738 0.644 . . . . 55.13 112.738 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' A' ' 79' ' ' ALA . 93.2 mt -117.73 11.19 13.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.633 0.234 . . . . 75.53 111.633 -172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 124' ' ' ILE . . . -72.84 2.44 33.14 Favored Glycine 0 C--O 1.23 -0.1 0 C-N-CA 121.165 -0.541 . . . . 51.12 113.82 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -89.41 -13.48 37.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 73.03 109.4 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.32 86.45 6.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.502 -0.772 . . . . 52.2 109.254 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.12 35.66 0.44 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.599 -0.728 . . . . 73.31 111.143 -171.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.04 -10.45 6.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.273 -0.421 . . . . 42.42 111.5 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -59.89 142.18 54.06 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.31 0.576 . . . . 73.25 111.88 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 90' ' ' GLU . 61.5 m-85 -90.25 145.28 25.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.754 -0.657 . . . . 71.42 110.663 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.561 ' HG3' ' CE ' ' A' ' 109' ' ' LYS . 1.3 ppt_? -160.32 127.79 4.49 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.911 -0.403 . . . . 72.31 109.911 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.37 150.27 21.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.83 -0.623 . . . . 34.33 110.233 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 101' ' ' LEU . 10.7 mtp180 -103.15 143.12 33.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.671 -0.695 . . . . 74.13 109.57 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.486 HD12 ' HB1' ' A' ' 26' ' ' ALA . 40.0 mt -111.69 123.34 50.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.107 -0.497 . . . . 53.23 109.795 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -69.85 90.35 0.32 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.974 -0.631 . . . . 61.21 112.188 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.7 pp -112.13 -7.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.844 0.354 . . . . 51.34 111.256 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -91.57 132.34 11.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.459 -0.877 . . . . 45.04 112.413 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -101.75 126.71 33.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.696 -0.483 . . . . 61.3 109.696 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.18 173.56 5.99 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.113 2.542 . . . . 51.13 113.307 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.13 -129.72 2.54 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.64 -0.984 . . . . 53.43 110.64 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.47 130.0 34.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.907 0.353 . . . . 73.1 110.211 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.463 ' HA ' HG13 ' A' ' 149' ' ' VAL . 55.5 mttm -62.59 -19.04 63.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.626 -0.715 . . . . 64.42 112.03 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.84 -51.49 60.73 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.201 0.815 . . . . 74.32 113.201 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -118.1 29.98 7.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.705 0.261 . . . . 72.13 111.705 -171.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.785 ' HA ' ' CE2' ' A' ' 152' ' ' TYR . 16.3 m -53.55 -31.77 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.479 0.548 . . . . 63.34 112.479 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.19 -10.6 59.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.915 0.339 . . . . 72.33 111.915 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.46 47.15 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.698 -0.763 . . . . 74.53 113.218 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.785 ' CE2' ' HA ' ' A' ' 149' ' ' VAL . 1.1 m-85 -75.83 -34.17 60.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.245 0.545 . . . . 70.41 110.532 -174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG11 HD22 ' A' ' 99' ' ' LEU . 28.8 m -66.37 -14.51 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.996 -1.002 . . . . 71.14 113.194 -168.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 154' ' ' LEU . 2.3 pt? -133.5 25.7 4.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.277 -0.569 . . . . 70.31 111.584 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.64 162.18 21.35 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.634 -0.986 . . . . 51.14 110.634 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -78.4 116.51 18.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.266 0.533 . . . . 73.53 109.811 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.528 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -79.75 138.55 54.18 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.36 -0.382 . . . . 70.1 110.389 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.31 157.35 26.53 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.588 2.192 . . . . 73.32 111.766 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.91 68.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 74.22 112.145 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 163' ' ' GLU . 85.7 mttt -79.7 -18.09 52.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.273 0.471 . . . . 64.51 112.273 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 -19.93 26.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.343 0.592 . . . . 65.31 110.148 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.03 -17.89 54.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.838 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 160' ' ' LYS . 52.0 mt-10 -55.92 -38.5 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.427 -0.351 . . . . 62.22 110.828 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.4 p -70.82 -23.78 62.42 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.607 0.242 . . . . 74.45 110.763 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.18 -51.09 49.72 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.518 -0.549 . . . . 73.31 109.518 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.77 -40.33 83.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.624 -0.716 . . . . 65.01 110.503 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -48.87 79.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.718 -0.674 . . . . 74.12 111.116 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.52 77.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 73.21 110.976 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.718 HG13 HG12 ' A' ' 30' ' ' VAL . 56.9 t -51.69 -41.67 29.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.011 -0.541 . . . . 63.05 111.698 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.99 -47.99 76.69 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.24 -0.436 . . . . 52.03 111.979 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -82.27 -31.01 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 73.31 110.724 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 176' ' ' LEU . 68.4 m -57.1 -41.15 78.4 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.346 -0.388 . . . . 75.11 110.942 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.2 m -84.89 -22.59 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.814 0.34 . . . . 73.14 111.621 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -70.86 -45.6 64.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 74.25 111.284 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' SG ' HD23 ' A' ' 191' ' ' LEU . 16.3 p -69.59 -17.61 63.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.312 -0.404 . . . . 71.45 111.49 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 172' ' ' SER . 78.0 mt -60.04 -38.99 84.38 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.649 0.24 . . . . 62.31 111.649 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 44.1 tt0 -62.4 -46.4 88.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.219 0.533 . . . . 75.41 110.347 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 48.1 mm -67.6 -37.59 79.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.615 -0.721 . . . . 62.53 110.464 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 184' ' ' LEU . 8.9 tt -56.45 -45.56 80.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 72.02 111.413 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 24.2 ptt? -76.74 -35.77 57.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.479 0.548 . . . . 71.51 112.479 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 177' ' ' GLU . 33.6 pttt -98.97 -35.96 9.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.865 0.691 . . . . 71.42 112.865 -173.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -105.82 -10.2 16.81 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.906 -0.318 . . . . 74.54 111.606 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.31 151.09 9.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.384 -0.913 . . . . 55.35 112.716 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.749 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 2.6 pt? -71.08 -24.85 62.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.481 0.181 . . . . 71.11 111.043 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 38.8 p -67.69 -33.0 74.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.913 0.387 . . . . 74.14 110.682 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -67.74 -41.72 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.54 . . . . 70.14 110.089 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.29 82.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.954 -0.566 . . . . 60.33 110.479 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -47.32 -37.95 11.86 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.803 0.69 . . . . 73.35 111.305 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -63.33 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.514 . . . . 75.05 110.906 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HA ' HG22 ' A' ' 193' ' ' THR . 9.0 mmt180 -69.5 -38.32 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 75.02 111.947 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 175' ' ' CYS . 3.0 tm? -59.88 -45.74 91.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.847 -0.615 . . . . 63.14 110.715 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -86.2 -18.93 30.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.117 0.414 . . . . 75.01 112.117 -176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.633 HG22 ' HA ' ' A' ' 190' ' ' ARG . 6.1 t -92.04 0.92 57.47 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.6 -0.44 . . . . 72.0 111.678 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -90.12 116.65 28.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.107 0.479 . . . . 71.25 111.396 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.33 153.25 41.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.51 -0.768 . . . . 73.13 109.077 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -82.79 86.84 6.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.837 0.351 . . . . 54.24 111.433 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 197' ' ' GLU . 12.1 pt-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.284 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.936 0.398 . . . . 75.14 110.521 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.26 146.51 32.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.128 -0.487 . . . . 73.25 109.753 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.6 t -70.17 -42.4 72.5 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 61.01 109.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -134.96 149.04 69.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 144.18 90.9 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.33 2.02 . . . . 74.01 112.261 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.56 141.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.726 -0.67 . . . . 75.33 110.962 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 91' ' ' GLU . 26.6 mmmt -102.36 -75.01 0.61 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 74.34 111.506 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD13 HD23 ' A' ' 81' ' ' LEU . 1.9 pp -121.83 150.34 42.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.226 -0.443 . . . . 64.13 111.172 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -122.35 134.16 54.64 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.743 -0.836 . . . . 63.22 108.743 167.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 78' ' ' ILE . 14.0 m -99.52 147.85 6.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 116.159 -0.473 . . . . 62.24 110.225 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.96 137.64 12.92 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.445 -0.883 . . . . 61.01 112.007 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -105.49 126.65 52.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.643 0.259 . . . . 72.32 110.412 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 66' ' ' ILE . . . -160.83 -170.45 2.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.078 -0.51 . . . . 34.31 110.471 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 42.4 m-80 -73.58 144.93 84.15 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.751 -0.659 . . . . 73.44 111.521 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.22 -27.65 13.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.176 2.584 . . . . 75.02 114.031 -175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -120.11 152.31 17.06 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.301 -0.952 . . . . 64.43 112.581 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 16' ' ' GLY . 35.8 Cg_exo -61.2 -26.17 81.89 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.098 2.532 . . . . 72.24 111.91 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.09 -30.24 68.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.764 -0.653 . . . . 73.22 110.166 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.744 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 12.3 m-85 -94.1 -13.97 26.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.509 -0.769 . . . . 65.45 109.536 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.55 -18.36 65.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.874 -0.603 . . . . 70.32 111.897 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HG3' ' HE3' ' A' ' 156' ' ' LYS . 53.5 pttt -88.38 5.43 42.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.173 0.511 . . . . 73.02 110.508 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.661 ' HB ' ' O ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -86.54 147.77 25.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 71.0 109.913 174.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 155' ' ' GLY . 24.8 mtp180 -58.14 -31.04 66.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.084 0.772 . . . . 75.43 113.084 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.564 ' HA ' ' OD2' ' A' ' 97' ' ' ASP . 0.3 OUTLIER -79.86 34.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 74.43 111.676 -175.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 28' ' ' ALA . 8.8 t30 -115.08 25.0 11.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.131 0.491 . . . . 63.31 110.533 -175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -50.99 -50.04 59.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.663 -0.699 . . . . 75.33 112.284 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -53.97 -41.47 68.25 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.289 -0.481 . . . . 24.4 113.752 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . . . -83.67 -35.05 24.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.213 0.507 . . . . 54.2 111.601 -176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.79 ' HD1' HG21 ' A' ' 169' ' ' VAL . 17.0 t-105 -61.87 -35.96 79.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 72.53 111.175 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 169' ' ' VAL . 34.7 m -83.96 -31.91 8.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.691 0.626 . . . . 63.24 112.691 -176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.8 -27.62 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.423 0.527 . . . . 70.12 112.423 -172.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -71.69 -33.54 68.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.227 -0.657 . . . . 74.42 109.227 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -59.14 -34.27 71.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 74.53 110.039 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.42 -45.39 87.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.981 -0.554 . . . . 65.4 110.55 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -63.92 -43.75 94.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 73.44 110.378 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ttt85 -59.84 -48.38 81.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.585 -1.189 . . . . 64.33 111.543 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.87 -44.59 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 74.03 112.003 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -83.83 -9.56 58.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.313 . . . . 55.53 111.404 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 t30 60.32 42.19 15.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.691 0.758 . . . . 43.14 109.675 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 35' ' ' ALA . 12.1 p -101.66 145.1 12.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.501 -0.772 . . . . 75.01 109.871 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -81.72 100.94 9.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 64.03 112.022 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 35' ' ' ALA . 2.1 mm? -76.0 111.84 11.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.17 -0.678 . . . . 74.1 109.17 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -104.54 131.68 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.721 0.296 . . . . 62.24 111.147 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -79.44 104.17 9.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.361 0.6 . . . . 72.13 109.444 171.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 48' ' ' PHE . 2.8 tp10 -103.96 117.83 58.65 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.957 -0.565 . . . . 64.41 109.658 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.09 -33.91 90.62 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.124 2.549 . . . . 74.14 113.788 -171.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -78.86 -12.92 60.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.033 0.382 . . . . 74.34 112.033 -175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.964 ' HB3' HD11 ' A' ' 65' ' ' LEU . 17.7 m-85 -108.39 3.88 23.8 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 122.388 1.09 . . . . 74.03 108.444 174.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 61.13 19.72 10.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.731 -2.032 . . . . 72.52 112.745 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.47 -165.54 25.04 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.653 -1.261 . . . . 74.34 113.457 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 42' ' ' LEU . 24.2 tp -93.34 121.28 34.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.611 -0.514 . . . . 72.44 109.611 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.617 ' HB ' ' HG ' ' A' ' 65' ' ' LEU . 14.1 t -120.56 151.5 39.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.069 0.461 . . . . 71.42 110.973 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.05 163.5 28.64 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.97 -0.559 . . . . 74.01 111.749 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' HB2' ' A' ' 61' ' ' GLU . 4.6 tmm_? -149.12 109.71 4.23 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.768 -0.827 . . . . 72.13 108.768 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.94 123.96 41.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.393 0.616 . . . . 71.11 111.681 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' GLU . 6.2 tt -91.62 113.32 25.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 74.12 109.762 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -126.5 153.68 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.044 -0.525 . . . . 74.24 109.689 176.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 62.82 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.846 0.716 . . . . 74.03 111.331 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.0 p -159.12 4.54 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.58 0.228 . . . . 54.25 111.444 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -133.47 147.04 51.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.925 0.393 . . . . 74.41 110.943 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.615 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -86.31 110.67 19.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 71.53 110.527 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 176' ' ' LEU . 9.9 tt -89.67 125.4 35.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.982 -0.554 . . . . 72.21 110.358 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' LEU . 57.6 mtt-85 -108.8 147.07 32.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.21 -0.45 . . . . 73.42 111.077 -176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 9.3 p -141.33 149.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.101 -0.5 . . . . 65.02 110.087 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.964 HD11 ' HB3' ' A' ' 48' ' ' PHE . 2.6 tt -152.22 127.07 9.6 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.666 -0.494 . . . . 42.4 109.666 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 4.3 tt -117.57 109.36 41.89 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 121.109 0.48 . . . . 75.0 110.615 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.0 128.19 14.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.742 2.295 . . . . 74.41 110.747 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -58.12 -53.83 53.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 73.34 111.32 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 73' ' ' LEU . 17.8 m -79.82 88.64 5.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.29 -0.414 . . . . 62.31 110.354 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -72.44 4.96 3.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.88 -0.6 . . . . 72.33 111.404 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.0 mmt -95.93 -70.67 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.014 -0.539 . . . . 71.02 111.13 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.434 ' H ' HG22 ' A' ' 69' ' ' THR . 27.2 t-20 -97.69 -40.96 8.32 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.942 0.719 . . . . 65.35 112.942 -171.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 97.1 mt -88.6 -1.03 57.85 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.479 0.548 . . . . 75.43 112.479 -172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 119' ' ' GLY . 4.4 p -59.87 -59.8 4.86 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.156 0.428 . . . . 74.21 112.156 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.51 -27.0 64.2 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.633 -0.794 . . . . 61.32 112.024 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.85 ' HD3' ' HD2' ' A' ' 126' ' ' LYS . 20.6 mmtp -58.21 -45.13 88.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 75.44 110.376 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.37 96.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.593 -0.73 . . . . 54.24 110.342 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.649 HG12 HG11 ' A' ' 10' ' ' VAL . 64.6 mt -62.99 -41.56 93.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.377 -0.828 . . . . 72.22 110.29 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . . . -55.32 -56.99 13.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.452 -0.794 . . . . 73.24 110.851 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.444 ' O ' ' HD1' ' A' ' 84' ' ' PHE . . . -59.96 -45.93 91.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.974 -0.557 . . . . 40.11 111.166 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 84' ' ' PHE . 25.3 tp -59.75 -53.94 52.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 74.11 111.285 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.84 78.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.432 -0.349 . . . . 65.41 111.163 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -64.14 -50.32 68.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.262 -0.426 . . . . 71.31 111.124 -175.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' HE1' HD12 ' A' ' 81' ' ' LEU . 2.3 p90 -74.62 -31.97 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.388 -0.525 . . . . 72.33 110.576 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.36 -20.06 55.35 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 120.759 0.314 . . . . 61.2 111.148 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 64.51 26.2 13.35 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.865 -0.607 . . . . 71.32 111.553 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.644 ' CG2' ' HB2' ' A' ' 91' ' ' GLU . 23.6 mm -87.73 138.81 18.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.538 -0.301 . . . . 73.54 110.227 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -82.4 158.33 66.46 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.283 -0.417 . . . . 72.15 111.135 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.775 ' HB2' ' HB3' ' A' ' 132' ' ' GLU . 75.6 Cg_exo -52.24 -29.61 38.68 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.565 2.843 . . . . 65.45 114.632 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' HB3' ' CG ' ' A' ' 132' ' ' GLU . 14.7 pt-20 -77.7 -8.54 58.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.094 0.473 . . . . 53.24 111.18 -177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.644 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 17.9 mt-10 -107.22 2.94 25.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.069 -0.715 . . . . 62.21 109.069 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.87 117.59 55.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.913 -1.039 . . . . 72.24 109.753 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 49.2 ttp -115.98 152.96 32.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.721 -0.392 . . . . 72.33 110.48 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 10' ' ' VAL . 2.5 p -134.12 121.89 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.439 0.638 . . . . 60.25 111.128 175.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.85 121.81 41.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.596 . . . . 52.41 109.504 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -137.47 156.01 48.64 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.707 -0.797 . . . . 64.13 111.96 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 24' ' ' HIS . 10.0 t70 -75.76 123.2 25.2 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.335 -1.302 . . . . 71.25 110.196 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 137' ' ' ARG . 14.9 tt0 -141.63 130.45 22.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.987 0.422 . . . . 65.14 110.891 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 2.1 pp -83.15 20.02 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.62 0.6 . . . . 71.43 112.62 -173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.02 -21.59 65.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.387 0.613 . . . . 31.53 110.466 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.705 ' HB3' HG23 ' A' ' 105' ' ' VAL . 95.6 mt -129.0 149.85 73.67 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.69 -0.686 . . . . 75.42 111.626 -171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.8 Cg_exo -65.25 163.31 29.69 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.044 2.496 . . . . 75.45 111.124 172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 28.6 Cg_endo -63.34 103.83 0.39 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.461 2.108 . . . . 45.22 113.156 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.28 48.61 0.43 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.824 -0.703 . . . . 53.15 113.586 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 101' ' ' LEU . 1.5 m -155.15 142.71 12.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.034 0.533 . . . . 72.4 110.265 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 191' ' ' LEU . . . -111.45 146.53 37.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.008 0.432 . . . . 74.42 111.753 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' HE3' HD21 ' A' ' 101' ' ' LEU . 62.8 mttt -140.91 146.91 38.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.096 -0.502 . . . . 53.45 110.429 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.62 ' HB2' ' OE1' ' A' ' 188' ' ' GLN . 1.4 m-85 -105.22 173.01 6.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.228 0.537 . . . . 74.54 111.707 176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.739 ' HE3' ' HG3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -157.28 119.07 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.179 -0.919 . . . . 71.13 109.357 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.4 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 51.6 tt0 -113.08 147.43 37.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.299 -0.63 . . . . 63.42 109.299 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.2 -113.94 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.44 -0.886 . . . . 23.21 112.48 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.635 ' O ' ' HD3' ' A' ' 109' ' ' LYS . . . -117.85 155.68 16.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.901 -0.666 . . . . 44.31 112.018 -174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.79 66.02 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.728 -1.225 . . . . 73.31 113.133 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -82.72 151.44 26.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.603 -0.517 . . . . 74.34 109.603 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -82.88 155.38 33.22 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.381 -1.088 . . . . 44.34 110.381 172.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.01 60.91 3.81 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.629 -0.796 . . . . 61.3 111.797 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -142.53 147.24 35.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.512 -0.551 . . . . 75.12 109.512 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -51.5 -44.31 62.51 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.315 0.385 . . . . 73.34 111.405 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 74' ' ' SER . . . -53.96 -50.19 55.87 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 121.203 -0.522 . . . . 73.33 113.092 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.31 -36.35 68.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.975 0.417 . . . . 62.13 110.463 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.54 -48.61 74.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.861 -0.609 . . . . 45.23 110.273 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.602 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 38.2 t70 -62.46 -35.68 80.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.596 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.4 m -56.38 -40.63 74.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.206 0.527 . . . . 74.13 110.666 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.9 -36.45 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.064 -0.516 . . . . 72.05 110.292 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.9 m -68.75 -42.88 76.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.791 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.85 ' HD2' ' HD3' ' A' ' 76' ' ' LYS . 5.1 mmpt? -67.22 -32.18 73.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.474 -0.33 . . . . 72.44 111.69 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 130' ' ' ASN . 86.8 mt -91.09 -25.95 19.38 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.602 -0.439 . . . . 63.11 110.669 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.84 -59.7 1.72 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 116.306 -0.407 . . . . 64.11 113.707 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -99.91 26.68 6.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.126 0.488 . . . . 73.44 110.667 -175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 133' ' ' PHE . 62.6 t30 -85.07 87.26 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 53.34 111.751 -174.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -117.66 2.3 12.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.791 -0.641 . . . . 54.22 110.904 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.775 ' HB3' ' HB2' ' A' ' 89' ' ' PRO . 6.9 tp10 -113.47 8.26 17.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.179 0.514 . . . . 74.03 110.664 -174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' ' OD1' ' A' ' 130' ' ' ASN . 25.2 p90 -70.21 134.25 47.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.378 0.608 . . . . 75.2 111.726 -175.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' MET . 43.7 m-85 -93.66 142.36 27.43 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.034 -0.728 . . . . 60.25 109.034 173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.739 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 5.8 ppt_? -156.59 150.02 24.44 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.103 -0.639 . . . . 51.04 111.3 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 pp -123.39 151.09 42.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.676 -0.693 . . . . 73.51 110.03 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 98' ' ' GLU . 6.4 ptp85 -115.88 136.04 53.42 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.896 -0.593 . . . . 73.22 110.018 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 26' ' ' ALA . 44.9 mt -100.13 129.69 46.19 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.523 -0.547 . . . . 75.34 109.523 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -81.74 116.62 4.25 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 74.11 112.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.463 HD13 ' OD2' ' A' ' 97' ' ' ASP . 9.2 pt -120.96 -14.46 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.657 0.265 . . . . 52.15 111.472 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' PRO . . . -104.99 123.7 7.73 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.228 -0.986 . . . . 53.54 113.855 -167.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 4.4 p-80 -102.83 134.9 19.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.348 -0.612 . . . . 51.54 109.348 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 142' ' ' HIS . 37.3 Cg_exo -61.28 104.19 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.973 2.449 . . . . 73.04 112.922 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -120.37 -117.4 2.58 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.321 -0.712 . . . . 51.41 111.321 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -88.15 133.36 34.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.972 -0.381 . . . . 65.25 109.972 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -77.29 -26.33 52.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.929 -0.578 . . . . 74.44 111.442 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.05 -31.66 58.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.361 0.6 . . . . 74.21 110.442 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.1 mmtt -109.54 31.03 6.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 74.41 111.467 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 152' ' ' TYR . 15.8 m -49.63 -31.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.975 -0.557 . . . . 53.22 111.077 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.62 ' HA ' ' HB ' ' A' ' 153' ' ' VAL . . . -54.98 -24.59 24.78 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.985 -0.552 . . . . 54.34 112.123 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -59.35 -54.93 33.73 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.07 -0.586 . . . . 72.51 112.088 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 149' ' ' VAL . 1.7 p90 -85.06 -15.46 43.95 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.752 -0.263 . . . . 65.35 111.587 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 150' ' ' ALA . 41.6 t -77.75 -54.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 31.02 111.804 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HA ' HG23 ' A' ' 22' ' ' THR . 3.5 pp -135.24 13.4 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.945 0.72 . . . . 73.55 112.945 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.592 ' O ' ' HG3' ' A' ' 23' ' ' ARG . . . -78.09 -177.29 47.59 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.983 -1.103 . . . . 42.11 111.381 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.563 ' HE3' ' HG3' ' A' ' 21' ' ' LYS . 14.0 mptt -97.21 137.28 36.48 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.998 -0.742 . . . . 61.12 108.998 174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' HB3' ' HG2' ' A' ' 162' ' ' GLN . . . -97.33 131.77 26.72 Favored Pre-proline 0 C--N 1.322 -0.596 0 C-N-CA 120.996 -0.281 . . . . 72.21 111.143 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 157' ' ' ALA . 12.2 Cg_exo -71.05 170.38 18.25 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.761 2.308 . . . . 65.55 111.295 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 163' ' ' GLU . . . -46.76 -58.04 4.28 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.732 0.641 . . . . 72.41 112.732 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER -55.56 -33.87 64.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.826 0.306 . . . . 74.43 111.826 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 24.3 tp10 -81.6 -38.95 25.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.152 0.501 . . . . 74.23 110.072 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.505 ' HG2' ' HB3' ' A' ' 157' ' ' ALA . 10.5 mm-40 -66.98 -26.47 66.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.887 -0.597 . . . . 71.12 111.505 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 159' ' ' ALA . 49.8 mt-10 -67.36 -29.06 68.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.02 0.438 . . . . 74.43 110.196 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.55 -38.82 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 54.21 109.862 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.4 tp -67.4 -40.29 85.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 71.34 110.476 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.21 -27.31 69.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.677 -0.692 . . . . 73.01 111.347 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.77 74.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.12 111.033 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.515 ' HA ' ' OE2' ' A' ' 171' ' ' GLU . . . -68.24 -24.18 64.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.279 0.562 . . . . 62.35 110.687 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 29' ' ' TRP . 54.5 t -74.47 -42.85 49.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.756 -0.656 . . . . 74.11 110.059 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -56.78 -45.74 81.97 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.746 -0.661 . . . . 62.55 109.619 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.515 ' OE2' ' HA ' ' A' ' 168' ' ' ALA . 36.8 mt-10 -58.53 -56.47 21.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.294 -0.866 . . . . 61.21 110.626 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.6 t -56.18 -47.86 77.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.032 -0.986 . . . . 60.44 112.199 -172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.56 -34.42 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 112.853 0.686 . . . . 62.22 112.853 -173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -83.56 -26.15 30.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.664 -0.414 . . . . 60.12 111.901 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 191' ' ' LEU . 31.8 p -70.76 -24.79 62.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.976 0.361 . . . . 53.02 111.976 -173.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.438 HD13 HD11 ' A' ' 62' ' ' LEU . 44.5 mt -68.38 -30.27 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.168 -0.213 . . . . 62.3 111.565 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 181' ' ' LYS . 39.7 tt0 -70.26 -45.4 66.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.444 -0.576 . . . . 74.32 109.444 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.8 mm -62.03 -41.16 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.569 -0.742 . . . . 73.23 110.552 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.2 tt -55.35 -41.42 72.51 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.717 -0.674 . . . . 74.05 111.513 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 19.8 ptp -84.1 -42.54 15.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.682 0.623 . . . . 73.4 112.682 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -101.45 -17.99 16.2 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.323 0.86 . . . . 71.14 113.323 -172.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.92 -10.59 13.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.531 -0.467 . . . . 61.13 111.38 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 98.39 148.35 23.45 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.621 -0.8 . . . . 35.51 112.021 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 184' ' ' LEU . 2.5 pt? -64.41 -23.69 67.37 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.806 0.299 . . . . 74.2 111.806 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 11.7 p -67.68 -38.84 84.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.978 0.418 . . . . 54.11 111.208 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -67.67 -40.35 84.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 110.212 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -61.73 -43.71 98.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.773 -0.649 . . . . 42.13 110.094 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 108' ' ' PHE . 42.5 tp60 -57.8 -49.7 75.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.582 -0.736 . . . . 75.14 111.039 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.39 -44.28 92.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.471 -0.331 . . . . 75.45 110.68 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 190' ' ' ARG . 23.7 mmt180 -63.66 -50.49 69.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 75.1 111.196 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 74.5 mt -61.79 -44.54 96.66 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.324 -0.398 . . . . 74.44 111.406 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -71.95 -10.85 60.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.279 -0.419 . . . . 75.41 111.245 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.9 m -96.12 -37.9 10.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.569 0.223 . . . . 73.5 110.888 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -71.5 124.37 24.5 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.909 -0.404 . . . . 73.21 109.909 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -145.7 152.27 39.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.371 -0.377 . . . . 74.43 110.603 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -67.33 135.23 52.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.135 -0.484 . . . . 72.21 109.735 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 117.924 -1.036 . . . . 73.21 110.546 -178.178 . . . . . . . . 0 0 . 1 stop_ save_